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ABSTRACT 
Federal legislation designed to transform the U.S. healthcare system and the emergence 
of mobile technology are among the common drivers that  have contributed to a data explosion, 
with industry analysts and stakeholders proclaiming this decade the big data decade in healthcare 
(Horowitz, 2012). But a precise definition of  big data is hazy (Dumbill, 2013). Instead, the 
healthcare industry mainly relies on metaphors, buzzwords, and slogans that fail to provide 
information about big data’s content, value, or purposes for existence (Burns, 2011). Bollier and 
Firestone (2010) even suggests “big data does not really exist in healthcare” (p. 29). While 
federal policymakers and other healthcare stakeholders struggle with the adoption of Meaningful 
Use Standards, International Classification of Diseases-10 (ICD-10), and electronic health record 
interoperability standards, big data in healthcare remains a widely misunderstood phenomenon. 
Borgman (2012) found by “studying how data are created, handled, and managed in multi-
disciplinary collaborations, we can inform science policy and practice” (p. 12).  
Through the narratives of nine leaders representing three key stakeholder classes in the 
healthcare ecosystem: government, providers and consumers, this phenomenological research 
study explored a fundamental question: Within and across the narratives of three key healthcare 
stakeholder classes, what are the important categories of meaning or current themes about big 
data in healthcare? This research is significant because it: (1) produces new thematic insights 
about the meaning of big data in healthcare through narrative inquiry; (2) offers an agile 
framework of big data that can be deployed across all industries; and, (3) makes a unique 
contribution to scholarly qualitative literature about the phenomena of big data in healthcare for 
future research on topics including the diffusion and spread of health information across 
networks, mixed methods studies about big data, standards development, and health policy.
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CHAPTER I. INTRODUCTION 
Big data is a phenomenon of data usage closely linked to the "Information Age" (Heudecker, 
2013). The term is common to many industries, in which 15 of the U.S. economy’s 17 sectors, 
companies with more than one thousand employees, store on average more data than is contained 
in the U.S. Library of Congress (Brown, Chui, & Manyika, 2011). With the advent of health 
information technology (HIT), namely electronic health records (EHRs), big data in healthcare 
has emerged as a “natural resource” that could potentially revolutionize how we deliver 
personalized medicine and improve the health of populations. Consider the following vignette 
which describes a vision of the future of health and healthcare, fueled by big data: 
At the level of the healthcare consumer, “big data” facilitated health 
improvement by applying massive computational utilities and the profound 
knowledge of systems biology to rich data clouds around each person. The 
billions of bits in each cloud came from inexpensive microfluidic devices enabling 
nearly continuous testing of blood for circulating proteins with bio-monitoring 
devices that could interface with personal simulations to predict future wellbeing. 
By collecting a person’s genetic code, zip code and everything in between, these 
systems offered the capacity to predict when people were likely to get a major 
disease and to die. Personal avatars (digital health coaches) helped people 
recognize and leverage the extent to which their health was shaped by social, 
psychological, and behavioral factors. Most cancers were effectively preempted 
and managed by 2030. Former Type I and II diabetics now faced happier and 
longer lives due to the ability to grow and transplant pancreatic islet cells from 
pluripotent stem cells. Healthier communities, more effective personal healthcare 
and more sophisticated self-care decreased the demand for physician services and 
hospital care. In the eyes of many, the revolutionary transformation in both health 
and healthcare in the decades leading to 2032 was inevitable given the rapid 
diffusion of knowledge to an engaged population with a deeply held aspiration to 
be healthy.
1
 
                                                 
1
 Institute for Alternative Futures. Health and Health Care in 2032: Report from the RWJF Futures Symposium, June 
20-21. Alexandria, VA: Institute for Alternative Futures; 2012. http://www.altfutures.org/pubs/RWJF/IAF-
HealthandHealthCare2032.pdf 
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The aforementioned vignette is not merely a pipedream – it is a likely reality. But a major 
roadblock persists: the definition of big data is hazy (Dumbill, 2013) and remains a buzzword 
(Davenport, Barth, & Bean, 2012). While big data in healthcare fervently grows weekly by some 
unknown order of magnitude, the difficulties and realities of sharing, linking, visualizing, and 
using big data in healthcare are magnified.  
Research Question 
This study addressed an important research question: 
Q1: Within and across the narratives of three key healthcare stakeholder classes, what 
are the important categories of meaning or current themes about big data in healthcare? 
 While not usually a focal source of data for public policymaking, my intuition lead me to 
believe that ‘stories,’ or narratives, from the perspective of those who live the experience would 
yield rich, in-depth descriptions of the big data phenomenon in healthcare.  In large part, this 
study was inspired by the science of epidemiology which studies the origin, patterns, and spread 
of an epidemic. Eysenbach (2002) coined the research discipline, infodemiology, which 
“identifies areas where there is a knowledge translation gap between best evidence (what some 
experts know) and practice (what most people do or believe)” (p. 763) about the distribution of 
information and misinformation on the internet. In “An Epidemiology of Big Data,” this study 
aimed to determine the practical meaning about big data and fill the translation gap between 
what some experts know about big data offered through the wealth of ‘grey literature’ and what 
healthcare leaders believe through their  cohesive ‘lived experiences’ of the big data phenomena.   
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Healthcare at a Glance 
Recent estimates released from the Office of the Actuary at the Centers for Medicare and 
Medicaid Services (CMS) project that aggregate healthcare spending in the United States will 
grow at an average annual rate of 5.8 percent for 2012–22, or 1.0 percentage point faster than the 
expected growth in the gross domestic product (GDP). The healthcare share of GDP by 2022 is 
projected to rise to 19.9 percent from its 2011 level of 17.9 percent (CMS, 2012). Not to be 
confused with the life sciences, translational bioinformatics (Butte & Shah, 2011) or biomedical 
sciences, which produced the groundbreaking Human Genome Project that propelled the life 
sciences to the forefront of big data by generating approximately one terabase (trillion bases) of 
sequence data per month (Hey, Tansley, & Tolle, 2009), healthcare (or heath care) differs from 
other commodities because it is typically provided in a series of separate but related delivery 
episodes (Hornbrook, Hurtado, & Johnson, 1985; Lameire, Joffe, & Wiedemann, 1999) and can 
be thought of as a bundle of attributes (e.g., diagnosis, treatment, prevention of disease, illness, 
injury, appointments, technology, insurance) that vary in cost as well as importance to the buyer 
(Weisbrod, 1991). The bottom line in healthcare is cost savings, which have been extremely 
difficult to achieve in the absence of a major health system transformation. 
The healthcare system possesses a large and growing elderly population that threatens to 
push the pace of upward spiraling healthcare price increases even higher than their already 
faster-than-inflation rates.  Expensive medical treatments, end-of-life care, health inequities, new 
technologies, fraud and waste are just some of the intended and unintended expenditures that 
wreak havoc on healthcare delivery system budgets. Unchecked healthcare inflation creates ever-
larger federal budget deficits, and pushes up the embarrassingly large number of Americans 
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without adequate health insurance. Brown (2011) estimates potential “savings from big data in 
the sector could be upwards of $450 billion annually” (p. 2). This unprecedented potential for 
cost reductions within the healthcare system has captured the government’s imagination and 
attention, as over $200 million in new federal commitments were announced in an effort to 
improve the nation’s ability to manage, understand, and act on big data (Re, Nter, & Mill, 2012). 
Big data’s role in healthcare cost reduction is vital. To understand big data in healthcare, big data 
in a general context must first be understood. 
Big Data in a General Context 
Big data is not a new concept or idea; however, there is no clear definition for big data 
(Zaslavsky, Perera, & Georgakopoulos, 2013). The term "big data" originated as a tag for a class 
of technology with roots in high-performance computing, as pioneered by Google in the early 
2000s (Hopkins & Evelson, 2012). A representative search of the term big data from Google 
yields a multitude of references : Big data BANKS (Kates, 1969); Big data BASES (Boehm, 
1975); Big data FILTER (Ernst, 1976);  Big data POOL (Porth, Badke, & Mieth, 1982); Big data 
SETS (Kinnstaetter, Lohmann, Schwider, & Streibl, 1988). One of the earliest references to big 
data was found in a dissertation that used the term big data as a subject key. The dissertation 
topic considered the problem of the optimal hardware architecture for advanced data 
management systems (Neches, 1983). 
Every day, we create 2.5 quintillion bytes of data — so much that 90% of the data in the 
world today has been created in the last two years alone. This data comes from everywhere: 
sensors used to gather climate information, posts to social media sites, digital pictures and 
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videos, purchase transaction records, and cell phone GPS signals to name a few. This data is big 
data (Davenport & Jarvenpaa, 2008). Big data is routinely referenced in many industries 
including banking, defense, and oceanography, whose information technology and computational 
methods are mature and robust. Consumer retail has been a commonly cited industry that has 
taken advantage of big data’s benefits. Large retailers like Target and Wal-Mart have used big 
data to develop business intelligence on consumer shopping patterns and behavior. By assigning 
a unique identifier to each customer that uses a credit card, fills out a survey, or provides their 
phone number, retailers are able to employ sophisticated statistical models to create targeted 
marketing campaigns.  
The volume of stored information in the world is growing so fast that scientists have had 
to create orders of magnitude of data, including zettabyte and yottabyte, to describe the flood of 
data (Kuner, Cate, Millard, & Svantesson, 2012). The digital world is expected to hold a 
collective 2.7 zettabytes of data by year-end, an amount roughly equivalent to 700 billion DVDs 
(Hardy, 2012). As hardware and software advance, the capacities of large computational 
resources provide us with the only practical and reliable sense of what “big” means.  This is 
particularly characteristic in an emerging digital information economy, where clickstream data 
give precisely targeted and real-time insights into consumer behavior.  Our purchases, searches, 
and online activities are being tracked to improve everything from websites to social movements 
intended to democratize entire countries.  
Earlier mainstream notions of big data were limited to a few organizations such as 
Google, Yahoo, and Microsoft, which did not produce scholarly communications but did 
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produce reputable, credible marketing whitepapers found in the grey literature. Big data as a 
marketing and services tool has emerged as a profitable growth opportunity for many firms 
across industries. But there is a dearth of scholarly articles on big data, particularly in healthcare, 
as it has not been widely studied in academic circles; hence, many of the attempts to define big 
data are found in grey literature, including conference proceedings, briefing documents and 
sophisticated marketing materials that target buyers of services and goods. The following big 
data definitions sampled from mostly grey and some scholarly literature show just how wide-
ranging and troublesome it is to adopt a definition of the term “big data:” 
  “Big Data” is a science of fielding algorithms that enable machines to recognize complex 
patterns in data. It fuses machine learning with a very deep understanding of computer 
science and algorithms and that, of course, is key to being able to take machine learning and 
deploy it in a very scalable way (Paredes, 2012). 
 “Big Data” exceeds the processing capacity of conventional database systems. The data is too 
big, moves too fast, or doesn’t fit the strictures of your database architectures. To gain value 
from this data, you must choose an alternative way to process it (Dumbill, 2013). 
 “Big Data” is the ability to mine and integrate data, extracting new knowledge from it to 
inform and change the way providers, even patients, think about healthcare (Roney, 2012). 
 “Big Data” is not a precise term; rather, it’s a characterization of the never-ending 
accumulation of all kinds of data, most of it unstructured. It describes data sets that are 
growing exponentially and that are too large, too raw, or too unstructured for analysis using 
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relational database techniques. Whether terabytes or petabytes, the precise amount is less the 
issue than where the data ends up and how it is used (EMC2, 2012). 
 “Big Data” is the ability to collect, process, and interpret massive amounts of information. 
One of the biggest potential areas of application for society is healthcare (Rooney, 2012). 
 “Big Data” is a bubble just filled with hot air – at least for now. Everyone is talking about it 
but when you dig a bit deep with a pointed question, very quickly you discover that it has 
nothing much to do with the Big Data (Shah, 2013).  
 “Big Data” are datasets whose size is beyond the ability of typical database software tools to 
capture, store, manage, and analyze (Manyika et al., 2011). 
 “Big Data” is techniques and technologies that make handling data at extreme scale 
affordable (Hopkins & Evelson, 2012). 
 “Big Data” is more data than our current systems and resources can handle (Fogarty 2012). 
 “Big data” is an explosion of available information, a byproduct of the digital revolution (I. 
Thomas, 2013).  
 “Big data” does not really exist in healthcare settings (Bollier & Firestone, 2010). 
 “Big Data” n: the belief that any sufficiently large pile of s--- contains a pony (Arbesman, 
2013). 
Recent trends suggest big data is a philosophy: an organizational culture that embraces the 
complexities of integrating, analyzing and transforming vast amounts of data into a valued 
organizational asset.  Young (2012) suggests “big data is only applicable to life and biomedical 
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sciences research and not capable of adding value to the bedside delivery of healthcare, where 
patient encounters are counted - not petabytes” (p. 8). 
Big Data in Healthcare 
It is an impossible task to accurately count the number of patient encounters and 
transactions because of the current fragmentation of the care delivery system and the abundance 
of information technology platforms that do not interact. Big data in healthcare is slowly 
changing with the advent of system development approaches, wireless grids, and semantic web 
technologies that are highly compatible with widely distributed systems. The expansion of digital 
technology is capable of synthesizing data sources from other industries including housing, 
transportation, and social services to create an explosion of data in every aspect of an 
individual’s personal health profile.  
Big data will enable the notion of personalized medicine, which provides physicians with 
a comprehensive understanding of a person's health and genomic makeup, rather than relying on 
a superficial understanding of other patients' histories (Horowitz, 2012).  Underlying the data’s 
sheer volume are valuable relationships among datasets and social networks, implying that data 
integration can expose new information that was not discoverable in the past. 
What has changed dramatically in the last twenty years is that computers have become 
more mobile, creating a robust mobile health (mHealth) industry where it is commonplace, if not 
necessary, for clinicians to carry handheld devices into exam rooms. Millions of smartphones, 
tablets, and other portable devices are generating and consuming data of increasing variety. 
Clinicians continue in 2013 to adopt mobile computing devices at a rapid rate, with nearly ninety 
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percent expected to use smartphones in 2014 and almost as many using tablets.
2
  Microsoft’s 
Google Glass is gaining a reputation as a potential disruptive innovation. The wearable device is 
now deployed during certain surgical procedures and outpatient visits and is not as impersonal 
and distracting as a handheld device. The masses of small, mobile devices represent enormous 
computational capacity; albeit each individual physician typically generates or consumes a 
modest amount of data.   
Big data is a challenge for industries such as defense, transportation, and banking. For 
healthcare it is even more formidable largely because patient data records cannot be so easily 
collected and freely shared; there are all sorts of technical, ethical, and public policy barriers to 
making such liquid data – liquid (Bollier & Firestone, 2010). Healthcare data remain in silos, 
fragmented and distributed across thousands of physician offices, hospitals, and clinically-
integrated delivery systems that themselves are composed of autonomous units (L. R. Burns et 
al., 2002). The real revolution is not in the machines that calculate the data but in the data itself 
and how we use it (Mayer-Schönberger & Cukier, 2013).  
Healthcare’s Big Data Drivers  
Bringing intelligent healthcare informatics to bear on the national problems of improving 
healthcare (Robertson, Dehart, Tolle, & Heckerman, 2009), reducing healthcare costs, and 
improving quality and health outcomes relies on an ability to take raw data and transform it into 
information that becomes knowledge for decision making. This is what fundamentally drives big 
data in healthcare. The next section provides a brief, but important acknowledgement of three 
                                                 
2 Data taken from Epocrates’ Mobile Trends Report based on a survey of 1,063 clinicians in May 2013. Internet 
Source: http://www.healthdatamanagement.com. 
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significant drivers beyond cost reduction pressures of big data in healthcare: health information 
technology, federal healthcare legislation, and healthcare consumers. 
Health Information Technology (HIT) 
The advent of health information technology (HIT) is expected to improve the 
management, analysis, and deployment of a tremendous amount of granular-level, patient-
centered data. For instance, a possible transition to International Classification of Disease – 
Version 10 (ICD-10) will require physicians across all clinical specialties to transition from 
20,000 codes under ICD-9 to 155,000 under ICD-10 – an almost eight-fold expansion.
3
 In an 
information-rich healthcare industry, basic HIT interoperability is still a daunting problem. Even 
with HITECH legislation that encourages widespread adoption of HIT across all healthcare 
settings including physician practices, hospitals, and laboratories, there are different scales of 
data, both structured and unstructured, that do not have the ability to connect on a single 
platform. Much of medical knowledge and information remains in paper form. And even where 
data is digitized, it often resides in disparate datasets and repositories in diverse formats. 
It is expected that through the adoption of HIT an extraordinary amount of structured and 
unstructured data will be generated, requiring a new level of computational strength and 
synthesis. As such, this data can be used as information to create knowledge to inform healthcare 
providers, consumers, and policymakers alike about topics ranging from highly complex 
questions at the point of care to pandemic forecasting.  
                                                 
3 McKesson. Source: http://sites.mckesson.com/achievehit/files/ICD-10_FAQs_McKesson.pdf  
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With EHRs slowly filtering into physician practices, it is the data - and lots of it - that has 
healthcare thought leaders and visionaries anticipating the threshold moment of “Healthcare 
Singularity” (Buchan, 2009), when healthcare knowledge becomes instantaneous (remember the 
2032 vignette?). When data was once considered tedious to manage and costly to store big data 
is now considered an asset to both individuals and organizations. Although the potential of new 
laws that promote information technology interoperability across stakeholder classes and 
consumer demand for “liberated” data on the health of communities are exciting, the spread and 
diffusion of medical knowledge is slow (Porter & Teisberg, 2006).  
Federal Healthcare Legislation 
Healthcare is a highly regulated field, with various laws guiding how healthcare data is 
used and reported (Sullivan, 2011). Healthcare legislation designed to reform an inefficient 
healthcare “system of systems” has been at the forefront of presidential political agendas for 
decades.  Over the past ten years, several major bodies of healthcare legislation have been 
enacted to provide Medicare beneficiaries with Part D drug plans, which closes the metaphorical 
“donut-hole” prescription coverage gap that describes the variance between initial drug coverage 
limits and catastrophic drug coverage thresholds; the Health Insurance Portability and 
Accountability Act (HIPAA) has standardized the exchange of essentially all healthcare 
transactions between physicians, hospitals and their business partners while also providing 
guidance on patient privacy and systems security; and, the Patient Protection & Affordable Care 
Act (Affordable Care Act), which is the most sweeping body of legislation since Medicare was 
introduced over 45 years ago, will introduce, among many patient protections, innovative 
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payment and coordinated care models designed to provide high quality healthcare at lower costs, 
rules against insurers dropping patients because of pre-existing conditions, and eliminates 
lifetime limits on medical expenses. The Affordable Care Act identified a host of old 
(administrative) and new (streaming) datasets (Figure 1) that must be collected, managed, and 
reported by healthcare stakeholders.  
 
Figure 1.A sample of structured and unstructured datasets collected under healthcare reform. 
Source: Patient Protection & Affordable Care Act 2010 
 
Though the new healthcare landscape promises to provide high quality, cost effective 
care to millions of new beneficiaries through federally-mandated Health Insurance Marketplaces 
and to people with preexisting health conditions, the deluge of data will certainly test the 
system’s ability to collect, store, and analyze big data. Still, there is skepticism that federal 
policies thus far have blunted big data’s potential in the public sector (Konkel, 2013). 
13 
 
 
Although the government has a long history of making biomedical science data available 
to the public, the Obama Administration’s Open Government Initiative has motivated federal 
agencies to make a wider variety of data available to “citizen scientists” at www.data.gov.  This 
website has the potential to create a secondary market for visionaries, researchers, and 
entrepreneurs to create new tools and knowledge for many stakeholders including healthcare 
consumers who lately have been inclined to provide open access to their personal health records. 
Consumers of Health and Healthcare 
A new healthcare information economy has materialized. Healthcare consumers now 
demand a new scale of data liquidity enabled by EHRs, laboratory information systems, 
medication-management systems which are interoperable with their personally controlled health 
records (PCHR) where they independently decide (Mandl & Kohane, 2008) when and with 
whom they share their individually identified health information.
4
 Healthcare consumers must 
now become researchers, or “citizen scientists.” However, beyond initiatives like Blue Button® 
Connector, which provides a limited number of Medicare beneficiaries access to historical 
claims data, access to the tools and information on par to the sophistication and rigor of that 
afforded to policymakers and providers allowing, them to better manage their own healthcare in 
the new health information economy is at best, scant. While some healthcare consumers so 
happen to be highly skilled data scientists, the masses do not have the necessary technical skills 
                                                 
4
 The Health Insurance Portability & Accountability Act (HIPAA) which includes provisions for protection of 
individually identifiable health information (formerly protected health information (PHI)) does not apply to patients who 
wish to share their own health information.  
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or even the requisite health literacy (and e-health literacy) skills to harness big data for basic 
healthcare decision making. 
Healthcare is growing rapidly in terms of the quantity and quality of data that is collected 
on a daily basis. The problem is that this data is growing faster than the consumers can use it. As 
the world’s population increases, the health and healthcare data problem will be exacerbated. 
Healthcare consumers are facing the challenge of not only selecting the best care for themselves 
and their families, but doing it in a cost effective manner based on the best available healthcare 
information and clinical evidence-base.  
The once skeptical healthcare patient engagement movement is slowly gaining 
momentum with the advent of technological innovations such as wireless grids, semantic web 
applications, and social networking approaches that revolutionize the way healthcare consumers 
collaborate, identify potential collaborators or friends, communicate with each other, and identify 
information that is relevant for them (Eysenbach, 2008). These tools will produce better ways for 
consumers to take charge engaging with physicians, government, and other healthcare 
stakeholders to reduce wasteful spending and improve population health.  
Big data also enables personalized medicine, which provides physicians with a 
comprehensive understanding of an individual's health, environmental, and genomic makeup, 
rather than relying on a superficial understanding of other patients' histories (Horowitz, 2012). In 
order for healthcare consumers to be effective participants in a reformed healthcare landscape, 
they require information from trusted, third-party sources. The Health 2.0 movement makes a 
uniform attempt to provide collaborative approaches to engaging healthcare consumers through 
credible information. For instance, Dr. Gunther Eysenbach coined the term “apomediation,” 
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which encompasses a socio-technological information seeking strategy where people rely less on 
a traditional intermediary, such as a pharmacist giving relevant information to a patient. The 
difference between an intermediary and an apomediary is that an intermediary stands “in 
between” the consumer and information. In contrast, apomediation means that there are agents 
(e.g., people, tools) that “stand by” to guide a consumer to high quality information and services 
without being a prerequisite to obtain that information or service in the first place. While these 
distinctions are not absolute (in practice, there may be a mix of both, with people moving back 
and forth between apomediation and intermediation models), it has been hypothesized that they 
influence how people judge credibility (Eysenbach, 2008). 
Who are the key healthcare stakeholders? 
From Congress who drafts healthcare legislation to patients who require evidence-based 
information to inform their treatment decisions, there are many stakeholders with an interest in 
the delivery of h. The Agency for Healthcare Quality and Research (2014) defines healthcare 
stakeholders, “as persons or groups that have a vested interest in a clinical decision and the 
evidence that supports that decision. Healthcare stakeholders include: patients, caregivers, 
clinicians, researchers, advocacy groups, professional societies, employers, and policymakers” 
(p. 11).  
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Figure 2. The many classes of healthcare stakeholders of the reformed healthcare ecosystem 
It is a highly complex task to understand the interrelationship between many healthcare 
stakeholders of the ecosystem (Figure2). At a very basic level, an episode of care is initiated 
when a patient (stakeholder) initiates and follows through on a scheduled appointment to interact 
with a provider (stakeholder) for clinical consultation and treatment of an ailment or illness. This 
simple scenario does not even take into account whether the patient has employer-based 
insurance or is a beneficiary of a public healthcare entitlement program, such as Medicaid or 
Medicare. The scope of events that precede and succeed a single patient encounter entails 
synchronization of care coordination, data collection and analysis, information generation and 
exchange, and knowledge in the form of policies, procedures, evidence-based medicine, and 
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provider report cards – underpinned by HIT. The point being, a single patient episode, regardless 
of its level of complexity, requires collaboration and exchange of information from as few as two 
to a multitude of additional healthcare stakeholders.  
Data Sharing 
Data sharing is complex and inconsistent within and across the many classes of 
healthcare stakeholders and are frequently hampered by the lack of foolproof de-identification 
for patient privacy, as data reside in many discrete data systems. The lines in Figure 2 depicts 
information technology interoperability where all stakeholders share their big data in a common 
data repository, creating massive amounts of data for healthcare decision making, shared 
knowledge for learning systems, and consumer choices. While such data repositories may exist 
locally or regionally, no such national data warehouse exists.  
This issue alone impedes opportunities for data mining and analysis that would enable 
precise predictive and preventive medicine (Robertson et al., 2009). The use of EHRs is 
producing more data-in-depth healthcare environments in which substantially more data are 
captured and transferred digitally, flooding stakeholders with data, generating an urgent need for 
new techniques and tools that can intelligently and automatically assist in transforming (Fayyad 
et al, 1996) big data into better information for decision making. 
An analysis of healthcare stakeholder classifications typically included federal, state, and 
local policymakers who create rules and regulations, consumers who demand healthcare 
services, and providers who supply healthcare services either at a cost or through charitable care. 
These three key healthcare stakeholders are central to achieving the industry adopted Triple Aim 
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of improving the experience of care, improving the health of populations, and reducing per capita 
costs of health (Berwick, Nolan, & Whittington, 2008). Grossmann (2010), in an Institute of 
Medicine series wrote, “by providing greater insight to patients, providers and policymaker[s] … 
data hold the potential to help transform the U.S. healthcare system” (p. 69).  
 
Figure 3. Information flow along the healthcare information value chain 
These core health system classes are situated at the center and both ends of the healthcare 
value chain: government (producers), providers (deliverers) and consumers (users) (Figure 3). 
The implementation of EHRs has contributed to a data rich healthcare environment in 
which substantially more data are now captured and transferred digitally, generating an urgent 
need for new analytical techniques and information management tools that can intelligently and 
automatically assist in transforming (Fayyad et al., 1996) big data into better information for 
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decision making. Yet, the three stakeholder classes that are the focus of this study have different 
goals and hopes for big data (Feldman, Martin, & Skotnes, 2012). An assessment of the 
readiness of the three key stakeholder classes was explored: 
 Government: As the largest producer of open source data for public use, government is a 
key contributor to the generation of information needed to achieve cost efficiencies in 
healthcare. Through government supported data initiatives like Healthdata.gov, providers, 
consumers and other healthcare stakeholders can have reasonable access to raw data for 
making choices about treatments (Clancy, 2006). Yet, government leaders struggle with 
the sheer volume of data they seek to manage.5 They lack a systematic approach to 
classifying and sharing quality, cost, and outcome data with other interested participants 
of the delivery of healthcare. Also, what is the proper and practical role for government 
in the face of a deluge of digital data (Kuner et al., 2012)?  
 Providers: They most frequently use data for healthcare delivery, value-based purchasing, 
and EHR reporting incentives. However, they often lack sufficient data aggregation 
and analysis tools to capture data and turn it into usable knowledge. The general 
perception is physicians are not prepared to use big data at the point-of-care for decision-
making.    
 Consumers: Consumers produce the bulk of big data. There is often an abundance of 
information available, but much of it is irrelevant to the decision-making process. Little 
is actually known about what kinds of data and information consumers need to 
                                                 
5
 Tech America Foundation Report (2012) Demystifying Big Data: A practical guide to transforming the business of 
government. http://www-304.ibm.com/industries/publicsector/fileserve?contentid=239170  
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make decisions (Edgman-Levitan & Cleary, 1996). Currently, consumers have more 
mobility, live longer lives and, healthcare is more shared than ever before. Consumers 
have little control within the contour of big data in an undefined, unregulated data 
environment. Ethical issues such as privacy, trust, and informed consent loom as major 
big data barriers.  
Collectively, triangulating the perceptions of these three “key” healthcare stakeholder classes 
represent an optimal starting point to understand the phenomenology of big data in healthcare. 
This research study is about discovering the important categories of “meaning about” big data in 
healthcare verses the “meaning that” which many theoretical frameworks, including Grounded 
Theory, Information Diffusion Theory, or Dewey’s Theory of Experiential Learning seek to 
ground or test research data. However, a short discussion of information sharing provides the 
necessary breath to understand big data in the context of healthcare. Value chain analysis in 
healthcare provides an intriguing framework that encompasses the vertical and horizontal 
integration of the strategic relationships and information sharing among healthcare stakeholders. 
In the next section, I introduce an aspirational value chain framework: An epidemiology of big 
data. 
An Epidemiology of Big Data 
Value chain analysis originally sought to examine the operations of a manufacturing 
enterprise by looking at the value or cost of inputs in terms of the value or price of outputs. In a 
typical value chain, money, products, services, information, or other goods are multilaterally 
exchanged between two or more participants. L. R. Burns et al. (2002) describes the value chain 
as “a virtual network designed to help move a produce (information) from the producer 
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(government) through an intermediary purchaser (provider), and eventually down to the 
consumer. However, in healthcare, a value chain framework “represents more aspiration than 
reality” (p. 11) because of its many “broken links.” Similarly, in epidemiology the “chain of 
infection” posits that for an infection to develop, each link of the chain must be connected. 
Breaking any chain of the link can stop the transmission of the infection. Analogous to the 
epidemiological chain of infection, in healthcare, information generated by big data might 
typically spread among healthcare stakeholders, at least in theory. When a link in the value chain 
that characterizes big data and information sharing in healthcare is broken, evidence-based 
medicine is unachievable.  
To express the origin, incidence, spread and control of information derived from big data 
shared between healthcare stakeholders, a notional and aspirational value chain framework, “an 
epidemiology of big data,” is potentially an important aspect of the big data “contagion” in the 
healthcare ecosystem. In the context of big data analyzed into information for knowledge, such a 
notional framework suggests that big data in healthcare evolves into information that is 
multilaterally spread among healthcare stakeholders, creating commodity value each time big 
data is exchanged and is “kinetically energized” by  the “invisible hand” of efficient organization 
which is embodied in metadata (Zeng & Qin, 2008).  
 An epidemiology of big data is not a construct of an IT system. Information derived 
from organized structured and unstructured data (big data) whose value is presumably increased 
(or decreased) through standardized multilateral knowledge and information exchange among 
and between all healthcare stakeholders, creating value add and ultimately healthcare intelligence 
for policymaking, decision-making, and care delivery (Table 1). In short, data’s value needs to 
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be considered in terms of all the possible ways it can be “spread” by members along the 
healthcare information value chain, not simply how it is used for its initial use (Mayer-
Schönberger & Cukier, 2013; Porter & Teisberg, 2006).  
STAKEHOLDERS GOALS CONCERNS 
Consumers • Understandable Clinical 
Information 
• Improved Data mobility 
• Improved decision making 
Better care coordination 
• Access to care 
• Affordable care 
• Security and privacy of 
personal data 
• Trustworthiness 
Providers • Performance based 
payments 
• Reduced administrative 
paperwork 
• Improved care 
coordination 
• Business Intelligence for 
ACOs 
• Additional regulations and 
paperwork requirements 
• Increased uncompensated 
care 
• Data Quality 
• Malpractice 
 
Government • Program Integrity 
• Quality Measures 
• Better health outcomes 
• Lower healthcare costs 
• Budget for infrastructure 
change 
• Prioritizing resources 
• Value-Based Purchasing 
Table 1. Information Goals and Concerns of Key Healthcare Stakeholders 
Collectively, little is known about how much key healthcare stakeholders really know 
about the magnitude of big data challenges and whether consumers are even aware of big data, 
much less how to leverage it for their own benefit. To support this claim, I immersed myself in 
an extended review of the literature which provided contextual background and supported 
identification and refinement of the research question and research problem (Ridley, 2009).   
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CHAPTER II. LITERATURE REVIEW 
This chapter describes the processes I used to conduct the literature review and identifies 
results and emergent themes derived from scholarly and grey literature. This information served 
as a backdrop to the data collected from the in-depth interviews. The literature review is 
foundational for an phenomenological research study; the literature does not guide and direct the 
study but serves as an aid once patterns or categories have been identified (Creswell, 2009). The 
preliminary literature review that began January 2011 underwent several revisions through 
March 2013. A modified systematic literature review (Frehywot et al., 2013; Mays, Pope, & 
Popay, 2005) was used to provide structure. In this research study, An Epidemiology of Big Data, 
an extensive reference list of scholarly (87) and grey (1,380) literature was reviewed and 
assessed for validity and usability.  
The questions, context, and content of healthcare management and policy are generally 
broader and more diffuse than those of the clinical world (J. L. Bellamy, Bledsoe, & Traube, 
2006), requiring the use of ‘grey literature’ in this study. Web of Science/MEDLINE alone 
cannot be used to effectively gather data about social science and humanities citations (Hutton, 
2009). The broad function of the literature review for policy relevant research is to help decision 
makers see and conceptualize the breadth of issues and broad models that can inform decision 
making about a policy problem. Reviews can involve a policy problem that has remained 
unchanged for years or it can involve a policy problem that is likely to emerge in the future. 
Increasingly, health policy decision makers and professionals are turning to research-based 
evidence to support decisions about policy and practice (Bell 2006).  
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Lomas (2005) concluded that historically, “policymakers are less commonly seen as a 
target audience for systematic reviews” (S1:36). Such rigorous literature reviews are relegated to 
clinical research. This approach is changing; the discipline of “systematic-type” reviews has 
filtered into policymaking, though not in the format or approach found in comprehensive 
systematic reviews.  
Mays (2005) found “there is no single agreed upon approach” (p. 1) to policy-related 
systematic reviews. But in answering policy questions, policymakers and managers will often 
need to draw on diverse sources of evidence – not only quantitative and qualitative research, but 
also other evidence such as expert opinion and explicit value judgments (Mays et al., 2005).  
A Dearth of Scholarly Literature 
While the grey literature on big data has exploded with vendors adding the term “big 
data” to marketing materials just to drive hype (Hopkins, 2011), there is a shortage of scholarly 
works, and therefore, we are no closer to defining the term for stakeholders to make sense of its 
true potential and application. In a Google search (09 Sept 2013), the term “big data” generated 
over 9.1 million hits. Most of the literature addressed big data collected and synthesized for 
providers while touching on big data in government including its policy implications (Konkel, 
2013) and its funding prowess (Leinweber, 2011; Re et al., 2012). Consumer-related big data 
research is almost nonexistent, as little is actually known about what kinds of data and 
information consumers need to make decisions (Edgman-Levitan & Cleary, 1996).  
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Modified Systematic Literature Review Approach 
The modified systematic literature review for gathering, summarizing, and synthesizing 
published and unpublished research is narrower than state-of-the-evidence reviews, but broader 
than traditional systematic reviews and may include not only published and unpublished 
research, but also published and unpublished non-research literature (Benzies et al, 2006). A 
systematic review essentially summarizes the best available research on a specific question by 
using transparent procedures to find, evaluate and synthesize the results of relevant study 
questions. The methodological approach to modified systematic reviews found in Mays et al 
(2005, p.9) study was adapted for this proposed course of research (Table 2).  
COMPONENT RESULT 
Explicit research question Within and across the narratives of three key 
healthcare stakeholder classes, what are the important 
categories of meaning or current themes about big data 
in healthcare?  
Explicit search strategy 
 
 
 
Search Web of Science/MEDLINE and Scopus on the 
search string: "big data"[All Fields] AND 
"healthcare"[All Fields]. Limitations are animal science 
related articles and the availability of free articles and 
citations. 
Explicit statement about what 
types of research evidence 
were included and excluded 
Continue to refine selection criteria that contain “big 
data” and “healthcare” in peer-reviewed journal 
articles, systematic reviews, government supported 
research, and meta-analysis. Also the discovery of new 
themes and keywords are the objective. 
Critical examination of the 
quality of the studies included 
in the review 
Examine relevancy to research question as reviewed in 
journals and authors frequently appearing in searches; 
examine relevancy of citations. 
Critical and transparent process 
of interpretation of the findings 
of the review:  
Assess applicability to the “delivery of healthcare" and 
identify a proven method of qualitative content 
analysis.  
Table 2. Five components of the modified systematic literature review 
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Where peer review is a key part of the systematic literature review process (Thyer & 
Myers, 2011), in this modified approach, I chose to forgo this important  activity due to time 
constraints. I instead relied mainly on the credibility of the journal’s peer review process.  
Peer-reviewed scholarly literature that met the aforementioned criteria was identified by 
electronically searching the following resource databases: Web of Science/MEDLINE (Syracuse 
University Library) and Scopus.
6
 Google Scholar was used to identify additional sources of 
scholarly and grey literature when Web of Science/MEDLINE or Scopus did not produce links to 
full text articles. Hutton (2006) found that “considering Web of Science, Google Scholar, Google 
and Web link information, through a varied approach to gather citations produces unique, 
relevant instances of the use of grey literature” (p. 12). Target literature included books 
(electronic and print) and scholarly articles on the primary search string and Boolean operator: 
"big data"[All Fields] AND "healthcare"[All Fields]. This approach was used to restrict the 
search to potential articles of interest and covered all possible combinations. Other key indicators 
were added as the literature review was refined. The term “large data sets” was often found in the 
literature but was not used in this study so to maintain consistency with the study term, “big 
data.”  
Investigator-led systematic reviews appear to be a clear method of progressively focusing 
and refining analyses so that policymakers (Lavis et al., 2005; Tranfield, Denyer, & Smart, 
2003), providers and consumers will find the resulting information both persuasive and usable.  
                                                 
6 At the time, PubMed was searched; however, no requisite citations were found. 
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Systematic Review Challenges 
As an emerging scholar-practitioner in healthcare, there are material challenges of 
employing a “less than summative systematic review” as found in Cochrane Collaboration 
Studies in epidemiological and economic research on clinical care. The first challenge is to 
minimize bias (Benzies et al., 2006). Systematic reviews provide specific methodological 
requirements, explicitness, and transparency in regard to the specific research question  (Lomas, 
2005) that helps to mitigate researcher bias. Another major challenge that persists with 
systematic reviews is to gain credibility (Lomas, 2005) among academic researchers, who firmly 
embrace the rigidity of gold standard scholarly methodological approaches. As with grey 
literature, scholar-practitioners must weigh whether the advantages outweigh the challenges of 
employing such methods. The intent with this research is to mitigate all bias by adopting an 
approach that is replicable and proven to researchers and policymakers in the discipline.  
Grey Literature Approach 
In credible, scholarly research, the use of grey literature should only be used in two 
contexts. First, grey literature could be used to supplement and triangulate information from 
empirical scholarly literature that meets the gold standard for evidence. A second way of treating 
grey literature is to trace the experience of a community and its policymakers with a particular 
policy problem (Bell, 2006). This research study utilized both approaches where applicable, with 
the goal of supplementing the scholarly literature found in the modified systematic literature 
review. The prevalence of the term big data in conference proceedings, corporate marketing 
materials, newspapers, and blogs provided needed breadth and depth to frame and understand the 
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definition, growth, and uses of big data in the absence of scholarly citations in peer-reviewed 
journals related to the subject. Grey literature was searched using Google and Google Scholar 
databases and was limited to consultancy reports, government briefings, conference proceedings, 
web articles, white papers, dissertations, newspapers and blogs from major corporations that are 
known to produce high quality industry sector documents. 
While not customarily the target of Cochrane Collaboration-style research, increasingly, 
health policy decision makers and other allied health professionals are turning to research-based 
evidence to support decisions about policy and practice. Decisions about whether to include grey 
literature in a state-of-the-evidence review are complex (Bell, 2006). To reduce the complexities 
of using grey literature, the following criteria were used to evaluate the grey literature cited in 
this study: 
 Source of the Report: Grey literature was from reputable consulting firms that conduct 
extensive industry studies in big data, from IBM, McKinsey, Forrester, Deloitte, SAS, 
Becker’s Hospital Review and Microsoft will be included. 
 Transparency of Methods: Data and other types of information about where the report came 
from, how it was analyzed, and how the final report was compiled were accessible.  
 Currency: Consultancy reports, government briefings, conference proceedings, web articles, 
white papers, dissertations, newspapers and blogs were sourced between January 2010 and 
April 2013.
7
  
                                                 
7
 Source: http://guides.library.upenn.edu/content.php?pid=286667&sid=2454523 
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Article Selection Criteria 
A two-step process to select literature was used.  First, an independent screen of titles, 
keywords and abstracts (when available) of search results was carried out to ascertain if a 
document met the general inclusion criteria. Subsequently, an independent assessment was 
conducted of the full text file of each source based on the predetermined inclusion and exclusion 
criteria. This review was limited to published references that directly described (1) big data in a 
broad context to capture wide variations in its definition and application across industries and (2) 
big data with a specific magnitude, to capture the specificity of themes in the healthcare-related 
literature.  Additional constraints included removing citation only references, and veterinary-
related (e.g., animal science) research.  
Aggregate results from the systematic review and the grey literature searches were 
entered into a Thomson Reuters Endnote x6 Reference Manager ® bibliographic management 
database and sorted by themes and important categories described in the following section. 
Preliminary Literature Search 
A preliminary literature search was conducted through Web of Science/MEDLINE and 
was used exclusively to initiate the modified systematic literature review approach to capture the 
scholarly literature. A secondary search was conducted in Scopus to find reputable articles from 
additional peer-reviewed journals in which the full-text of the article was available. An analysis 
was conducted of duplicate documents and relevance. Where no full text or abstract was 
available, I searched Google Scholar and found many of the PDF and HTML files used in this 
dissertation thesis. Google was searched to find select grey literature based on the inclusion 
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criteria (consultancy reports, government briefings, conference proceedings, web articles, white 
papers, dissertations, newspapers, and blogs from major corporations that are known to produce 
high quality industry sector documents). Initial searches on the three databases led to an 
inclusion of documents procured from U.S. Federal Government administered websites. 
Results from the Literature Review 
The literature search began with use of the following search terms and Boolean operator: 
"big data"[All Fields] AND "healthcare"[All Fields].  Through the Web of Science/MEDLINE 
database, 87 documents were found in peer-reviewed healthcare management related journals 
(69). Government research support, reviews, letters, and editorials (18) constituted the balance of 
the documents found. Prevalent research areas were computer science (25), medical informatics 
(19), and healthcare science services (17). However, the most unanticipated research area that 
tied for second (19) was information science/library science. Journal articles specifically focused 
on research or life science disciplines including bioinformatics, genetics, biology, and 
engineering, or non-health related disciplines, including computer science and information 
science. Other areas of inquiry on big data are found in the energy and aerospace industries. 
Because of the paucity of results, a second search was performed with the key indicator 
of "big data"[All Fields] only, using the Web of Science/MEDLINE database. The return was 
significantly larger, yielding 562 articles in various journals, including Sensors, National 
Academy of Science and Journal of Animal Science. The journals on computer science had a 
wealth of information on big data. Also conference proceedings were rich in usable information. 
During the literature review, the term “big data” was still trending in healthcare. A review of my 
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results from the Web of Science/MEDLINE search found no author who emerged as a thought 
leader on the big data phenomena. The following argument table (Table 3) justified the 
fundamental reasoning for conducting this study. 
ARGUMENT STEPS RELEVANT  REFERENCES 
Big Data is exploding in healthcare (Cukier, 2010; Dumbill, 2013; Feldman et al., 
2012; Lomas, 2005; Villars, Olofson, & Eastwood, 
2011) 
Big Data has been slow to adapt in 
healthcare 
(Porter & Teisberg, 2006; Young, 2012)   
Big data in healthcare requires a 
clear definition and subsequent 
taxonomy 
(Brown et al., 2011; Brynjolfsson & McAfee, 
2011) 
Stakeholders are central to the 
healthcare information value chain 
(L. R. Burns et al., 2002; Gorman, 1995)  
Dialogue between policymaker 
social scientist, and consumer 
(healthcare information value 
chain) must grow 
(L. R. Burns et al., 2002; Dumbill, 2013; 
Leinweber, 2011; Lomas, 2005; Porter & Teisberg, 
2006; Roper, Winkenwerder, Hackbarth, & 
Krakauer, 1988) 
Metadata is fundamental to big 
data, interoperability, and 
information exchange in healthcare  
(Burns, 2011; Gantz & Reinsel, 2011; Parsons et 
al., 2011; Pavolotsky, 2012) 
Drawing together published 
literature, ‘grey’ literature, decision 
maker’s experience, and 
researcher’s knowledge and 
experience make the best practice 
and policy decisions 
(Lavis et al., 2005) 
Data scientist and trusted 
apomediation are necessary; data 
scientist profession consists of 
many titles, some of which have 
existed for years in healthcare 
(Brown et al., 2011; Chen, Chiang, & Storey, 
2012; Davenport & Patil, 2012; Eysenbach, 2008) 
Table 3. Argument chart to conduct phenomenological study 
32 
 
 
The initial search was organized into four themes: “Big Data,” “Drivers,” 
“Methods_LitReview,” and “Methods_Qualitative.” As I conducted a deeper analysis of the 
literature through citation analysis to discern themes, additional categories emerged, including 
“Stakeholders,” “Data Scientist,” “Privacy,” “Ethics,” ”Narrative Medicine” and “Metadata.”  
These categories shaped the refinement and development of a credible research question.  
The process of arriving to a very clear and concise research question was an iterative process that 
took skill and time. The literature presented a compelling case to conduct this research.  
Most articles included in this study mentioned big data in the context of healthcare 
delivery.
8
 In some cases, the general application of big data across industries where the term has 
matured was used for definitional purposes. Additionally, bibliographies of all documents 
retained (peer-reviewed and grey literature) were reviewed as part of a “snowballing” technique 
to find further relevant resources, including other documents and applicable websites. In all, over 
200 documents are included in the review. 
Analyzing the Evidence 
There is a strong correlation between the categories of “Big Data,” “Information 
Sharing,” and “Stakeholders.” This seems like a logical relationship, but patients within the 
consumer stakeholder class were often left out of the information value chain; I believe there is 
great potential for further study on this topic. The notion that “modern medicine is an 
information science” (Hood & Friend, 2011; Litvin, Cavanaugh, Callanan, & Tenner, 2008) is 
                                                 
8 The term “healthcare” was often used as part of a reference list of industries where big data is or could be used. The 
context of the article was not directly related to healthcare. These articles were eliminated. 
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intriguing and is viewed or articulated in different ways: “personalized medicine, information-
based medicine.”  
The master codes that synthesize across categories are: 
 Big data (large data sets) 
 Information Sharing 
 Metadata 
 Stakeholders (focusing on “patient” as the stakeholder) 
The initial categories/columns helped me to organize the main points of each article and 
provide a map which I used to look back to either further study the work of the authors cited or 
find literature where I found potential gaps. As I scanned the literature a second and third time, I 
found some additional codes:  
 Computation & Analytics 
 Data quality 
 Knowledge management 
 Privacy (HIPAA) 
 Data Scientists  
Observations from the Literature Review and Emergent Themes 
The modified systematic review of the literature on “big data” and “healthcare” produced the 
following initial cohesive observations: 
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 There is a dearth of scholarly research on big data in healthcare. This is significant because 
of the exponential growth in healthcare data types, the volume of data, and the speed at 
which data flows. Further inquiry requires rigorous study. 
 The gulf between “life sciences” and “healthcare” is closing – fast. Big data is entrenched in 
life sciences research, including genetics, biomedical research, computational biology, and 
nanomaterial science. However, these advances are quickly making their way into point-of-
care decisions (e.g., shared physician and consumer decisions about treatment plans).  
 There is no consensus on what big data means in healthcare. Depending on the stakeholder, 
big data has different meaning, even within stakeholder classes. This makes achieving an 
interoperable platform almost impossible. Of the many big data definitions in both scholarly 
and grey literature, only one article was found that attempted to define “big data in 
healthcare” big data refers in the healthcare context to longitudinal medical claims data for 
millions of patients linked to their EHRs (Begley, 2011). 
 Consumers do not have enough trustworthy, credible information to understand the scope 
and depth of big data and its impact on their health and healthcare.  
 Patient informed consent and privacy regarding the use of an individual’s big data are as 
challenging to overcome as interoperability of HIT. 
 Data Scientist is a generic term that requires no unique skill beyond that of a statistician. In 
fact, depending on one’s need for big data, a basic level of education will suffice (e.g., citizen 
scientist).  
 Industry and marketing firms have dominated the proliferation of big data through 
conference proceedings, marketing materials, white papers, and blogs. 
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Based on the grey literature, there were six dimensions to big data that conveniently began 
with the letter “V”. Gartner, the information technology and advisory firm, captured the 
industry’s attention by introducing the popular “3 V’s” of big data - Volume, Variety, and 
Velocity. The table below (Table 4) provides an inclusive overview and characteristics of the six 
dimensions of big data that are noted in various documents in both scholarly and grey literature.  
CHARACTERISTIC DEFINITION 
High Volume (G) Enterprises are awash with ever-growing data of all types, easily 
amassing terabytes—even petabytes—of information. 
 Turn 12 terabytes of Tweets created each day into 
improved product sentiment analysis. 
 Convert 350 billion annual meter readings to better 
predict power consumption. 
High Variety (G) Big data is any type of data - structured and unstructured data 
such as text, sensor data, audio, video, click streams, log files 
and more. New insights are found when analyzing these data 
types together. 
 Monitor 100’s of live video feeds from surveillance 
cameras to target points of interest. 
 Exploit the 80% data growth in images, video and 
documents to improve customer satisfaction. 
High Velocity (G) Sometimes two minutes is too late. For time-sensitive processes 
such as catching healthcare fraud, big data must be used as it 
streams into an enterprise in order to maximize its value: 
 Scrutinize 5 million trade events created each day to 
identify potential fraud; 
 Analyze 500 million daily call detail records in real-time 
to predict customer churn faster 
Veracity  One in 3 business leaders don’t trust the information they use to 
make decisions. Establishing trust in big data presents a huge 
challenge as the variety and number of sources grows.  
Value 
 
Value in healthcare is the health outcome per dollar of cost 
expended (Porter & Teisberg, 2006). 
Variability 
 
A variety of formats as opposed to just one relationally 
structured data set (Hopkins & Evelson, 2012). 
Table 4. Six Characteristics of Big Data, Including Gartner’s 3 V’s  
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The review of the literature demonstrated that scholarly journals in Web of 
Science/MEDLINE provided relevant scholarly works about big data in healthcare compared to 
select grey literature. A possible reason for the lack of literature includes publication lags: grey 
literature found in industry cycles through peer review much faster than scholarly journals. 
Companies providing solutions in information technology, engineering, and other science-based 
firms have a mission to drive revenue and can quickly publish marketing research and other 
materials (e.g., white papers, conference proceedings, blogs, etc.). Companies have sought to 
capitalize on a subject few outside of their disciplines understand. The literature review was 
continuously revisited and refined throughout the course of this study for accuracy and relevancy 
and to ensure adherence to required elements of the modified systematic review standards.    
The next two subsections of this chapter are important themes that emerged from the 
literature review: metadata and data scientist. A third theme, privacy, also stood out, but requires 
a full research paper to do justice on this very important topic. The intent is to provide a brief 
overview and discussion of these important themes. While I did not expect the key healthcare 
stakeholder narratives to capture the full essence of these two themes, each topic serves as 
important background information to the interpreted ‘story’ that this research study produced.  
Metadata 
At the very core of HIT interoperability is metadata. The Office of the National 
Coordinator for Health Information Technology (ONCHIT) issued an advanced notice of 
proposed rulemaking (ANPRM), which solicits public comments on the metadata standards. 
Metadata standards provide guidelines regarding structure, values, and content (Zeng & Qin, 
2008). The metadata standards under consideration relate to: 
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 Patient Identity Metadata – These metadata relate to patient identity and include: a 
patient’s name; date of birth; address; zip code; and relevant patient identifier(s).  
 Provenance Metadata – These metadata would be used to provide information on the 
“who, what, where, and when.” Provenance metadata would include: a tagged data 
element (TDE) identifier; a time stamp; the actor; and the actor’s affiliation.  
 Privacy Metadata – Privacy metadata would include a policy pointer and content 
elements descriptions such as data type (e.g., consultation note) and sensitivity (AMIA, 
2011). 
Metadata is foundational to healthcare data trustworthiness. Various sources of big data 
are generated by all key healthcare stakeholders who have the potential to create unimaginable 
amounts of data from structured and unstructured sources of data. Where administrative claims 
data (e.g., financial, procedure codes, place of service, demographics, etc.) were once the 
primary source of data for healthcare decision making, the underuse of unstructured sources of 
data puts organizations at a severe competitive disadvantage. Data quality and origination loom 
large in the reformed healthcare market. With competition for healthcare consumers and limited 
financial resources, healthcare organizations, including hospitals, Accountable Care 
Organizations, and technology vendors must share data and knowledge to remain viable. 
Systems integration, or interoperability, of fragmented information systems is the conduit to 
information sharing among stakeholders. While it is believed that the Volume, Velocity and 
Variety of big data are unmanageable, data about data, or metadata, is growing twice as fast as 
the digital universe as a whole (Burns, 2011). 
 Fundamentally, metadata helps interpret and transform data into information (Gudea, 
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2005). One kind of metadata is provenance (also referred to as lineage and pedigree), which 
tracks the steps by which the data was derived and can provide significant value addition in such 
data in-depth e-science projects (Simmhan, Plale, & Gannon, 2005). Metadata in the form of 
provenance information records the how, where, what, when, why, which, and by whom of data 
generated in a scientific experiment (Sahoo, Sheth, & Henson, 2008). Metadata provenance is 
broadly referred to as a description of the origins of a piece of data and the process by which it 
arrived in a database. Most implementers and curators of scientific and healthcare databases 
would like to record provenance metadata, but current database technology does not provide 
much help in this process. Databases are typically rigid structures and do not allow the kinds of 
ad hoc annotations that are often needed for recording provenance in an EHR and personal health 
record environment (Acar et al., 2010). Better understanding of how to create, harvest, and 
exploit metadata is a very near-term problem to be addressed by today’s information 
management professionals. New capture, search, discovery, and analysis tools can help 
organizations gain insights from their unstructured data, which accounts for more than 90% of 
the digital universe (Burns, 2011). 
 Data Scientist 
The term data scientist is a generic term that includes business analyst, data architect, 
engineer, and research analyst. Indeed, with the rapid increase in the Volume and Variety of 
health information, clinicians that interact with information systems departments are in high 
demand and the chief medical informatics officer (CMIO) and chief nursing informatics officer 
(CNIO) are recent additions to the ranks of data scientists. Even with these developments, 
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demand for data scientists has raced ahead of supply. The shortage of data scientists is becoming 
a serious constraint in some sectors. 
Roper (1988) suggested in his seminal article on data and health information that “the 
science of healthcare evaluation, still in its formative stages, requires certain resources: money, 
data, and people trained in the evaluative sciences, such as statistics, mathematical modeling, and 
epidemiology” (p. 3). The data scientist has received an excessive amount of attention with the 
emergence of big data. The definition of data scientist has many connotations. The National 
Science Foundation (2006) identifies the following capabilities as core to the role of the data 
scientist: 
 conduct creative inquiry and analysis; 
 enhance through consultation, collaboration and coordination the ability of others to conduct 
research and education using digital data collections; 
 be at the forefront in developing innovative concepts in database technology and information 
sciences, including methods for data visualization and information discovery; 
 implement best practices and technology; 
 serve as a mentor to beginning or transitioning investigators, students, and others interested 
in pursuing data science; and, 
 design and implement education and outreach programs that make the benefits of data 
collection and digital information science available to the broadest possible range of 
researchers, educators, students, and the general public. 
Harvard Business Review touted the data scientist as the sexist job of the 21
st
 Century 
(Davenport & Patil, 2012). The U.S. alone will need 140,000 to 190,000 people with deep 
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analytical skills by 2018 just to keep up with the pace of innovation (Brown et al., 2011) and the 
explosion of big data. As big data emerges as a driver of value (Porter & Teisberg, 2006) for 
public and private sector companies across every industry, analytics is a competency required for 
essentially every position.  
Pryor and Donnelly (2009) identified four data analytic roles: data creator, data scientist, 
data manager, and data librarian. They acknowledge that “in practice, there is not yet an exact 
use of such terms in the data community, and the demarcation between roles may be blurred” (p. 
160). In their definition of these four roles the crucial words “training” and “formal 
qualification” are for the most part absent. Data creators are described typically as researchers 
who have acquired a high level of expertise in handling and manipulating data; data scientists 
appear to be working closely with data creators and may be involved in creative inquiry and 
analysis; and, data managers tend to be computer scientists, information technologists, or 
information scientists who have taken responsibility for the facilities necessary to store, access, 
and preserve data. Data scientists understand analytics, but they also are well versed in IT, often 
having advanced degrees in computer science, computational physics, biology, or network-
oriented social sciences (e.g., social network analysis). Their advanced data management skill set 
— including programming, mathematical, and statistical skills, as well as business acumen and 
the ability to communicate effectively with decision makers — goes well beyond what was 
necessary for data analysts in the past. This combination of skills, valuable as it is, is in very 
short supply (Davenport et al., 2012). 
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CHAPTER III. METHODOLOGY  
Study Design 
This section describes the research design, data collection methods, and analysis 
approach used to conduct a phenomenological study using narrative (Clandinin, 2013; Amedeo 
Giorgi, 2009; M  Van Manen, 1980), with the aim of discovering important categories of 
meaning about big data in healthcare through the insights and perspectives (Cyr & Reich, 1996) 
of three key healthcare stakeholder classes. To allow the study participant narratives to remain 
the focus of this study, a more detailed description of the research methodology can be found in 
Appendix A. 
In exploratory qualitative research, social phenomena are investigated with minimal a 
priori, or presumptive, expectations in order to develop explanations of a phenomena (Guba & 
Lincoln, 1985). I contemplated grounded theory or another theoretical framework, but decided 
against doing so since exploratory qualitative research does not rely on the creation or adoption 
of a conceptual framework where the abstraction of the subject to be studied may alter or even 
not capture the most important characteristics to be analyzed (Guba & Lincoln, 1985). Rather 
than being constrained by a structured framework, I chose to stay true to the tenets of 
phenomenology, which allowed a cohesive ‘story’ to emerge from the frequent, dominant, or 
significant themes inherent in the raw data (D. R. Thomas, 2006). As such, this method required 
me to be able to thoughtfully, and unbiasedly, interact with the participants of the study and to 
better understand their individual and collective experiences (Creswell, 2009).  
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A purposive sampling strategy, which allowed me to exercise my expert judgment with 
inclusion and exclusion of study participants, was used to identify the best healthcare 
stakeholders to provide “thick descriptions”(Creswell, 2009; Geertz, 1973; Guba & Lincoln, 
1985) about the big data phenomena in healthcare. The literature review complemented the 
discussion, description, and interpretation of the participant’s stories.  
Study participant narratives were analyzed using a general inductive approach for 
qualitative data analysis (D. Thomas, 2003). This study produced three important contributions 
to the understanding of big data in healthcare: (1) thematized experiential knowledge about the 
meaning of big data in healthcare; (2) produced an agile definition of big data that can be 
deployed across all industries; and, (3) added to the dearth of scholarly qualitative literature 
about the phenomena of big data in healthcare for future research on topics including the 
diffusion and spread of health information across networks, quantitative studies, standards 
development, healthcare value chain analysis, and health policy. 
As a rising scholar-practitioner who has been deeply immersed in many traditional and 
innovative practices of generating evidenced-based methods in healthcare including integration 
of patient preferences (Sackett, Rosenberg, Gray, Haynes, & Richardson, 1996), randomized 
clinical trials, and quasi-experimental studies, my current interests in big data in healthcare are 
exploring phenomena through multidisciplinary narratives (e.g., government, providers, and 
consumers) and subsequent scientific analysis of the collective data to ultimately inform further 
health policy. The results of this study confirm a natural collaboration and research agenda 
between the disciplines of information science and health policy, as medicine adopts the 
discipline of information science (Hood & Friend, 2011; Lester, Zai, Grant, & Chueh, 2008).   
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Such an approach resonated with my curiosity about the social and lived experiences of 
individuals who use and rely on big data as information and knowledge to meet their 
professional and organizational objectives. Borgman (2012) suggests “that by studying how data 
are created, conceived, handled, managed, and curated in multi-disciplinary collaborations, we 
can inform science policy and practice. Data are the ‘glue’ of collaboration, hence one lens 
through which to study the effectiveness of such collaborations is to assess how they produce 
and use data” (p. 7). This study was designed to answer the following research question: 
Research Question 
Q1: Within and across the narratives of three key healthcare stakeholder classes, what 
are the important categories of meaning or current themes about big data in healthcare? 
Study Influencers and Rationale 
In addition to the construct of epidemiology, my approach to this research study was 
initially influenced by a study design used in Cyr and Reich (1996), Scaling the Ivory Tower: 
Stories from Women in Business School Faculties, which provided powerful detailed narratives 
about “women’s personal choices, trade-offs, risks and chances that unfolded as they built their 
careers in competitive academic organizations” (p. 1). Independently, each story chronicled 
women in various stages of their academic career: early-career, mid-career, and leaders in 
academia. Most compelling to me is that aggregately, their stories were the impetus for action, 
policy change and influence for other women in academia and other fields facing the same trials 
of overcoming personal and professional challenges and the satisfaction of fulfilling dreams. 
Summaries of each story followed their narratives and a brief snapshot of each contributor, 
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recurrent themes, interesting issues or challenges, and the lessons learned from their collective 
experiences was provided in a final summary chapter. This important study provided a 
“methodological blueprint” to guide my study approach to answering the study’s research 
question. I am hopeful I executed their methodology with the same rigor and preciseness. 
As I began a deeper dive into the practical application of big data in healthcare, I was also 
strongly influenced philosophically by an emerging social dimension to medicine: narrative 
medicine. Traditionally, healthcare organizations have used troves of quantitative data (e.g., 
laboratory values), qualitative data (e.g., text-based documents and demographics), and 
transactional data (e.g., a record of medication delivery) to understand a clinical phenomenon of 
interest. Narrative medicine “describes the practice of medicine supported and reinforced by the 
ability to listen to, absorb, and act on stories” (Charon, 2006, p.1). I contacted Dr. Rita Charon at 
Columbia University. Dr. Charon is considered the foremost authority on narrative medicine. I 
believe our conversation was mutually informative; her perspective influenced my ideology 
about healthcare narratives which is fundamentally different from narrative medicine, which Dr. 
Charon describes as “a private conversation between a patient and a skilled physician.” I posited 
that healthcare narratives have a theoretical orientation that applies narrative inquiry skills 
across and between all healthcare stakeholders involved. Narrative skills are those that enable 
one person to receive and understand another person’s story, including the skills needed to listen 
actively, to understand what another person’s story means, to attain a complex and accurate 
interpretation of the story, and to grasp the situation of the other person and their perspective, in 
all of its complexity (Roscoe, 2009).  
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The next chapter provides details on the data collection procedures and each study 
participant “lived experience” of the big data phenomena in healthcare.  
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CHAPTER IV. DATA COLLECTION  
This chapter contains a review of the data collection procedures and the data collected 
from the semi-structured interviews of the nine study participants. For an in depth description of 
the methodology, see Appendix A. 
 The unit of analysis is the narrative – narratives of individuals that have shared 
experience with the phenomena (Creswell, 2009) of big data in healthcare. Study participants 
were identified through a purposive sampling method. Semi-structured interviews were 
conducted with a total of ten key healthcare stakeholders: three policymakers; three providers; 
three consumers (advocates); and, one healthcare leader with a global perspective across the 
three healthcare classes (Figure 4). However, the global perspective interview (BasInt1) was 
omitted because it did not meet the established parameters described in the Interview Guide and 
eventually created a fourth stakeholder category that fell outside of the study design. Thus, nine 
interviews were used as part of the data explication, results, and discussion.  
Sampling Frame 
Boyd (2001) regards “two to ten study participants” (p. 93) as sufficient to reach 
saturation and recommends “long interviews” (p. 95).  
 
Figure 4. Interview sequence of selected healthcare stakeholders 
47 
 
 
Most studies of narratives are based on small samples, fewer than 50 cases (Bernard, 
2006), simply because there is so much work involved. I chose cases on purpose – not randomly 
– dividing the sampling frame into three strata (e.g., government, providers, and consumer 
advocates). I selected three study participants within each stratum to capture their experiential 
narratives. This method allowed me to discover, describe, and interpret in detail themes, 
challenges, and categories of meaning that were similar and different across the subgroups 
(Teddlie & Yu, 2007). This sampling method is not to be confused with quota sampling, in 
which the researcher decides on the subpopulations of interest and on the proportions of those 
subpopulations in the final sample (Bernard, 2006). This was a small study that fit the purposive 
sampling approach.  
Snowball Sampling as a Supplemental Strategy  
When necessary to mitigate the risk of study participants falling out of the study, I relied 
on snowball sampling, which produced a sample of study participants through referrals made 
among people who shared or knew of others who possessed the same characteristics that are of 
interest to this research (Biernacki & Waldorf, 1981). Snowball sampling as a supplementary 
sampling strategy was invaluable as it allowed me to capture a geographically disperse study 
participant sampling frame but also required me to slightly modify the study design’s data 
collection method from exclusively face-to-face interviews to a mix of both telephone and Skype 
interviews. Such a modification was appropriate because the study did not require me to elicit 
emotions and body language through observation – only study participant narratives. 
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Recruitment 
Key informants are people who know a lot about their culture and are, for reasons of their 
own, willing to share all their knowledge (Bernard, 2006). It is critical to be certain of the 
knowledge and skill of the informant when doing purposive sampling, as inappropriate 
informants will render the data meaningless and invalid (Tongco, 2007). During the recruitment 
phase, I made initial verbal inquiries through email, phone, and in-person, with sixteen potential 
study participants who met the following selection criteria (Table 5). 
  POLICYMAKER  PROVIDER CONSUMER  
Title Senior Executive 
Service (SES) (ES – 
Level I - Level V)  
Upper management 
MD or DO 
Register Nurse  
Manager 
Hospital Executive 
Director 
Executive Director 
Chief Executive 
CIO 
Responsibility Provide leadership 
in a federal or state 
healthcare agency 
that provides or 
supports the 
development of 
national healthcare 
policy 
Provide senior 
executive leadership 
for a large integrated 
delivery system, 
accountable care 
organizations, or 
hospital 
Provide executive 
leadership  in a 
recognized 
patient/consumer 
entity; Advocate for 
healthcare issues or 
part of a multi-
advocacy agenda  
General Criteria 
across the three 
stakeholder 
classes 
 Be of at least 18 years of age and be willing to participate in a 
qualitative research study; 
 Have at least ten (10) years of work experience in a healthcare 
related field;  
 Currently represent a federal government, provider, or consumer 
advocate organization, in the healthcare sector; 
 Possess a working to expert knowledge of “big data” and 
“healthcare” and possess in-depth insights into the current 
challenges and future opportunities for big data in healthcare; 
 Fully participate in both initial and follow up interviews; 
 Be willing to speak freely and engage in a conversational, two-
way in-depth interview sharing rich, detailed narratives about 
professional “lived experiences” in big data and healthcare. 
Table 5. Selection criteria based on a purposive sampling strategy 
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CHAPTER V. KEY HEALTHCARE STAKHOLDER ‘STORIES’  
To maintain the confidentiality of each study participant’s name and professional 
organization, I assigned a unique code for analysis and a pseudonym generated by an online tool 
to each study participant and provided a general description of the type of organization where 
each is employed. Each study participant’s pseudonym is found under the title of their story. To 
further protect their identities, I deleted any references to their educational institutions, board 
appointments, research centers, and proper names of colleagues mentioned in their respective 
narratives. I also omitted references to geographic locations that appeared in the narratives. 
Before offering the key healthcare stakeholder narratives, below is a brief profile on each study 
participant categorized by their respective key stakeholder class. 
Study Participant Profiles 
Government Stakeholders 
Mr. Peter Erazo is a director at a federal government agency. His role is to provide 
leadership, strategic vision, and execution around data, data analytics, and data dissemination. 
He has held a variety of healthcare roles. 
Dr. Myles Renneker is a director at a federal agency. After completing medical school, he 
was assigned to work on projects dealing with quality, patient safety, and electronic health 
records. Beyond his medical education, he earned an M.B.A.  
 Dr. Matthew Blocher is a senior fellow at a government agency. His education is mostly 
in mathematics, physics, and chemistry.  After graduation he began working in the life sciences 
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industry and has been conducting research for more than two decades. As a healthcare thought 
leader he directs various scientific projects. 
Provider Stakeholders 
Dr. Nickolas Thompson is chief clinical information officer (CCIO) of a regional 
integrated delivery health system. His primary responsibilities are to sequence the health 
system’s technology and optimize the data analytics of the organization.   
Dr. John Boyken is an associate dean at a medical school. After medical school, he 
became very interested in informatics and computers and the role that information technology 
and information management would play in healthcare. 
Dr. Barry Jensen is the chief quality officer at an integrated delivery system. He leads 
research that has an immediate impact on care delivery operations within the delivery system.    
Consumer Stakeholders (Advocates) 
Dr. Darwin Watkins is executive director of a patient-centered healthcare organization. 
He earned a medical degree and a master’s in epidemiology. After epidemiology training, he 
became the director of a research department at a regional health maintenance organization. 
Dr. Arnold Daniels is executive director of a non-profit patient advocacy organization 
that helps patients find money to pay for medical co-pays and premiums. He completed a doctor 
of pharmacy degree and has a master’s degree.  
  Dr. Frances Milburn is medical director at a patient-centered quality association. His 
responsibilities include oversight of clinical informatics and quality improvement. With a public 
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health background, his medicine background complimented work in chronic illness care from a 
population health perspective.   
 
The following table (Table 6) is a brief summary of study participant’s profiles: 
 
CLASS TITLE ORGANIZATION TYPE EDUCATION 
Government Director Federal Agency Statistics 
Government Director Federal Agency Medicine/M.B.A. 
Government Senior Fellow Federal Agency Math/Physics 
Provider CCIO Integrated Delivery System Medicine 
Provider Associate Dean Teaching Hospital Medicine 
Provider Chief Quality Officer Integrated Delivery System Medicine/Physics/Biostatistics 
Consumer Executive Director Patient Research Medicine/Epidemiology 
Consumer Executive Director Nonprofit  Pharmacy/Research Methods 
Consumer Medical Director Quality Improvement Medicine 
Table 6. Profile of study participants occupation and education 
Study Participant Narratives 
The following study participant a priori narratives on big data in healthcare are presented 
in the study participants own words. The interview data was abridged without losing the essence 
of their stories. To reiterate, pseudonyms and generalizations of people, places and organizations 
were used to strictly protect the identity of each study participant. Narrative titles were chosen 
from the study participants own words that best demonstrated the spirit of each ‘story.’ 
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 “A Whole Heap of 1’s and 0’s” 
“Peter Erazo, M.S.” 
Professional and Academic Experiences 
Mr. Peter Erazo is a director at a federal government agency. His role is to provide 
leadership, strategic vision and execution around data, data analytics, and data dissemination. 
He’s held a variety of healthcare roles. 
Meaning of Big Data 
I think that frankly the expression of big data has become a little overused. I personally 
prefer the term “smart data,” but if we are talking about big data it’s traditionally defined by 
volume, variety and velocity.  Again, I think for that breakdown I think you can have many, 
many important data driven activities that contain some but not all of these.  I think obviously the 
rapidly emerging technologies in this area do allow people to crunch ever larger numbers of data 
in helping us bridge the gap between structured data analysis and unstructured data analysis, 
which I think is very important. 
I think big data in healthcare can manifest itself in a number of ways. We can get the data 
to market quicker whether that’s for internal analysis or distributing it to people externally.  So, 
big data could mean getting researchers data that is weeks old instead of years old.  Big data 
could mean routinely giving providers granular information of the beneficiaries they treat instead 
of shrugging your shoulders and not being able to do anything about it.  Big data could be large 
scale hypothesis free data mining to maybe find an insight to correlations that weren’t available.  
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Big data could mean the integration of administrative clinical and other patient generated data.  
So, it means lots of things in my mind. 
I think the jury is still a little out, again to the extent that big data helps inform clinical 
files as far as effectiveness and real operational type medical decision making.  Then, yes, I think 
it can help evidence-based medicine. As far as the attributes of big data that are different from 
traditional analysis, again, I think it’s the ability to quickly secure in an agile manner to combine 
different datasets and have developed insights that we may not have from administrative data 
alone.  So part of that is storage and part of it is new data matching techniques. 
Medicine as an Information Science 
I’m not sure I’m qualified as a non-clinician, but yes. 
Healthcare Big Data Drivers 
Practically one of the biggest drivers of big data in health care is the Affordable Care Act 
because what it does is places data and the ability to harness and leverage data at multiple points 
throughout the healthcare ecosystem at the center as opposed to at the trenches.  Data used to be 
a byproduct of healthcare delivery. Now for successful healthcare delivery and healthcare 
transformation, data, it used to be you could almost argue it needs to be the center  with 
providers and beneficiaries orbiting around it or at the very minimum it needs to be on the same 
level as what was previously considered the other core components in healthcare delivery,  
clinical knowledge, etc. 
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Sources of Data and Data Scientists 
The sources of data that we use are pretty varied even though I’d say that administrative 
data is the foundational component.  It actually meets the volume and the variety criteria we use 
records for multiple parts of the Medicare system, the Medicaid system, the enrollment data, 
hospital data, physician data, assessment data, laboratory data, Medicare data, and Medicaid 
data.  I know we’d obviously be interested in adding other paired data to the mix. Then there’s 
survey data and there is some pretty rudimentary Meaningful Use attestation data but we don’t 
have any actual Meaningful Use data yet.   
We’re working hard to integrate quality data for the various cooperative reporting 
mechanisms and it’s important we get a reliable clinical data stream we’d obviously be interested 
in incorporating that.  So, that’s what we work with.  Again, everybody’s conception of big data 
is different.   
I have people who manage big data for me. I have a team of skilled data scientists who 
are part IT knowledge, part systems integrator, part subject matter experts, part analyst 
programmer; a data scientist isn’t necessarily one person.  You have a data scientist practice in 
which people specialize but talk to each other but you might have somebody doing the IT 
integration stuff and another separate subject matter expert and another programmer.  So to put it 
in perspective, again, I know that some people consider big data not to be “big” until it’s in the 
trillions, but we manage 400 billion discrete pieces of information that talks to each other pretty 
well and pretty efficiently, and it’s growing by about four or five billion data records a year. 
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Organizational Challenges 
I think the main challenges are cultural and leadership for this agency to truly transition 
to data-driven decision making.  The impetus or the commitment is at the very top and its other 
people’s sense that the commitment is not there.  Ultimately, data driven decision making won’t 
gain traction.  Another challenge to data driven decision making is that occasionally government 
agencies are not necessarily in control of their own destiny and they may be subject to external 
political pressures that render data driven-decision making moves.  These are the biggest 
challenges. 
Unintended Consequences 
I think one of the unintended consequences in the case that I have seen is that people 
think that big data is a panacea and again this gets back to the mix of human capital that you 
need to integrate big data successfully into your enterprise.  I think there’s a mistakenly held 
belief, not necessarily at my agency, but you know among other aficionados of big data that if 
you just install a minute stack that everything will magically be solved.   
I think another unintended consequence is purely relying on machine learning without the 
application of subject matter expertise and also the application of a clearly defined set of goals 
can lead to an organization of big data actually distracting an organization from its core goals 
and outcomes. 
Big Data’s Future in Healthcare 
I think everybody’s hope is that in five years’ time, there will be widespread integration 
of administrative, clinical and patient generated data that will be available through big data; it’s 
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assuring that the right person gets the right data at the right time and the right format for them. 
So it will be a big plus for analytic purposes directly to patients if that’s appropriate to providers, 
etc. while obviously obeying all privacy laws and regulations.  So the one thing I know very little 
about is that people tend to get excited about biometric data. I’m not even sure I know enough 
about biometric data to get excited about it.  But I know when people talk about big data they 
mention that a lot.  I think also integrating device interoperability and the data that comes from 
medical devices is potentially very important. 
Metaphors and Symbols 
People like buzzwords but there’s no question that we’re dealing with great volumes and 
types of data than we ever have before, and we have the tools to deal with it.  I think that the true 
challenge is you can have all the data in the world but until you translate it into actionable 
information, it’s really just a whole heap of 1’s and 0’s. 
Closing Thoughts 
I think big data is an area of incredible promise for healthcare that is also currently 
fraught with hype and over promising.  So there will be hits, there will misses, and hopefully 
again in five years’ time, we’ll have a lot better idea of what exactly we should be doing with all 
this data.
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“Mapping the Knowledge Base of Medicine” 
“Myles Rennaker, M.D.” 
Professional and Academic Experiences 
I’m a physician by training. I had a mandatory service requirement and was assigned to 
work on projects dealing with quality, safety, and electronic health records. I became very 
interested in that and I went to business school instead of going back into residency thinking that 
there were many things that were going to change about healthcare, including increasingly 
information technology changing healthcare which was apparent even back in those days and the 
whole quality issue became fascinating to me – how you actually measured clinical performance. 
I’m interested in the issues of quality, safety, and how you can use IT to enhance the quality and 
safety of care including through electronic health records.  
Meaning of Big Data 
What big data means to me is just using information technology to analyze databases that 
have large units of whatever it is, whether it’s patients or accounts, or customers – just getting 
beyond small scale and having very large volumes of data to analyze.  Nobody’s ever defined it 
for me. I’ve heard it used a lot and I guess that’s what I’m thinking it means. I would also say 
that I never thought about it until you asked me. I just assumed that I sort of knew what it was. 
The advent of our increasing capacity to store things and the processing speed has 
allowed us to do things that were very hard to do even a fairly short time ago.  I can remember 
working with computers and processing stuff where it would actually go overnight and at least in 
the realm I’m familiar with you don’t have to do that very much anymore, you can process so 
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many transactions, so many records in such large databases and it’s so fast that I think that has 
ushered in the concept of big data.  I do think that to some extent big data has become the latest 
buzzword, the latest fad, the latest craze, and to some extent I don’t know how much new there is 
in big data other than the fact everybody is getting excited about it. At many conferences they 
talk about big data as if suddenly somebody invented big data and then came along and it’s a 
new thing.   
It really is an evolutionary thing and I think that it has a potential to perpetuate a myth 
that persists in IT generation after generation:  That if somehow information technology can sell 
substance problems that people haven’t put their minds to, the computer just does what you tell it 
to do and if you haven’t solved the problem of structuring the analysis right, the computer is 
going to do it for you.   
An example is the electronic health record where we’re very poor at structuring clinical 
information so we come along and we turn everything into electronic form and we somehow 
expect that electronic records to solve all our problems and it doesn’t do that unless you think 
through how you’re going to structure the data before it goes in and what everybody else is 
doing.  You’re going to have big data and right now there are over 2,000 records that have been 
certified by CCHIT as meeting the Meaningful Use Stage One criteria and they’re all written in 
different languages, different interfaces, different databases and they can’t talk to each other.  So 
it’s kind of a mess. 
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Medicine as an Information Science 
It’s clearly an information science.  If you’re going to treat a patient you’re going to use 
symptoms of the patient, you’re going to use physical findings from an exam, you’re going to 
use laboratory values, you’re going to use imaging, and those are all data. But at the same time 
they don’t all get put into a computer and processed to get the answer.  The computer is not a 
human brain and while we have computers that attempt to match many of what people do, much 
of what doctors do we don’t have computers that can do all that doctors can do and that final step 
of processing, especially in complicated cases really needs to take place in the human mind, but 
it is processing of data for sure.   
So I would say yes it’s an information science, but it’s one that has not been entirely 
encompassed by man-made; it’s aided by man-made IT. 
Healthcare Big Data Drivers 
I don’t think big data has had the kind of impact in healthcare that it’s had in other 
industries and that doesn’t mean I don’t think it can down the line, but I think we haven’t 
structured the information in healthcare to the extent necessary to allow big data to have the kind 
of impact it will potentially have on the future and it’s not an indictment of the healthcare 
industry.  So many people are critical of healthcare and say healthcare is in the 18
th
 Century and 
healthcare is extraordinarily complex. I was giving an international speech in Europe. While I 
was talking about measuring quality and safety somebody got up and asked me, ‘well why don’t 
you do it just like a bank has an ATM,’ and I didn’t laugh but I felt like it.  I just said because 
everything isn’t an integer, it’s not as simple as a balance sheet or income statement, or a 
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checking account. It’s a whole different ball game and the relationship between processes and 
outcomes in healthcare is not totally defined. You can give the same drug to two patients in the 
same way, the same age, the same diagnosis and they’ll react differently, and it’s just we’re not 
making patients.  
I mean in most other industries, the service is defined by the industry or is produced by 
the industry, we’re dealing with patients that are highly complex organisms which in some 
respects, many respects, black boxes. We know something about them, but we don’t know how 
they’re going to react to everything and they have many complicated problems and it’s all 
underneath the surface and we have to do diagnostic tests to get a little bit of it. So healthcare is 
enormously complex and so it’s just a whole different realm.   
It’s not like big data allows the retail industry to behave differently just by the volume of 
processing because we’re still not processing things that are very elementary in other industries 
because we haven’t structured the knowledge to be able to go into the computer.  For instance, 
I’ll give you a concrete example, let’s say we have three different electronic health records, three 
different offices and they get three patients in there with abdominal pain, an elevated temperature 
and elevated white count have tenderness in the upper right quadrant of the abdomen, well those 
are the classic signs of appendicitis.  So the way that information first of all, most of that 
probably gets put in the lab IOB and the temperature will be in there, the patients symptoms will 
be free text, it won’t be probably won’t be in a defined field and there’s no program in there that 
says this is the definition of an acute abdomen or even with the probability of 95% or whatever, 
it’s the definition of an acute abdomen and therefore you should think about appendicitis.  Those 
laboratory values will just sit in the lab area of the electronic record.  The temperature will sit in 
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the vital sign section, the narrative will sit in the narrative, nothing ties them together, there’s no 
way to compare, there’s no way to go into a database of thousands of patients and say how many 
of them had an acute abdomen.  The data aren’t structured that way.  Could they be? Yes.   So I 
think big data is not able to move things in healthcare the way it is in other industries.  
Having said that, the drivers that are pushing IT, getting us more into big data that will 
invite us to try and answer the questions that will allow computers to be more helpful are 
certainly driving costs.  The question, healthcare cost is making people say we’ve got to marshal 
information technology to make this whole power of data more cost effective and produce more 
for our providers.   
Then the increase in technology, the improvements in technology for other purposes as 
well as in medicine are really, really good. The improving technology is making it easier to do 
the things that you need to do in healthcare to be of more assistance to the people providing care.  
So I think that’s changing.  What is not happening in an organized structure way is to try to 
analyze clinical medicine and represent it electronically in defined fields so that everybody can 
talk to each other and we could represent all the complexity in medicine. I can’t ever foresee a 
time when you won’t want to have the ability to collect narrative for at least some of the 
electronic record.  But we need to get, right now probably the majority of most records, it’s 
certainly true, the majority of most clinical information records is in narrative form and you can’t 
use big data on. So we need much more of a structured knowledge base and that work isn’t really 
going on in a very organized way right now. 
I want to get people to use the same definition for enough time so that we can aggregate 
data, match it up against reality and then refine the definition so that the sensitivity and 
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specificity of it, the accuracy, when the true positives and not a lot of false positives, not a lot of 
false negatives, so that all gets worked out by making the definition very precise and having 
people record it that way.  It’s the opposite end from natural language processing which says put 
it down in a precise or sloppy way we don’t care about. We’re going to go in and search for 
whatever we can find and we’re going to hopefully be able to find things that are similar with a 
clear degree of accuracy.  I want to go on the other end and say we’re going to be very precise 
and then we’re going to use that precision to refine the definition over time based on big data.   
I’ve actually been engaged in such a process. The first thing you found out about is 
whether the standards worked or not, and so you could actually refine the measures by 
processing large amounts of data against those standards and validating it with the actual real life 
circumstances and that way the definitions could get more and more precise over time.  We need 
to go through the whole knowledge base of medicine that way and map it. No one is even talking 
about doing that right now so we’re a very long way from getting medicine to the point where we 
can do the kinds of things that they can do in other industries where the structure of data is 
simpler. 
Sources of Data and Data Scientists 
All of those skills of epidemiologists, biostatistician, physicians, all of those things are 
important skills.  What I found in the quality area is there’s a kind of unique skill of being able to 
think logically and distill the measurement process into binary form so that words like 
‘consistent with’ or you know anything like that can’t be measured.  You have to find a way to 
triangulate what you’re after and use binary thought processes to try and reduce highly complex 
situations to something that can actually be measured in concrete terms.  So I don’t know if that 
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makes any sense but it’s sort of like you look at the beautiful color that you have on your module 
on different colors and it looks analog really, but at the end of the day you got a machine 
language that’s all 1’s and 0’s.  When you measure quality, everything has to be in 1’s and 0’s at 
the end of the day. Then you have to realize that it’s as good as you can get with it. You always 
have to be humble about whether you’re right in an individual case or not, but the better you get 
with measuring so you can at least be right about trends and populations. 
Organizational Challenges 
I have found it difficult to find clinicians who have the ability to stop practicing medicine 
and to turn around and think about things in very objective binary ways.  It’s not impossible but 
it’s hard. But one of the things when you’re looking at quality, you’re basically looking 
retrospectively. If you want to do big data, it could be populous in real time patients, but then 
you have problems with denominators and patients that are evolving. If you want to look at a 
population where it can be static and you can have denominators that allow you to draw 
conclusions, its material that’s going to have to be completed at some point in time and to get 
people to look retrospectively and think that way instead of thinking prospectively on the terms 
of uncertain conditions. That it might seem it would be easy to do, but apparently it isn’t so easy. 
For instance, you can’t use pathology reports to find out whether a surgeon made the 
right decision to operate because you didn’t have them at that time or she didn’t have them.  You 
have to use the presenting symptoms and lab values and so on and so forth, it’s a time the 
decision had to be made to operate or not, so that may sound simple but I’ve actually tried to set 
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standards with people to say things like just go use the pathology report, you can find out 
whether the operation was needed or not.  
Big Data’s Future in Healthcare 
My hopes for big data in healthcare would have to do with the fact that I hope we have 
common standards for how to represent the major clinical problems that patients have, both 
processes and outcomes of care, so that when electronic health vendors revise their programs, 
they write to those common standards and data get collected in defined fields in electronic 
records in a way that we can begin to compare apples to apples and we can begin to understand 
that what we’re doing with treatments across the board because the results from one record can 
be compared with results from another record.   
Also, that incidentally would make transferring information from one provider to another 
a lot easier.  Right now, we have thousands of different health records and then a handful of 
other major vendors and then a whole bunch of do it yourself. Overall, there’s just an enormous 
variety of electronic records out there that are not interoperable and can’t produce information 
that can be benchmarked or compared or learned from really.  So my idea would be that 
information could be moved more easily, could be benchmarked, compared, trended over time 
and I don’t think that’s unique to me – everybody has that vision. But I think it’s going to take a 
little longer because I think the complexity of structuring the knowledge base of clinical 
medicine is a job that we haven’t even defined how to do that job yet. Nobody has said much 
about doing it in a regular way.   
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Closing Thoughts 
I have one last thought and that is in healthcare we tend to spend a lot of our time 
analyzing healthcare data that exists in electronic form knowing that it’s incomplete and 
inaccurate to do the job, mainly billing and administrative information and sort of throwing up 
our hands and saying we know the analyses aren’t very complete because the billing data doesn’t 
have everything. But it’s the only data we have so we’re going to use that and we’re going to 
base judgments on it. Since the billing data represents probably some tiny fraction of 1 or 2% of 
the clinical information about a patient in any setting, those data are not sufficient to make the 
kinds of judgments that one needs to make in terms of quality, safety, reimbursement, or policy.   
So I think that when we get to the point where we define the data we need to then figure 
out how to get it in an efficient and effective way. We’ll be far better off than saying okay what 
data do we have, how can we shoehorn that in, or try to stretch it to make what we need to do.  
So on defining what the objective of whatever endeavor we’re in, whether it’s quality or safety, 
or policy, defining the objective then defining the data that we need, the questions that we need 
to answer in order to drive that objective and then getting the data to answer the questions, doing 
so in that order instead of taking the data that we have is an essential step in moving this whole 
field forward.   
We have been churning in terms of analyzing, re-analyzing, and making more and more 
powerful sophisticated programs to analyze administrative data for 30 years now and we haven’t 
really moved along very well because the essential information you need isn’t in electronic form. 
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“My Big Data – Your Big Data” 
“Matthew Blocher, Ph.D.” 
Professional and Academic Experiences 
My education is mostly in mathematics, physics, and chemistry.  I graduated college and 
worked in the healthcare and life sciences industry and have been working in that field in one 
way or another ever since. It wasn’t  a trajectory that was straight into the medical field, but 
physics, mathematics, problem solving, handling data, and understanding analysis is one of those 
skills that you can apply to just about anything. It’s one of those things full of interesting doors 
that opened and once I got into it and really understood what could be done, it was a lot of fun.   
I was really into the mathematics because it was much more rewarding.  
I started out primarily as a drug discovery analyst, a person who was doing computer 
aided drug design in a lab and helping other researchers do their research. Basically, I did the 
computational part whether it was designing drugs or explaining how proteins interacted and 
doing simulations.  I quickly understood that one of the biggest issues that I had interacting with 
people was trying to explain the amount of data that they had and how much I generated to them, 
so I started looking into visualization as well and got more into the graphics and visualization as 
I tried to communicate more and more information to the investigators.   
Meaning of Big Data 
I’m going to be like a lot of the folks that I’m reading on a lot of the blogs right now.  Big 
data has become I think an over-bloated word.  What I mean when I say big data is ingesting and 
integrating lots of data, lots of complex data that may be able to be used to answer questions 
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either more rich questions, or answer questions more deeply and get down to the causes as 
opposed to just kind of scratching the surface.  I’m literally interested from the etiology all the 
way down to the molecular and cellular levels.  I have data coming in about your age, your 
background, your genetic background, hopefully the microbiome and all of the bacteria that live 
inside of you.  How do those interact?  When I start looking at not just the data, but all of the 
possible connections between all of the data, then I have a huge explosion of the data space that I 
need to explore to be able to find answers to the questions that I’m asking and trying to eliminate 
red herrings and false starts quickly.  To me that’s big data.   
If I can answer those questions, it can then lead me to more relevant questions of causes 
and the etiology of the disease. Once I understand, if a particular gene is mutated in a way that 
isn’t necessarily obvious, that it causes the problem but it leads to something two steps down in 
its pathway, I now can develop a drug against that and correct that disease. That’s something 
that’s important and right now we’re not able to easily mine that. I’m searching for the holy grail 
of biomedical research, to be able to go and say I can find those hopefully, true associations and 
then we can ask the critical question that really is, if you will, the question to be able to address 
that disease. 
Medicine as an Information Science 
I would say that information science pre-dated medicine and allowed medicine to 
prosper. Until you were able to collect evidence objectively and to classify that in terms for 
differential diagnosis, the idea of classification of information and really the application of what 
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your definition of information science is actually allowed, in my opinion, the development of 
medicine.  So of course the answer is yes; it’s absolutely an information science domain. 
I’ll take some of the examples that we’ve gotten recently and trying to get into.  That kind 
of streaming data coming in, that kind of availability and the fact that it’s the human view of the 
data and it’s transferring, it’s gaining knowledge out of that data, transferring it to the human so 
that the human can actually do something useful with it. At the same time there’s a cultural shift 
going on where people are much more willing to share it. 
You know it was taboo to talk about things like that let alone put it on a public space 
where the whole world can get to it.  There’s a real shift where people are much more willing to 
post their genomes online. I could just go to Amazon and pull it down and do an analysis, but 
that’s clearly what a thousand genomes project and now you know the 10,000 genomes project 
and all the other projects are going.  People are now making data available in the hope that 
somebody can come along and use it in a much more meaningful way.  Further, we’re now 
recognizing even more acutely that it isn’t the professional scientists that will always find that 
link. There are other people out there that are citizen scientists and allowing them to have access 
to this data as well. They may come up with a solution that no one ever thought of.  
Healthcare Big Data Drivers 
I think there are a whole lot of drivers to this. The data complexity, the data volume is 
increasing and the richness of what is there is increasing to go out to ask questions we never 
could ask before.  We’re also collecting a lot of junk but clearly that’s the big deal, right? You go 
gold mining and it’s not all gold.   
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I think genomics and the ability to do sequencing is the first statement of it.  I think that 
monitors that have come from telemedicine are really driving that as well.  I no longer have to 
own all the computational facilities to be able to store my data and to analyze my data.  It can be 
distributed around the globe and I think that that’s driving the decision for people to both collect 
and store a lot of the data.  I think that clearly the internet is a huge factor.  We also are have an 
aging population that grew up relatively privileged and they’re viewing mortality differently 
now.  
Cancer and other diseases are big problems and I think too that the change in lifestyle we 
have where we’re starting to see metabolic diseases are much more prevalent in the world.  
We’re starting to see what were at one time typically western diseases or health issues becoming 
a global problem.  A problem that was let’s say antibiotic resistant, the disease that occurred in 
some small country in Africa that people in America didn’t care about it and now all of a sudden 
within 12 hours that disease could be sitting here in New York LaGuardia Airport and spread 
across the United States just like SARS. I think that was a giant wake-up call for people.  So 
we’re realizing that focusing just on a small area is not going to solve this. The problems are 
global now and the data has grown globally. 
Sources of Data and Data Scientists 
I bristle just a little bit at the term ‘data scientists’ because every scientist whether they’re 
a professional scientist or not is a data scientist because a scientist without data is a philosopher.  
So I understand what people are saying. But at the same time it kind of lets people off the hook 
that if they’re doing science that means that they don’t mean data.  So going back to where does 
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data come from?  We generate a lot of data here and I’ve been talking about a data tsunami 
coming ever since about 1999-2000 as we were just getting ready to see the human genome 
project made publically available.  We were getting lots and lots of data coming in from the 
genome sources from that point and we were ingesting it and trying to be able to analyze it at 
that point.  You also have MEDLINE/PubMed, you have the National Library of Medicine has a 
ton of information that they store and they serve up free to the public.  You’ve got a lot more 
sources coming in now, such as I said in the Human Genome Project, you’ve got the Human 
Microbiome Project, you’ve got European projects, even the Chinese now are starting to 
contribute and make their data available.  So you’ve got a lot of information coming in from just 
the research world, but I think the healthcare world is starting to throw information out there as 
well and I think people making their health histories available through direct consumer 
marketing like at 23andMe.com where you send in your DNA and they start giving you 
information.  People can argue whether or not that’s a good thing or a bad thing. Of course 
everything can be abused in one sense or another so you know there’s much more of that risk.  
And if you have children and there’s a genomic disease or whatever I think people are just much 
more aware and motivated to go in and try to explore.  So I think that the source of the data is 
coming from everywhere.   
I think that we’re starting to see the boundaries of the different sciences break down 
which is a good thing.  You know the people used to be in either medicine and research and 
biology or another discipline. Now it’s crossing back and forth. Chemistry crosses back and 
forth; physics comes in and crosses. There’s a lot more information now for people coming in 
and bringing in physics information into what goes on in oncology and what goes on in various 
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other fields.  Cross fertilization is bringing new views into the questions that we ask and the 
answers that we can get. 
Organizational Challenges 
Organizations don’t want to share and we’re not necessarily incentivized to share.  I think 
the monetization of big data causes some biases and perhaps maybe even causes certain things to 
be left out which might be critical, even in a large federal organization.  Just remember a large 
federal organization is made up of people and you’ve got people who are trying to advance their 
career, they want to keep their job, they want to grow their lab, they believe their research is at 
least as important if not more important than everyone else’s, so they want to drive that.  That 
means having a competitive advantage over somebody else and in today’s world that is 
information and sometimes that’s data, and especially if I haven’t mined all of the data; 
therefore, I want to hold onto that data forever because there may be another nickel I can get out 
of it.  That’s an unfortunate view the world that’s short-sighted in my opinion but then that is 
human nature and I understand it.   
All too often, the more data we have, the more fodder we have to beat it into submission 
and say what we wanted to from the start. Organizations, like people, suffer from such biases and 
challenges. Big data can also be used to open new areas to question and suggest new alternatives. 
People have shown that, in the case of ulcers, that there’s a bacteria involved.  We get caught in 
research bias and so we get rushed.  I mean you can take big data and you can use it with your 
blinders on to prove a lot of different things, or you can take the blinders off and be surprised.  
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So we all too often have our blinders on. But I think it’s mostly, even in a large organization like 
the federal government because it’s made up of people. 
Data Sharing 
We do share, but in my opinion we don’t share enough. No one has the answers by 
themselves and sharing data, sharing experiences, working together, working across in 
collaborations is a way that we really drive findings and unexpected findings where you didn’t 
realize that ‘A’ and ‘B’ were connected because I’ve been studying ‘A’ for 25 years, you’ve 
been studying ‘B’ for 25 years and we never talked. But if we can make the data more available 
then it could be a person who’s never done research in either ‘A’ or ‘B’ but mined the data set 
and came back and said did you guys know that there’s a giant correlation here.  But we don’t 
incentivize that. We're just beginning to develop organizational programs to facilitate ‘data 
science.’  
As much as I appreciate privacy and I really like to be private as much as I can, we have 
to be able to share that data and we have to have as many eyeballs looking at it as possible.  Are 
there going to be people that may do various things with it? Yeah, that’s life.  I think most of the 
barriers are cultural and legal as opposed to technical. 
Unintended Consequences 
So, let me tell you something what’s going on, a transformation I’ve seen over the years.  
Very often in computational sciences some people are doing theory and they crunch on 
computers and do math, and there’s those people over there that go in the lab and they do lab 
work and they generate data.  Then it became people in the labs realized they needed these other 
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folks and started to collaborate with them.  That progressed to maybe we should incorporate 
them into the lab and started hiring some of them, but yet the problem was that data was still 
completely localized.  So now there’s a lot of folks who were bioinformatics professionals who 
were at universities who don’t really have labs but they have now been able to say I can call up 
‘Company A’ and get cell lines, I can have that company send it to ‘Company B’ and do the 
sequencing, I can have them send those cells to ‘Company C’ and have them look at proteomic 
analysis of it and I can have company ‘B’ and ‘C’ send me all the results so that I can do the data 
analysis.  I never did an experiment and I never interacted with an experimentalist, but I have 
data and I’m now integrating it with all the other public data that I have and I’m getting some 
really interesting results.  
We find the similar type of things here where often times we’re asked to analyze one type 
of investigator’s data and then we’re asked to analyze a different investigator’s data and we’re 
going say maybe you guys should talk because we’re finding commonality between them.  And 
if that data was put together in a larger context then even other investigators that might be a little 
more inclusive to actually advance research and drug discovery and hopefully cancer 
therapeutics or even diagnosis at a much more rapid rate. I think that one of the commonly 
discussed things is when Google says we can start looking at searches and we can tell the CDC 
when there’s about to be an outbreak. That’s an authentic unanticipated finding by mining big 
data.   
I think as we start doing more and more global sensors and people share their life we’ll 
see even a lot more. We’re in a really exciting time to see an even bigger explosion and 
understanding of the integration of data from bacteria and viruses in humans because my guess is 
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we’re already starting to see such an interesting ecosystem. The ecosystem includes all of this 
and how we rely on bacteria and viruses, they rely on us and other animals that this is turning 
into a really complex scenario. 
Big Data’s Future in Healthcare 
I never want to see a parent have to lose a child over something as stupid as something 
that we can solve in a medical sense. There are a lot of things where we’re getting ideas 
integrated with genetics, we’re getting information about environment, and we’re getting 
information on health. Clearly this web of all of these interactions and the interaction between 
you and me affects our health.   
We’re looking at human-beings holistically. The reductionist approach I think as useful 
as it has been. It needs to be augmented, I won’t say it needs to be replaced, but it needs to be 
augmented, a much more holistic approach.  I can look at cells all day long but until they're 
organized into tissues, into organs and into systems and then into whole species and individuals 
it really sort of doesn’t matter. So it’s understanding human health, understanding how choices 
we make in shifting policy decisions so that we put investment where it matters the most as far as 
human condition and I think letting people realize their full potential as far as health and 
happiness as well.  My vision is if it can lead to opening and the democratization of health, 
because clearly we’re having a fight over healthcare in this country. 
There’s a huge disparity in terms of economics and wealth in this country, but you know, 
we have to somehow make it to the point where everybody has a fair chance to healthcare and 
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education and emotional and mental well-being and I’m just hoping that maybe the data that we 
come across will help humanize everyone as opposed to just the few and fortunate. 
Metaphors and Symbols 
In my opinion, we don’t have a language that’s commonly accepted to discuss this issue, 
and when people first started talking about these various types of problems whether it’s the Jim 
Gray’s talking about the Fourth Paradigm, or whether you’re talking about data tsunami or 
you’re talking about big data, you’re talking about whatever other metaphor people use it’s the 
problem that I don’t have a common language.  I’m trying to communicate often times to 
funding agencies, policymakers, other thought leaders in the field that I need resources or trying 
to talk to other people in the field saying I’m trying to prepare for this or I’m trying to deal with 
that, or here’s where other people are at and we don’t have a common language to say this is 
what we’re talking about and I think that the reason because it’s relatively young. We come up 
with these terms to start building up some sort of language and we use a term like big data.   
Well now you’ve got a lot of other people come into the field who think maybe this is 
something either interesting to them, something that they should know about, something they 
haven’t dealt with yet, but maybe they think there’s a problem or hearing somebody else talk 
about a problem that seems similar to what they’re saying and they’re using that term; therefore, 
that would be the same term as they have, so you’ve got a lot of people who don’t understand 
what the original context was that maybe the first person or first few people used for that 
language and then repeat it. That’s why I say if I look at it today and big data has kind of lost 
some of the meaning that it had at the early part and maybe even gained, and eventually will 
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probably gain maybe a specific definition to make it useful again.  I think it’s the problem that 
we’re all trying to communicate something that we’re seeing .We’re all trying to describe our 
view of big data and you know we have different experiences and we’re all going to explain it a 
little bit differently and so big data to me is complexity and difficulty in analyzing and 
understanding it.  Somebody else is just here for pure volume, you know, and other people it’s 
the velocity of numbers and sensors coming in.  It’s all of that, and I think that’s just right now 
it’s a complex phenomenon that none of us fully understand; therefore, you get a lot of different 
colorful terms. 
Closing Thoughts 
Big data is a tool to solve problems and answer questions.  Like any other tools, it can be 
used both for good and for bad and it’s just the reality we have to live with. There needs to be a 
central policy of how we treat these large quantities of data and how we share the data and I 
think we could go back to I think to your central question of data sharing and acceptable use 
policy. I think it basically comes down to a sharing and acceptable use policy that is going to be 
very critical about how valuable big data can be to the population as a whole as we go forward in 
the future.  Clearly, if this is all held by one secret government agency and used as to invade our 
lives that may not be a good thing. At the same time if it’s trying to keep us safe from nefarious 
folks who are out to hurt us, then that’s a good thing. The debate continues.
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 “Always Create Data for a Purpose” 
“Boris Jensen, M.D., M.P.H.” 
Professional and Academic Experiences 
I started a Ph.D. track for physics, heard about medicine, applied to one medical school 
and they accepted me.  I joined the university faculty in biostatistics and was appointed professor 
of biomedical computing.  I built the first computer network for a school of public health and 
established the computer network for the biostatistics department.  My organization is an 
integrated delivery system of hospitals and employed physicians: about a 60% primary care, 40% 
of specialty mix. We are a charitable not-for-profit intended to be extremely patient-driven.     
Meaning of Big Data 
Turns out, there are many definitions for that term.  Let me give you three.  I’m going to 
start with some of the other ones that are commonly used in the marketplace and then finish up 
with mine.  One definition of big data is that you have truly stunning amounts of data, but it’s 
very well focused, it’s not random data at all, just collected for specific purpose but just in truly 
massive quantities.  The data that you collect you then analyze looking for rare events that was 
actually one of the original meanings of big data, right.  Another related one, is if you’re doing 
genetic sequence you know what you have are enzymes that will cut up DNA and you get them 
cut at particular points but in random lengths and then you can sequence the resulting lengths of 
DNA. What you get out of them you can analyze to figure out what the original genome was. 
You’re dealing with truly massive amounts of data in doing this. So that’s the first class.  
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A second class is data mining. The idea behind data mining is that you found a bunch of 
existing data of different types just anywhere you could find them.  It tended to be again very 
large amounts of data. Then you applied automated statistical routines to them in the belief that 
this would give you some sort of insights that you would find associations. It’s really a 
hypothesis generating exercise.  You find things that became useful.  This particular one, I’ve 
come to the opinion from having done research all my life that good answers come from good 
questions.  
The idea that you just run statistical software and it’s going to happen by useful 
association. You have to filter this with so many spurious associations finding anything that’s 
useful that it’s not a very productive use of time.  That’s called data mining.  Ten years ago, it 
was massively counted, about leaving some of these computer programs that now run down 
through the databases and find these associations an almost magical learning from it.  It never 
really materialized.  It even felt like you’d think it would.  At least a chunk of the current 
emphasis on big data is the reprise of that. Now, this is the cynical side of me talking. You see a 
consulting group selling this as some sort of a black box magical solution to a not very intelligent 
system leader.  
The third class of big data for me is the kind I find useful. Dr. Deming, from who I 
learned quality theory, use to say that ‘aim defines the system.’ That’s the fundamental truth.  
That is particularly true for data systems.  You build data systems, they cost so much money to 
actually collect the data it’s quite expensive. They’re built for specific designated purposes and 
it’s fairly important that you know what the purpose is before you start. Well, Deming also said 
that you should organize the thing around the processes, so quality improvement of course is the 
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science of process management.  While some years ago we went through and analyzed all the 
care we delivered and were able to identify a series of processes that make up the bulk of our 
work.  We started with a little over 1,400 identifiable clinical processes.  We used our existing 
hospital and outpatient data to prioritize them on the basis of number of patients affected and 
health risks to the patient which turns out they have a really tight correlation to cost of care.  
We organized it through our enterprise data warehouse which contains roughly about two 
petabytes of storage.  But what it is – is patient care data done over time organized along these 
processes of care and then you use those data to understand and systematically improve your 
care delivery.  Now when I say you use it to organize and understand and systematically improve 
because of the way it’s organized any patient who comes in to receive care us effectively was on 
a trial.  But another way of thinking about it, for every patient who comes in we track what 
happens to them.  We know what happens to them. By the way that we’ve structured that system 
as we care for patients I can measure what its actual outcomes are at least within our population 
the way that we delivered the care.  
For example, I could track for medications and for complications that aren’t recognized 
in their initial approval process. I can also track the actual outcomes of care associated with a 
particular treatment. So when we sit down to counsel a patient, its informed consent and here are 
your treatment options. I can tell them actually here’s what you’ll get with this treatment and 
these are the results you should expect.  
Now it turns out those datasets are fairly extensive, they take the form of registries or 
data marts. They’re effectively a registry but many times end up with millions and millions of 
records just because we’re tracking all patients.  
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Medicine as an Information Science 
I’ve been saying for 20 years that medicine is inherently an information science; the 
better data you have the better you can diagnose.  The more effectively you can select treatment, 
the better you can actually see those treatments. It’s unquestionably an information science.  
Healthcare Big Data Drivers 
I think of it a little bit differently.  I just did a carefully designed data system that is very 
purpose specific.  They’re designed for a specific utility a specific purpose and they just happen 
to collect massive amounts of data but they’re always for a specific purpose.  There are an 
infinite number of data points I could collect.  There’s effectively no limit to them, so good 
answers come from good questions. Nearly always to answer that good question you have to 
have data that matched that question. They’re very purpose specific.  
Now once you have the data it turns out that you tend to get really rich data because, 
explicitly because they are the right data for clinical management, clinical process management, 
and many times you can take those data and they’re more likely to be useful for other 
unanticipated applications, you darn well better have the ability to modify your data systems on 
the fly because more often than not that’s what you’re going to have to do, you’ll find that it will 
point you toward an interesting question.  You’d really like to examine in detail but then as you 
start to examine that question you realize that you’re missing a few critical data elements without 
what you really can’t interpret the data, and so you’re going to have to go back and somehow 
add those data in order to properly answer the question.  So you build that into the structure of 
your data system. Ask questions and then generate useful data on the fly.  
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Sources of Data and Data Scientists 
I have master’s level analysts whose time is assigned to a particular clinical area and 
they’re the main analytic resource for the clinical teams for managing and improving care, 
testing changes in care, deploying best care, and tracking performance in the system.  Now it’s 
the funniest thing on this, most of my statisticians have some computer science background and 
regard themselves as fairly competent data architects. So as far as I can tell all of the data 
architects see themselves as analysts but when you’re more than past familiarity with both fields 
you’re different, and they’re radically different. So you got to make sure that you have both of 
those areas available to you because it’s specialty knowledge, really profound specialty 
knowledge on each side of the line and you have to get people working where they are most 
effective in that regard.  So part of my job is to manage that and defend it.   
Organizational Challenges 
What I routinely get is an administrator who can understand the budget but they don’t 
understand why I get so excited protecting that professional environment for my analysts. Now 
it’s easy to show the performance that you get by protecting it.  But on the other hand, somebody 
has to know and be able to manage them.   
When I talk about having a rigorous method, we figure out what data I need to manage 
the specific process.  So rather than it’s called availability bias rather than just using the data that 
I happen to have available because I’m already collecting it for financial purposes.  I understand 
that’s big data where you’re repurposing existing financial claims data and then trying to make it 
somehow work for these other things. 
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As you might imagine, you can completely justify some fairly significant outlays that 
you’ve invested for purposes of clinical management.  Now the fact that it also becomes a full 
learning system that allows you to generate through knowledge at a paralleled rate, that’s just a 
really nice side benefit. So what you’re doing is a mining aim. 
Data Sharing 
We are discussing with some of our colleagues what might happen if they were collecting 
the same data fields for the same conditions and the other thing it means, imagine if somebody 
raises a question about best care. Effectively, my routine care becomes the control arm of the 
trial and so I can run ‘X’ therapies in amazingly short periods of time if we decide that it’s worth 
the effort to do it.  We had a fight that cropped up in the system about two medications that you 
can use for community acquired pneumonia which one is best for a patient.  We eventually 
decided that it was worth the effort required to run a full trial on them, a full randomized 
controlled trial and we put about 5,000 patients in about three or four months. The routine 
treatment under that protocol was the control arm.  So you kind of standardize treatment and so 
routine treatment was the control arm and then what you do is you just inform the patient, get 
informed consent in other words and then you randomize them and just have two therapies there 
so it becomes just part of routine care.  That cost has dropped to a fraction of what it was before.  
I think of it as sharing at two levels.  The first level you share is existing data and that 
depends a little bit on the current capabilities of the systems collaborating together. You simply 
share existing data, whatever you happen to have.  By far the most common data are financial 
data, whether technically claims data, it’s not purely financial, but mostly financial. So you share 
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claims data from the system.  Now the next step which we’re starting to do is rather than just 
straining existing claims data, you take a step forward and you start to generate specific clinical 
data that has a lot more meaning as you might expect has a whole lot more meaning.   
Imagine that we’re addressing a specific clinical topic like diabetes mellitus. The 
argument is that diabetes is kind of diabetes whether I’m in New Hampshire, or Minnesota, or 
Oregon. When you look at it, we ought to be collecting about the same data in about the same 
way as my process management system.  You see the whole key is to be able to justify this thing 
on a financial basis as a care management system.  That’s how I get the justification for it, that’s 
how I get money guys to put up a lot of money because it costs money. You’ve got to design 
them to that purpose so that will get better clinical performance.  If I remember the goal, the best 
medical result at the lowest necessary cost.  So the way I hope to sell it if I don’t wait for my 
colleagues to come get me is I basically hold myself accountable.   
Unintended Consequences 
Well, first of all big data is never used for its intended consequence. So however you care 
to classify that in terms of being useful and actually managing care is so badly incomplete and 
there’s a beautiful theory you can relate to it, it has to do with what’s called decision layer in a 
process setting.  An unintended consequence is it tends to create a group of clinical partners for a 
massively cynical ends to make change very difficult because it destroys trust.  It’s interesting 
because it’s not just insurance companies, you can argue that most of the report card scoring 
systems of people are out there creating and using these datasets trying to repurpose existing data 
somehow and when you evaluate them technically they don’t produce an actual result.  By that I 
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mean they, if you measure the confidence intervals or the scores that they produce the confidence 
intervals are so modestly useless. This is actually pretty well known. 
Big Data’s Future in Healthcare 
There’s this concept that effectively every patient goes on trial because of the way the 
data systems are structured. Now the jargon we used for that is a learning healthcare system 
where you build the learning, the knowledge management and it’s an information science tool 
that comes out of this you quickly learn is it’s perhaps the key capability in a system like this, it’s 
knowledge management.  How do you identify best practice knowledge, how do you 
systematically and routinely deploy it into routine use.  What it means is I get much better 
clinical data in a real-time feed.  Now the next piece beyond that is when you’re using these tier 
process models you use the clinical processes to drive your care delivery, you can use it to 
integrate research.  So I can justify this stuff purely on a financial basis see, that’s the idea 
behind it. And then how do you use the resulting structure to rigorously learn from your 
experience.  That’s the learning system.  
I want to get to the point where we will run at least 1,000 published papers in a single 
year. And by the way that’s quite reasonable, that’s not unreasonable. See for me that’s big data. 
But it’s interesting, it’s not random data. It’s big but it’s not random.  A lot of people seem to 
think it’s random; no, it’s not random.  I’ve got colleagues in some of the other big integrated 
systems if we can start to collaborate together and as we work out the content of those data 
systems together so that we share the data back and forth it will accelerate the whole process.  So 
the things that I could run a trial on that it would take me six months, I mean that’s compared to 
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ten years right now, the structure I might be able to get them done in six months. Under that 
structure we could do it in three weeks or at least that’s the idea.  
Closing Thoughts 
We probably did cover it, but here’s how I would say it: big data doesn’t mean 
unstructured data. You always create data for a purpose, right.  That’s the human creation.  It 
always has purpose, you have to understand the purpose if it’s going to be effective. And then 
everything else is just a tool.  
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“Big Data Means Greater Truth” 
“John Boyken, M.D.” 
Professional and Academic Experiences 
I became very interested in informatics and computers and the role that IT and 
information management would play in healthcare but I had no training or background in it.  In 
my first two years of medical school, I had the opportunity to work in a lab that was focused on 
using technology to help transform the way we teach our medical students and I found it just 
fascinating.   
I then started my clinical years of medical school and really became very interested in 
general internal medicine, mostly in-patient hospital medicine, and I did my residency in internal 
medicine and during that year became reconnected with this world of the power of health 
information technology to the point where I said this is going to be a big part of my life and I did 
a two year research fellowship in medical informatics. I began to realize how important big data 
was not only in our clinical and research missions but especially for me very important in our 
education mission and how we could use the same analytic approaches, we could use the same 
structured data collection, the same storage techniques, the same warehousing even the same 
software analytics tools to begin to transform the way we measure our students, our house staff 
and our faculty as we do our patients and our research subjects and our genes and proteins. 
Meaning of Big Data 
So that’s a good question because it is a popular term that means a lot of different things 
to a lot of different people.  I would say what it means to me and what it should mean to 
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healthcare it means two things.  First, it means turning data into knowledge and insight, that’s 
not a database, that’s not a data warehouse, it’s the actual analytics.  So that’s the first part 
carrying data into knowledge and insight, but that only gets you halfway there.  Second, I think 
the other part of big data is actually using that knowledge and insight to change practice, to 
change what you’re doing into big decisions.  A lot of people are heavily involved in producing 
knowledge and insight from massive data sets but that last of actually translating what you learn 
into agile dynamic operational changes and informing what you’re going to do next. That’s the 
part that I think has the least maturity in all of this. It’s the most exciting and potentially 
powerful part.  
I arrived at this definition through experience.  It’s experience of building systems, 
building dashboards, synthesizing very large amounts of educational data and seeing the power 
or the lack of power that those conclusion could have by whether or not  people were embracing 
them and using them to make decisions and implement changes or just using them to make slides 
in a PowerPoint presentation.  
Big data is different from data. The type of competencies of the person who potentiates 
the big data, your analytics people and the research people answering these questions, their 
competencies are fundamentally different from someone who’s working with small data and it’s 
more about the analytics than that, the algorithms and the causality sort of detection than it is 
about things like more straight forward regression analogies.   
But when it comes to the volume of data, that’s arbitrary and it’s really a spectrum. It’s 
big and it tends to involve from a very engineering perspective, it tends to involve database 
storage technology that is not your standard desktop or even your standard relational database, so 
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that’s important.  I would say that often times people approach big data with the viewpoint that it 
contains answers to questions they don’t yet know whereas they approach small data with how 
can we answer this existing question using the data in front of us.  I think that both of those 
approaches have opportunities and pitfalls but I’d say that that’s kind of one of the differentiating 
factors. 
Medicine as an Information Science 
Yes, absolutely, medicine has always been an information science. But whether or not 
that information has been at the individual patient level or at the group of patients a provider 
takes care of or at the population level has been the things that have changed.  So when we see 
the big data revolution we’re seeing that transformation of the maturity of information science in 
medicine go from that individual patient, the anecdote to the types of patients, the whole 
constellation of patients I’ve seen my career, to understanding the relationship of clinical and 
biochemical data across population which is truth, that is big data.   
Healthcare Big Data Drivers 
I think that the availability of big data is certainly something that’s driving it and that 
definitely correlates with technology, whether it’s clinical technology to measure biochemical 
signals from people or sequence genes or sequence proteins or sample the air or whatever. The 
availability of data is one thing that’s driving it.  I’d say that the willingness to base decisions 
and planning on truth and the desire to have more finely grained and precise measures of truth is 
another thing that’s driving this thing.   
91 
 
 
People want to know especially in healthcare, how we’re doing, what is quality, what is 
safety, how can we be more efficient both to make our patients healthier, but also to make the 
care we deliver less expensive and more efficient overall.  I think those things are big drivers as 
well. 
Sources of Data and Data Scientists 
That’s a complex question in our environment.  So since we are an integrated academic 
medical center in our school, in our hospital our one entity we don’t have many political barriers 
between data that is in our clinical world, in our research world and in our educational world.  In 
fact, our leadership is extremely committed to transparency of those data and through as many 
people having appropriate access to them as possible so that we can make better decisions and 
we can be stronger because of them.  If we don’t have access to these things it’s a missed 
opportunity.  That being said we have safeguards in place with our IRB and we have other data 
access request review boards that say what people can and can’t do with the data and who can 
and can’t see things to protect our patients and to protect our students for the most part.  
We have fairly robust resources of people who work on the data and infrastructure, so we 
have a large central data warehouse team an enterprise data warehouse team and then in my 
group for education we have a full time person whose job 100% is to run our education data 
warehouse and to create all of our reports and dashboards.  Then we’ve also just created in my 
group a new division of education quality in analytics who are the scientists who work off of the 
data, who work off of creating the analytics and using the data and the knowledge and insights to 
translate them into decisions about how to improve our students, our faculty and our patients.   
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The tenant of what makes a psychomatrician  or a data analyst or a data person are 
becoming much more about these competencies of managing large data sets of implementing 
analytics, of working with warehousing and non-relational databases, so these skills are key and 
they’re not easy to find in people.  We don’t look so much for content expertise, in our world it’s 
not like we’re going to go out and find somebody who necessarily is an expert in health data but 
they can learn that here.  The stuff that we really are looking for is for them to have the ability to 
use these tools to figure things out to invent new tools and event new knowledge and new 
techniques etc. 
Organizational Challenges 
So the organizational challenges are about, you know, are related really to agility, right, 
the ability to keep up with all of the conclusions and knowledge that you draw.  There are often 
organizational challenges although we’ve been pretty lucky in respect to them about 
transparency and people willing to share the data or people worried about sharing data or 
fighting for silos or turf we haven’t seen that much here.  A big organizational challenge that is 
often overlooked is that you need to create value from the data for the people who are 
contributing the data.  For example, here for our medical students and our faculty they conduct 
all these evaluations of each other and these evaluations are very important, they monitor the 
performance of people, they monitor the educational quality and if they’re entering all these 
things and they don’t see the value that aggregating all this data and analyzing it provides then 
they just view it as just an annoying server they have to keep fiddling out.  So if all we do are 
create tools that show our deans and our vice presidents what these data mean and we don’t give 
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any feedback back to the people who are contributing it, it’s going to extinguish itself very 
quickly.   
Data Sharing 
Almost all of our sharing is where we’re giving data to somebody else has been internal.  
We have physically integrated our education data warehouse, our clinical data warehouse and 
our research data warehouse, we said let’s take this beyond this step of sharing, let’s just 
integrate these actual data and eliminate all of the technical silos and that has been amazingly 
powerful.  Especially in healthcare it’s hard to share some of this data outside.  The good news is 
that the government and the state government, federal government and state governments, are 
beginning to take the data that they’re paying us for with Medicaid and Medicare and many other 
things and put it out there for us to use, for researchers to use and so when it comes to some 
clinical data, performance data you can actually begin to download big datasets publicly online.   
I’ll give you an example of something we just did in the last few days. The health 
department publishes every single hospital discharge of every patient per year online and you can 
download this massive dataset. It’s like a one gig CSV file that has every single discharge, what 
the diagnosis was, what the procedures that were performed, what zip code the patient had, what 
age they were, their gender and the license number of the doctor that took care of them so we 
know who the doctor was and that is this giant dataset that we can use that the state is facilitating 
by putting it out there, it’s terrific, it’s awesome.   
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Big Data’s Future in Healthcare 
My hope is that we get increasing transparency that data portability across the silos of 
organizations, of research settings, of educational settings is key because we need our big data to 
get bigger.  We need to actually aggregate this stuff.  So to do that what does the future need – it 
needs standards.  It needs standards for clinical data, standards for research data, and standards 
for educational data. That’s beginning to emerge but it’s definitely not there yet.  We need 
reasonable and rational policies around how to protect these data but also how we can flexibly 
use and release the data.  
Often times the barrier to sharing is not political or financial -- it’s regulatory.  I’d say 
that we also need the ability of the consumer whether it’s the patient or the student or the 
research subject to have access to their own data and be able to do more with their own data if 
they want to be able to move it around or integrate it with some other source, etc.  But 
empowering the people whose data it is should be an important value for all of us as we go 
forward.  I think that one of the things that we’re not yet seeing and that we should is so big data, 
especially big clinical data has enabled things like hospital report cards and there’s a hospital 
compare websites where you can go online and say is this hospital better at hip replacements 
than that hospital and make a choice based on it.  So we haven’t seen, we’ve seen a lot of big 
data being used to produce these things but we haven’t seen the general public embrace those 
kinds of things to make their decisions.  So we haven’t seen people outside of these ivory towers, 
outside of these research topics where experimental pilots or you know clinical improvement 
that’s real but it’s happening top down as opposed to bottom up.  We haven’t seen that sort of 
grassroots use of big data, you know, there’s lots of stuff that’s happening in the consumer side 
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with Twitter using big data for cure locations and detecting trends.  It would be great to see the 
people say let’s use this data to help us make decisions. They already do on Amazon; they should 
do the same thing when it comes to picking where they’re going to have their hip replaced.  Our 
hospital was just ranked number one for quality and safety, so I can say that with confidence that 
they should use those data to make their choice to come here.   
Insurance companies and that’s how they’re going to run their practice, that’s how 
they’re going to negotiate with insurance companies, and that’s how they’re going to make sure 
they’re doing a good job and these things have not been extremely present in medical schools so 
we are really interested in changing that.  The Affordable Care Act and the whole direction of the 
content of data and quality driving how we evaluate how we’re doing and how we make course 
corrections makes that even much more important. But these are the things that absolutely need 
to be very prominent in medical school, they are the critical skills of the future physicians, the 
present physicians, and they’re not taught nearly to the degree that they should be in medical 
schools in general.   
Closing Thoughts 
So there is new science that’s only potentiated by big data and that’s a whole other thing.  
But here like in the clinical world or the educational world, big data means greater truth. It 
means answering questions that were not answerable well before. But it also does mean 
potentially really empowering consumers and that’s one of the most important things.   
The integration of genomic data and phenotypic data, which is clinical data in the 
electronic medical record, is something that every academic medical center is racing to do 
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because the answers are not going to be in one or the other.  The answers are going to be in the 
combination of both and so that is absolutely the future, a very reasonable approach.   
I think that we’re going to see a lot of start-ups in this space, a lot of companies that are 
going to race to fill those voids inexpensively. I think that the federal government is also going to 
play a role in all of this and they’re going to provide some views of data from their perspective.  
So it’s uneven right now but I think it will rapidly become more uniformly used. And it will 
become cheaper. 
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 “The Art of Applying Information and Evidence” 
“Nickolas Thompson, M.D.” 
Professional and Academic Influences 
I graduated medicine/pediatrics and took on an internal medicine position and at the same 
time was doing a pediatric hospital rotation at one of the local hospitals. I got pulled into the 
research informatics side of the equation. We had competed for clinical translational science 
award for a couple years and I wrote the informatics section and we got funded. Then I had a 
very unusual opportunity after having done some consulting work. While I was doing my work 
at the university, I had a chance to go to the Middle East and work at an ultramodern from the 
ground up pediatric and women’s hospital.    
As the chief clinical information officer (CCIO), my responsibilities are more around 
sequence in technology over time into the future and also working on kind of re-orchestrating the 
data analytics of the organization and other jobs not otherwise specified. When I got here, a lot 
of people were using beepers and pagers and so forth and so moved them all over to smartphones 
so we can leverage that platform.  I had them use usernames and passwords across a bunch of 
applications so I’m moving them over to single sign-on tools so that they can just tap their ID 
and get into the systems if they need. I saw them using a fairly old version of EPIC so I 
accelerated the path to get to EPIC 2014 just to get to contemporary code.   
Meaning of Big Data 
Well, I like the definition that Gartner coined years ago where big data is a high volume, 
high velocity, high variety information asset that demands cost effective innovation, you know, 
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basically something used to enhance insight in decision making. So the key I think is sort of 
insight discovery and hypothesis testing.  So what does that mean for us? If I look at better 
velocity it means that if we look at current systems and how we copy in the traditional data 
warehouse model, so EPIC is a MUMPS-based programming system; it’s not relational so every 
day from MUMPS to Clarity which is their relational data base. We need something to be able to 
get that to load faster and we need something that is going to be able to process that in a velocity 
fashion.  Then for the health system to have better variety it means pulling more than just the 
data that we have, public data, other forces of data not typically used for healthcare really for 
more of the hypothesis generation.   
Then for volume it means accommodating the ever increasing deluge of data that’s 
coming from our own data sources. EPIC is the obvious one, but there are other things like 
location condition-based services, patient outcomes, all the biomedical device interfaces we have 
in the organization sort of like IV pumps and vents and physiologic monitors and so forth. And 
then I suppose you could add another of the Gartner’s V’s, Veracity, meaning that all the 
transactional systems work properly when people enter things perfectly the way it’s supposed to 
that doesn’t always happen. I think that can sometimes be an issue in terms of trusting the data or 
people finding the system to be too inefficient so creating a separate data warehouse that are 
cleansed within themselves but don’t come back to the main data warehouse.  Sort of some of the 
traditional data warehouse problems that we have.   
Then for healthcare, I think we need to do our best to learn lessons from other industries 
because we’re not the only regulated industry in the market area, banking, insurance others are 
regulated and still using big data more than we are.  
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Medicine as an Information Science 
My direct answer is no.  I would say medicine isn’t just an information science; it’s also 
about smartly moving information around clinicians. It’s the application science of information 
as well so you know the art of translating patient’s observations when they come in with signs 
and symptoms, their complaint is the history of the physical exam, the art of applying 
information and evidence in particular patients. That human therapeutic relationship between the 
patient and the team, between the patient and the doctor and so forth, so I’d call it that medicine 
includes information science, but amongst other arts and sciences that it has to dip into.  
Healthcare Big Data Drivers 
It’s probably going to be a combination of some things that other industries are seeing 
and some things that are very specific to healthcare.  So IBM will say that 80% of the data that is 
deemed collected is unstructured and therefore potentially untapped until we use big data tools.  
Also, I’ve seen several times that 90% of the data that is currently being produced ever has been 
produced over the past two years kind of suggesting that we’re in sort of an accelerated 
exponential growth of the amount of data that’s coming to us.   
But from a healthcare perspective there’s one very, very important part of the missing 
piece which is value based purchasing and moving away from the lack of accountability of fee—
for—service.  This whole ‘sign and forget model’ to get the patient and then send them off 
somewhere and if they come back is more money for me.  So moving more towards the database 
means that I’ve got to start showing in, you know, connecting the dots of things that are outside 
of my line of sight.  As I take care of a patient I need to really make sure they’re actually doing 
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better because otherwise somehow it’s not going to work out for my practice for example.  So I 
think value based purchasing is a pretty big driver to find out what other things can help fill the 
gaps for me in terms of understanding what’s going on with a patient, could be behavioral 
economics, it could a number of other things.  I think another one is the Office of the National 
Coordinator has been pushing these Meaningful Use Standards and that’s resulted in an 
abundance of data, and there’s more demand on doing analytics with the data and they’ll be 
actually in Stage Three more expectations around producing outcomes and you can’t really 
produce outcomes without data.  So I think that’s going to help as well.   
I think there’s a desire to maintain a competitive edge, you see all that, you’re just doing 
the old data warehouse thing and just like anybody else would because the invented tool is 
beginning to mature at the warehouse level but for those of us who are kind of embraced in data 
science and data scientists and trying to push the envelope I think that we’ll be able to keep that 
competitive edge.   
I think another thing is the fact that hardware is getting faster and is available at low cost 
points.  We compel them to use it as a result looking to solve some of the data problems by 
throwing more hardware at it to be able to have it crunch faster through new software 
applications including Hadoop, MapReduce, and NoSQL that Google has had for a while. I think 
healthcare organizations are starting to understand a little bit the fact that they’re sitting on a 
mountain of data that they’re not necessarily tapping into that’s not really being acted upon. So I 
think they’re trying to figure out if we have all these people that we’re paying in healthcare to 
basically collect and digitize all the information from the patients and the EMR’s are we really 
using that data that they’re collecting to potentially affect the patient’s health.  I think other 
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things like new data sources including genomics, senomics, and other ‘-omecs’ that are out there. 
Metropolomics, for example, are generating huge amounts of data that need to be processed in 
ways different than we have in the past.   
Sources of Data and Data Scientists 
  I want to caution one thing: I think our health system, is still reasonably early in the 
trajectory relative to big data.  I think we’re kind of proceeding kind of cautiously. I can give you 
some concrete examples. We do some work with natural language processing like most people 
do.  We’re finding some ability to go from unstructured text to structured text. Imagine out of the 
million radiology reports that were generated last year or this past year we were able to take what 
was being dictated and turn that into a structured text that’s in a CDA mark-up and it kind of 
ends up in an XML format and you know the natural language processing is helping us do that. I 
can use that to be able to do correlations with other things, even the imaging data to understand 
health. If I understand that this report is normal and that the image that I have here is normal, I 
can send both of those to a machine loading tool and basically, over time, get the machine to help 
me figure out what’s normal and what’s not normal.    
I think that there are some key things in terms of our desire to get closer to real time. I 
mean it’s really not very useful for me to identify that a patient is in need of something 24 hours 
later after the opportunity has kind of come and gone.  So our looking at our current system 
that’s 24 hours behind is helping us in some ways but really not, it helps us maybe more in a 
population health side, but not so much on a prospective what am I doing with the patient right at 
the point of care side.  We are still very SQL dependent and are slowly shifting over to other 
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options to embrace NoSQL and MapReduce.  We’re just starting to look into social media and 
geospatial data from tweets.  We’re trying to get an idea of the behavior economics.  
Organizational Challenges 
I think one of the problems is trust in data quality and data fidelity.  I think people don’t 
really know yet if this is something worthwhile yet. We put everything in a little black box and it 
comes out the other end and it gives me a relationship. People are not so sure if that actually is 
true or not. So to the degree, at least initially people will be able to use it as hypothesis 
generation and maybe the hypothesis testing is actually occurring on the standard enterprise data 
warehouse tools.   
I think there’s still a very limited skill set out in the industry in terms of the people who 
know how to do this, so it’s going to be hard to recruit a team of data scientists.  There are some 
programs out there but there are not a whole lot of people that come out through them. They’re 
going to get mopped up very, very quickly.  I think a correlation to that is finding somebody 
who’s got 10 years of experience in big data is going to be pretty impossible to find.  So getting 
experienced people, there’s going to be a lot of on the job training and that’s going to be a 
challenge for people.   
Then there’s no proof points yet really that are real concrete in terms of projects that are 
out there especially in healthcare, but in terms of what the outcome is if it’s going to be 
something that will be feasible from an economic or even a regulatory standpoint is still a little 
bit of an open ended question. I think that’s still out in terms of being able to figure out if that’s 
going to happen.  Then you know, all this work may generate a lot of reports but I wonder to 
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what end it will produce data but the question will be to what extent will the data be useful to 
actually produce an outcome and I have some examples of things that we are working but it’s 
right on the tip of the hype curve right now and I think it’s not going to be the kind of solution 
that’s going to solve all data problems.  
Finally, it used to cost billions of dollars to sequence the DNA and now we’re down to 
like $1,000 and then it’s anticipated that in the next few years we’ll be down to a $200.  It’s 
going to be pretty useful to create an account where you can go to Google and look up your 
genetic code and figure out what things are associated with that.  
Data Sharing 
First, it’s kind of important to talk about what our capabilities are in terms of our set up.  
We have a computer computational predictive modeling set up that basically we use for 
personalized predictive medicine.  So we have some of our staff that are taking vast amounts of 
data from clinical and molecular radiographic economic data to create basically models that can 
help inform decision support the doctors make every day and we use high performance computer 
cluster that has the typical multicore and we have 400 core, 50 CPU’s at 2.2 terra bytes worth for 
computational ram that have some in memory database management systems which is kind of 
the newer way of doing it and plenty of dedicated storage.  So the center basically is going to 
leverage this parallel cost of computing to be able to do some of the mathematical and 
computational modeling that’s necessary. With it, we’re part of a collaborative developed to 
identify what’s in your DNA and how the patient presents where there’s a relationship that can 
basically be put into the EMR itself.  So that particular project has a couple of parties you know, 
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one is to from the EMR get a precise phenotype and the other one is to basically return an 
actionable genomic result so that we do something different with the patient so that the use case 
is something I can’t give medication for a patient like Warfarin but I usually start at 5 mm but 
this particular patient I may want to start only at 1 mm because if I were to start at 5 mm, they 
would have a brain bleed, so it helps me to understand where I’m starting certain medications 
based on a genetic code.   
We also are involved in a collaborative project that established a virtual data warehouse 
of basically it simplified data sharing by having a very reasonable similar data model that’s 
federated across all different organizations and it has demographic data, physical measures, 
personal medical history, management treatments, diagnosis, health claims and so forth and 
basically this data model retains control and stores data and stores kind of standardization across 
all sites and people can use this as a tool to do their research. It’s an immense data depository as 
you can imagine.  I think the third example is the Whole Genome Sequencing component. It’s 
more of the genetics side of the equation over the patient’s life span and helps predefine clinical 
context based on the genetic information.  So I think that’s hopefully going to help us with 
neurogenetic diagnosis decision support in the electronic medical record so some of the things 
you see in 23andMe.com by maybe more sophisticated in terms of patient genomic test reports 
and that kind of thing.  
Big Data’s Future in Healthcare 
Again, I don’t think it’s going to necessarily replace what we currently do.  I think you’re 
still going to need people who are going to have to, you know, the big debate is will it be to the 
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point where I don’t even need extraction tools and I don’t really even need semantic errors, and I 
don’t even need data marts and data warehouse anymore because I can basically just take 
information in an unstructured format and then just put it into this box and it’s going to tell me 
how the data is actually organized and what the correlations are and what’s the approximation 
size and so forth.  I think that’s a little bit too nirvana.  I’d love to get rid of the infrastructure and 
not to even think about it and have systems basically think about it for me.   
But I think especially probably in healthcare there’s still always going to have to be 
somebody who’s going to be the data steward, who’s going to really make sure that people 
understand what something means. I want to recast our current system into a data warehouse 
model. I want to turn that into a logical data warehouse that has your standard component that 
has an ETL in tune data warehouse and then starts giving us different data marks, but also for 
certain data sources can tap into the big data needs and then for others that are more real time I 
use more of an operational data store as opposed to a data warehouse.   
So something that hasn’t been fully mapped out into the analytical processing scheme 
that I want or something that’s more real-time feed that I can actually act upon much quicker.  So 
there will be some components that are real time, some components that are like data warehouse 
and dashboard based and then some components that are for big data for large data sets and for 
better insight.  So I can go to my big data to find the hypothesis.  I can go to a data warehouse to 
test that hypothesis and I can use my real time data to basically put that hypothesis into action 
with decision support.   
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Metaphors and Symbols 
You may be somebody who likes the whole quantitative self-movement.  You may get on 
the scale and it gets WiFi’d and set up to your computer or you may track your sleep, you may 
track your mood, what you eat, a number of different things that could be tracked and you could 
do that every day.  That information is going to become very helpful because it will help a bit of 
phenotype documentation, so when we’re trying to match it up with a whole series of EMR 
derived data or decision support, you know, it kind of gives us a better idea of behavior 
economics of what’s going on with a patient. There are other things that we were talking about in 
terms of pills and medication compliance and there are all kinds of tools that are now making 
themselves available that go beyond just the actual bottle having some sensor in it. In other 
words, you swallow this and like a potato chip that activates in your stomach and sends out a 
signal to a little sensor that’s on your skin and tells me exactly when somebody has taken a 
medication versus not and it’s actually been ingested and digested.  So those kinds of things will 
be pretty helpful.   
I think other things in terms of matching patients up with clinical trials will be helpful as 
well, getting a better idea of simulation platforms when you’re trying to figure out how people 
respond to different medications. I think the promise of the big data is the fact that you can use 
all kinds of sources whether it’s social media or even peer view literature like what IBM Watson 
is doing where they just consume all the literature so people don’t have to read it. I’d much 
prefer this because I can’t possibly get through the literature; yet, there’s some useful stuff in 
there and if I can have a computer absorb it and then I can just ask it questions and it can tell me 
well based on the literature X, Y, Z then I think that could be beneficial.  So a lot of the 
107 
 
 
personalized medicine type of initiatives that match the patient to a treatment requires a lot of 
information and data to make that happen all in real time. I think the key thing is if you set the 
issue, if you generate data that’s great, but we got to make sure we generate the causal 
relationship as well.  So I think that’s always a challenge.  
Closing Thoughts 
The battle for Accountable Care Organizations and the Affordable Care Act, you know, 
is really being fought here and we’re able to demonstrate for example that we can make money 
on Medicaid patients and that we can make money on Medicare patients if we look at a 
population base level instead of this individual fee for service.  I think that’s the thing we 
differentiate ourselves with, we’ve invested in IT infrastructure, we’ve invested in bundles of 
quality care and we’ve invested in care coordination and we’re now able to demonstrate as a 
result of having done that. We can get better mortality numbers and better outcomes for the 
patients in a way that’s going to be compatible with where the legislation is going as opposed to 
being forced into it.  So I think the fact that we’re in the big data equation now is just testament 
to the fact that we like to stay on the leading edge and we want to be able to help solve the 
healthcare equation as much as possible and help share that information with everybody else so 
that we can just take better care of patients.   
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 “Learn to Talk to the Patient about Data” 
“Darwin Watkins, M.D., M.P.H.” 
Professional and Academic Experiences 
I was a family physician working at a neighborhood health center and later in my career I 
kind of got talked into going and getting  a degree in public health/epidemiology and I was 
actually interested in doing that because computers were just coming to the neighborhood health 
centers in those days and I was very interested even then in what you could do with 
computerized data from healthcare delivery in terms of beginning to understand your patient 
population and what were the common problems and what worked and what didn’t work.  So as 
far back as 1983, I could see that that was a very good idea.  After I took my epidemiology 
training, I wound up at a place which over the next ten years just moved hugely into 
computerized data. From 1984 through really 2000 we made huge investments; whereas, when I 
first got there, you had to do almost all research by abstracting paper medical records. By 2000, 
just about everything was in computerized databases and all you had to do was link them 
together.  You had a population of three million people and you could build registries and you 
could do comparative effectiveness studies and other kinds of functions. 
We were at the head of the curve then; others were too. We had a very large defined 
population and really good databases even at that time and they just kept getting better through 
the 20
th
 Century and then they got a full-fledged electronic health record and that took a little 
getting used to because we were very used to the computerized data systems which kind of 
backed up this simpler electronic record. So we had all the lab results, all the prescriptions, all 
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the diagnoses, all the visits and visit types and all the procedures. Subsequently, we switched to a 
real EHR so we had all the notes and stuff was in a very different structure.  But certainly we 
continued to be able to do richer and richer analysis.   
We think big data are important because we think the kind of studies we want to fund are 
really best done in real world settings and the best way to do some of those studies without 
completely disturbing the natural setting. In the process we want the whole enterprise to take 
advantage of the big data from electronic health records and other computerized databases that 
these systems have with the active involvement of the patients, and the active involvement of the 
clinicians, and the active involvement of the systems.  We have a particular notion called patient 
engagement and we want the patients to be engaged but we also want to take advantage of the 
bigness of the data that are now accumulating and answer important comparative questions. 
Meaning of Big Data 
To me it simply means lots of data, lots more than you’re used to and you know, the 
reason big data is important is because without it you wind up with studies that are almost 
always too small.  Smaller than ideal, because it’s just simply too costly to go out and collect all 
this data on the very large numbers of people that you need.  So we’re hopeful that the existence 
of these big sources of data allows us to do studies in a million people instead of 10,000.   
And the reason that’s important is because first of all everybody feels more confident 
generalizing from an unselected population of a million people than from a much smaller 
population where you had to really work hard to get these people to participate in your study and 
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give you the data, a much more selected volunteer population.  So advantage number one is 
you’ve got real world data now, unselected data.   
Advantage number two is we’re really interested in how treatments work for individuals. 
In the past, because studies couldn’t be that large nobody could afford to fund a million person 
clinical trials study. You really always had to settle for the average affect, the average difference.  
You know, I had a randomized trial and I got 100 people in each arm and the average response 
rate was 70% in treatment A, and 60% in treatment B, the average difference, and that’s about all 
you can do; with 200 people that’s all you can do, and it wasn’t statistically significant.  You 
know, never mind that each arm had people of all ages and all levels of co-morbidity and 
certainly they differed genetically dramatically.  So if you can increase that tenfold, then you can 
begin studying the same comparisons but you can subdivide them into males and females, over 
75 and under 55 with a genetic marker versus without.   
So big data number one is usually more representative and number two it’s much more 
powerful and allows you to zero in and get much more refined answers and ultimately that comes 
back to being able to tell the individual patient this is what works better. 
Medicine as an Information Science 
Well medicine could become an information science I think if the clinicians and patients 
got actively involved in it. I think, I like to imagine that back in the 16
th
 Century when somebody 
went to the doctor that doctor had maybe a few books, but he also he made mental notes, or 
perhaps he kept written notes of his patients and he learned from patient to patient and he passed 
on what he learned, he kept it on paper, he kept it in his head, did his best to learn everything he 
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could from each experience and passed it on to future younger doctors and took it with him to 
see the next patient.  I think that with the arrival of the computer we could see the same thing but 
on a much richer, more detailed, more accurate, precise scale.  So I think if clinicians got into 
that frame of mind, they’d pay more attention to what they were writing in the electronic health 
record.  If patients got into that frame of mind they’d answer patient reported outcomes 
measures, they’d participate in randomized trials at higher rates.  
So I think that healthcare delivery, medicine as you call it, could become an information 
science. It could become clinical research if the patients and the clinicians become willing 
participants, and I think most clinicians in the long term if they had time and were incented 
properly would be happy to do that.   Patients I think it’s going to take a little bit more work just 
to get them to accept the fact that a lot of the things doctors are doing to them they’re doing 
without good evidence you know.  They’re doing with uncertainty and so I think that we have 
work to do and elsewhere there’s work to be done to convince patients, doctors, delivery systems 
that clinical care really ought to be research, you call it information science. Everybody 
participates in some kind of learning. 
Healthcare Big Data Drivers 
Well I think probably the main drivers are a desire to be able to bill accurately, okay, so 
that’s a huge driver of electronic health records believe it or not and the second one is a, you 
know, this rapid rise of performance measurement.  So you know, one of the things that I saw 
drive the deployment of computerized clinical data systems in EHR was when NCQA began 
asking for all these performance measures and Kaiser wanted to monitor its own performance 
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and improve it.  To do that they had to be able to measure that performance in an affordable way, 
you couldn’t have millions of people sitting down with paper records trying to figure out what 
the blood pressure level was, so you needed it in the computer.  So I think those are probably the 
two biggest drivers.   
I think clinical efficiencies lagged way, way behind and in fact I think it isn’t necessarily 
more clinically efficient.  It might be higher quality care but it takes much more time.  It’s not 
you don’t wind up going home faster at night because you have an electronic health record; in 
fact most people say the opposite.  So I think billing, accurate billing with the increasing 
requirements of data related to billing and performance reporting are the two biggest drivers that 
occur to me. That’s the reason we picked the electronic health record that we did pick at my 
previous job because it was the leading electronic health record for billing. 
Sources of Data and Data Scientists 
Others basically generate the data and we haven’t made any significant effort yet to gain 
possession of copies of data I would say and that’s maybe not even in our future, you know. We 
don’t aim to become a big data processing shop. We are going to support this infrastructure and 
it will in fact ultimately become a data processing shop, but we won’t be driving it, it won’t be 
here.  
We do require that everybody who’s been funded to submit a final report and a version of 
that report gets put up on the website, so we do publish reports from our studies, but we also 
strongly encourage grantees to publish in the scientific literature and we use other means when 
the findings are really important and need to disseminate the findings more broadly. 
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I think the bigger the data sets the more complicated I think the platforms that are used 
for storing it and for analyzing it.  So you know, all of a sudden you’re moving to Oracle and 
beyond to places I don’t even know. You no longer are just keeping little SAS data sets sitting 
around and so I think that’s one thing that takes a lot of programmer expertise at a high level and 
then there are statistical, analytic kinds of questions that come into play and so you need the kind 
of expertise that asks the question.  
Organizational Challenges 
First of all it costs a certain amount of money to extract the data and analyze it.  So 
organizations spend billions building up these systems but they have a hard time justifying 
spending a million to analyze all that data, so it just is crazy but that is seen as a challenge.   
Trusting the data and the methods that were used to analyze it can be a second.  Changing 
practice based on what one sees in the data is a third because sometimes even though you see it 
still the incentives aren’t necessarily aligned to make it easy to change.  Let’s say you have a big 
system and you’ve got a bunch of cardiac surgeons and you’ve got a bunch of cardiologists and 
you do an outcome study yourself and you find that either the surgery or the stents that the 
cardiologist placed are not doing as well as the alternative. You want to move in one direction.  
Well you know you’re going to have a certain amount of opposition there and from the people 
who are being told to do less and so incentives, the incentives to act on the data.  I’d say 
spending the money to analyze the data, trusting the results, and knowing that the results are 
really reliable and should be acted on and then rearranging the incentives in the organization so 
that you can actually make the move that the data suggests you should make. 
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When you’re using real world data you always have to ask yourself whether the fact that 
one treatment looks like it leads to better outcomes than another than a competing treatment.  
One explanation is that one treatment is better than the other. That’s what you’d like to think but 
first you have to resolve the possibility that it might be because the patients are different and that 
there’s confounding selection bias that patients who get one treatment are just different in ways 
that effect outcomes from the patients who get the other treatment.  So I think another huge 
question is what do you do about missing data?  So a lot of clinical data has lots of ‘missingness’ 
in it and how do you sort of account for that ‘missingness’?   
Data Sharing 
What do you do if five systems each have part of the data and they don’t actually want to 
send their data anywhere, they don’t want to share it?   So this notion of distributed data 
collection, distributed queries, and distributed analysis is a big methodological issue that people 
are working on. Let’s say I’m the CEO of a health plan and some of the researchers in my 
organization are in part of a network and they’re in along with people from United Healthcare 
and Blue Cross Blue Shield, as a CEO I might be concerned that the data that we shared might be 
used for some purpose other than the stated research questions.  So you know, you feel better 
saying couldn’t we accumulate the data here and be ready to look at it whenever you ask, but 
we’ll just send you the aggregated results on the questions you asked then you can figure out 
how to put them together with those from United Healthcare and Blue Cross Blue Shield. So I 
think there’s a lot of interest in the idea of distributed analyses.  
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Unintended Consequences 
Well I think the critical thing is whoever provided the data and that includes the patients 
as well as the systems, need to be kept in the governance. If you get to the point where this data 
is getting repurposed, pretty soon you’re going to have somebody that’s very angry and decides 
to withdraw.  
Big Data’s Future in Healthcare 
I think that our vision is that delivery systems, whether they are big HMO’s, whether they 
are neighborhood health center networks, whether they are Accountable Care Organizations 
which are starting to come together all around the country and turning communities into systems 
of a certain type, they will begin to see it in their interest to capture the data, to ask and answer 
the questions, to share the findings broadly, and to drive quality up and cost down as part of what 
we call a learning healthcare system.  So you know, you’ve got to get familiar with data and 
convinced that the data can actually lead you to decisions and then you’ve got to overcome those 
other barriers which are spending the money, trusting the findings, and changing the incentives.  
I think that that’s got to happen, it will probably eventually happen but not as soon as it should.  
Closing Thoughts 
Well, just a couple last things, three things.  Number one, something we didn’t talk about 
today but is going to be part of big data pretty soon is genetic information.  I think it’s just a 
matter of time before doctors are ordering genomic screens, the whole genome, and somebody is 
going to have to store that information somewhere and when it’s stored then somebody is going 
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to want to use it for research, so that’s number one and that will take a lot of space, that will be 
really big data.   
Number two, there’s a lot of work to be done on patient privacy and the oversight of this 
research.  Yes everything has to be done to keep this data secured and protect people’s privacy. 
On the other hand, when these studies are not posing any physical harm to patients because 
we’re just looking at data, you do not need to require that a patient sign a 10 page or 20 page 
consent form.  Even in certain randomized trials, yes, you need a consent form but it doesn’t 
need to be 20 pages long if it’s a very low risk question.  So I think figuring out these issues 
about now that we’ve got big data, how do we work with IRB’s and human subjects oversight to 
rationalize how we use it and how we talk to patients about use.  I think a subpart of this is we 
have got to learn to talk to the patients about how these data, how and why these data are being 
used and why it’s a good thing and certainly leave room for people to opt not to participate, but 
mainly beat that drum that, you know, we’re practicing with uncertainty.  We don’t know what 
we’re doing and we can learn from the data and you could contribute.   
The third thing is just the extreme costs. We have to look for ways to make this more 
efficient cost-wise and I think part of it is deciding that there’s enough value in getting the 
answers to the questions that can be asked and that you give up on the notion that your data is 
one of the ways you make money.  I think some of the big HMO’s and others have seen their 
data as a commodity that they can capitalize on and that really gets in the way of data sharing 
and being in the learning healthcare system.   
As for patients having the ability to make data driven decisions, part of the research we 
fund is research on how do you help patients make these kind of decision.  So it’s one thing to do 
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the studies and get the data, it’s another thing to present the data in ways that patients can 
appreciate, even the clinicians can appreciate.  When you get to genetics, most doctors wouldn’t 
have a clue what to do with the results of a genomic screen, so you really need to figure out ways 
to take the data and take what’s known and put it into a format that people can use it.    
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 “A Sentinel that Signals Problems Ahead” 
“Arnold Daniels, Ph.D., Pharm.D., M.A.” 
Professional and Academic Experiences 
Towards the middle to the end of the 90’s the drug costs were going up dramatically, the 
cost of the benefit.  Some drug companies would ask us to do really unethical things to cut their 
costs without making hard decisions.  I was always in a position where I could stump it and I was 
caught off guard by this so I sought some formal training and some help from some different 
ethicists that could help me figure this out and I wound up working with a couple very prominent 
philosopher ethicist types. From there, I wound up doing a doctorate in medical humanities 
because once you get into the ethics and you start to understand the place of illness and the 
human condition really want to understand that, it’s the humanities that renders it much more 
clearly than any science does.  So I pursued the ethological end, that’s where my mind usually is 
and my greatest interest is where illness and the arts kind of work together.   
The research we did was often using that huge administrative claims database and we had 
combined it with other things.  So it could be prescription records, it could be prescription plus 
medical, but we had tens of millions of people that we had data on that we would use to do 
various research, look for various trends, help for our planning.  We used it to affect drug 
selection, drug utilization by sending messages to docs, sending messages to pharmacists, 
messages to patients. We could send docs information about a certain patient’s patterns of drug 
utilization, and did, so they could take care of their patients better.  We worked with public 
health officials from time to time to show them certain trends.  Sometimes, we were just being 
120 
 
 
silly and we would look at things like the effects of drug utilization after a certain TV show and 
focus on it.  
My patient advocacy organization has been around for quite some time now.  We are 
responsible for I think at the highest level beating back the utilitarian impulse we all have which 
is to do the most good for the most people. We also have patient assistant programs that can help 
patients find money to pay for co-pays, premiums, etc.   
Meaning of Big Data 
Big data has gotten to be almost like a parody. ‘Big pharma’ was a way of distinguishing 
the big institutional pharmaceutical giants that had almost unlimited resources and influence 
whereas those who were not ‘big pharma’ didn’t. So that’s how I understood the first use of big 
data in that fashion. I don’t think of big data as any particular company. I think of it as data sets 
that have huge numbers of elements and are organized in a way that can be mined to discover 
things, but also can be used to alter the course of events and improve performance and outcomes.  
I think of it mostly in a predictive way. We helped physicians and pharmacists make decisions 
about drug use for individual patients at the moment their deciding based on what is in the files, 
how we can access it, the sophisticated systems and the software allows us to access it, analyze it 
and produce something that’s usable in split seconds.  So big data to me is not just a big data set; 
it’s also how it can be used to alter a course of events or approve some sort of outcome from 
parking to healthcare.   
I arrived at this description by seeing it, being involved in it.  I was part of the group that 
would write rules that would affect how certain prescriptions that came in through our system, 
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how they would be adjudicated,  you know, when would we send an alert out to a pharmacist that 
says look below.  We tell a patient that more information is needed before we can adjudicate the 
claim or not based on what was in their file or not. I saw the power of big data or what was 
available from a lot of the big database sites we were in. I’m paying attention to what’s going on 
out there like what IBM does with some of these cities: manage traffic, manage water, etc. I 
mean every time you turn around it’s a big data conference; it’s the big thing. 
Medicine as an Information Science 
I’m going to say no. Medicine can use it, it applies it but it’s not it.  Medicine still 
requires listening to the stories, it’s touching and hearing and smelling, and all that.  So 
information is part of it, like I said information is part of the decision support systems but that’s 
all.   
Healthcare Big Data Drivers 
Some of it is the science. Now that we’ve sequenced the genome, now big data involves 
the computational biology, you need big data to just be able to make sense of all that genetic 
information.  Some of it is just trying to make sense of all the information that we have now so 
it’s an organizing approach.  How do we make sense of all the data that we’re getting from the 
science?  There’s a lot of pressure on clinical performance and there’s a lot of pressure on the 
economics and with good reason.  There’s thinking that you can use a lot of information to create 
these decision support systems needed to come from big data.  Again, it’s kind of the predictive 
analysis. That helps people understand what they should do or help them make decisions.  I 
would say that those things that are driving it in healthcare. 
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Sources of Data and Data Scientists 
I think where big data could come in real handy is the diagnostic odyssey.  The average 
time for people with a disease to get diagnosed is eight years.  It ranges from eight minutes to 80 
years, but it’s a long time and you just hear these stories constantly of people who have gone 
from doctor to doctor to doctor, test to test to test and it just takes a long time and while if you 
spent some time in healthcare like in the clinics and in the hospitals and while you see that the 
docs will always list the disease and their differentials to show their brilliance and their chops, 
it’s rare they’ll go after it because the mantra in medicine is common things happen commonly 
so don’t waste your time on the esoteric.   
What big data could do is to help bring some precision to when a patient is presenting 
whether or not there’s a strong likelihood of a particular illness.  This is what I suggested to my 
Watson friend there at IBM was you could add into this, they take a lot of the clinical data, 
scientific data, but I think you should add in the patient experience.  That trajectory is 
meaningful.  What docs do they go to first? Which ones sent them on their way? What was the 
sequence of docs they saw? What sequence of drugs they might have been given, what was the 
sequence of tests, are there certain things that you could make out of that that are consistent or at 
a high predictive value for a given disease that you could interrupt that odyssey early.  That to 
me would be an important application of big data in healthcare. 
Unintended Consequences 
I’ll tell you, in my professional focus, time really matters, and there’s so much damage 
done by that duration that the time it takes to get diagnosed, so much damage done in that period 
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of unnecessary tests, etc., that it lowers that risk.  But that risk is there. All it can do is predict 
and so there’s certain probabilities of being right but it comes with the probabilities of being 
wrong so it could be a problem.  
Repurposing of data – it’s happening actually. I don’t know if we’d say data is being 
repurposed, there’s a bit out there, there are a lot of drugs that are sitting in laboratories or were 
on the market and taken off for a variety of reasons that are being repurposed for rare disease. I 
suppose what comes with those drugs is information on them and they wind up, there’s several 
drugs that have just either fallen by the wayside and get brought out because additional 
investigations find out that they have a role there.  So it’s a combination of bringing out the old 
drug and using the information available.  But that’s big and actually causes a lot of problems 
because it could be effective therapy where there wasn’t any before. But sometimes they pull out 
these drugs that cost pennies and they get repurposed and then charge hundreds of thousands of 
dollars a year.  But with the drug comes data.  I suppose you could say it’s been repurposed. 
Big Data’s Future in Healthcare 
Well the hope is that its use is predictive in a few ways.  One is to be able to use it for 
surveillance, to be able to find in clinical trials. And so those one in a million events that can kill 
people, one in 100,000 are myths and so big data should be able to conduct a surveillance that 
serves as a sentinel to find the signals or problems ahead.  So part of it surveillance for problems 
… picking up signals that could not be picked up in the pre-clinical testing phase.   
The other is to be able act as decision support for patients and for whoever is taking care 
of people to know that with a certain set of attributes and certain environments what’s going to 
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happen to these patients with a range of options.  That’s the future state that I’d like to see.  Now 
it’s threading the needle, I don’t know if you have, but I have, where there’s way too much of a 
reliance on technology and information I think on the part of healthcare professionals.  Even just 
these clunky electronic health records, the doc doesn’t even look at you anymore. They’ve got 
their head in the computer, let alone take the stethoscope out and listen or just take a look at you 
or listen to your story.  So the future state also somehow doesn’t create this automaton of a 
healthcare professional, nurses, you name it, who forgets that there’s a human-being setting right 
there and just produces these weird robotic type of interactions where they don’t think about the 
situation.   
Metaphors and Symbols 
I’ve used it but I count on experts to help me with it when I need it.  So to me big data is 
very non-descript.  I can’t come up with a metaphor because I really don’t know. It’s not 
descriptive enough for me. I don’t know if people in big data, I wouldn’t know what they’re 
talking about or when they talk about it, do they mean just how it’s set up, are they just talking 
about volume, are they talking about a certain type, are they talking about certain capabilities 
with it, or is big data just like lots and lots of information in a particular area or does that also 
encompass the things you can do with it, I don’t know. So to me it’s too vague to even come up 
with a metaphor. 
Closing Thoughts 
I think the cause of big data would be better served by characterizing it more clearly for a 
lot of us and their own constituencies if they want to be able to move forward.  People can be 
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afraid of it, so between not really understanding what’s meant by it and by being afraid of any 
big thing, it needs to be clarified and demystified because I’m not sure what the hell they’re 
talking about.  
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 “An Unnecessary Euphoria” 
“Frances Milburne, M.D.” 
Professional and Academic Experiences 
I spent about 13 years at a managed care plan were my involvement with data and 
analytics really was about primarily learning how to think about populations in healthcare 
because as you probably are aware most clinicians really only think about the patient in front of 
them or a handful of patients at a time and aren’t really used to thinking in terms of populations.  
Certainly my public health background and then the fairly exciting work that was going on at 
there at that time in the early 1990’s on population management and how clinical medicine 
needed to be thinking about chronic illness care from a population perspective.  That was work 
that was done by Ed Wagner and his colleagues. I found that very intriguing.  
I left the managed care plan in the late 90’s because I’d actually been sharing my practice 
with a clinician who had gotten informatics training and was also an internist and I became 
aware though just conversations with him about how important the electronic health records 
were going to be.  This was long before there were any electronic health records but I then had 
the opportunity in the late 90’s to help start up a clinical network for a university. So that was 
really where I began thinking about data from a clinical perspective on a more organized fashion.  
I do not have training in informatics; it was really on the job.  So I moved after several years into 
a role of being the medical director for clinical informatics. While I was in that role what I 
basically did was start setting up reporting out the backend of the EHR’s which nobody was 
doing at that time.  In fact, even though we were using what is now probably the pre-eminent 
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EHR in the country, it did not have any way to report out of the backend and so I actually wrote 
a grant to one of the pharmaceutical companies to get a beta version of their relational database 
that’s now just standard operating equipment for the EPIC installations but we tested it out and 
started generating clinical reporting out of the backend for things like diabetes, heart disease, 
hypertension and stuff like that.  So that was really my experience, it was on a very, very 
practical application.   
Another activity that I was involved in that sort of overlapped with that somewhat or at 
least from a privacy and security perspective was essentially set up at the request of several 
governors at the time try to come up with some national standards for health care information 
exchange simply because each state had its own rules and regulations and policies and 
procedures and it was becoming very, very challenging to exchange health information across 
state lines.  So that was some insight into some of the issues around handling large data.   
Meaning of Big Data 
What big data means to me is that you assemble information from multiple sources that 
then get assembled in a large dataset and who knows where that actually resides in various 
servers around the country or even around the world I suppose which is sort of euphemistically 
referred to as the cloud and assuming that privacy and security constraints are being 
considerations for being adhered to which is I think a big question mark.  Then you know there 
are certainly ways that large datasets can be used to recognize patterns which are otherwise hard 
to spot.   
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I don’t even know where it’s all coming from but I think there’s a sort of euphoria being 
built around big data that is not necessarily, I think it’s, and you get this sense there’s this sort of 
train leaving the station and everybody is supposed to get on it and yet as I said I think where 
information has the greatest potential to improve health and raise cost is in the way it’s used in 
individual provider’s practices and in delivery systems. But, I think there are some really risky 
things about big data.  
Medicine as an Information Science 
Clearly medicine is a very information rich endeavor.  I mean it’s one of the most 
informative, it’s orders of magnitude more data rich than finance let’s say.  A lot of the models 
that we come up with for certain thinking about how to handle big data are based on finance, but 
it’s just orders of magnitude more complicated.  So I think there’s no question that it’s an 
information science.  It’s more than that though because it doesn’t lose its human side. What I’m 
referring to is the fact that so much of the information we use in medicine is imprecise or 
irrelevant or just background noise. Computers are really good are really good at setting things 
up so that they flawless. They will do the same task with the same information over and over 
again so they’re very good for example at prompting humans to remember to do things that have 
to be done over long time intervals that are really easy for us to forget like screening and they’re 
very good at presenting information in patterns that we’ve programmed the computer to present 
information in. The other thing computers are really good at is when we have to actually slow 
down and think something through and figure something out then computers can organize 
information in ways that make it easy for us to solve difficult problems. So that’s really the use 
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of computers. But we have to remember all the time that computers aren’t anywhere near as 
smart as the person that’s using them, so what the human brain is really good at is recognizing in 
patterns where we didn’t know there was a pattern, computers can’t do that at all.   
But I think it’s unrealistic to expect providers and patients to really adhere to strict 
privacy and security standards which for the past 10 years we’ve taken very seriously and then 
just find out that we just sort of shrug our shoulders. I think it really is a crisis that has to be 
addressed. 
Healthcare Big Data Drivers 
I think industry really sees big data as an opportunity to selectively market to the 
American people based on their individual healthcare needs. Now this may get sort of promoted 
as if we can figure out which patients need certain drugs and we can get those drugs to them we 
can improve their health. Unfortunately, the background reality is that Americans take way too 
many medications; only a fraction of them really provide benefit. Certainly blood pressure is a 
good example and some of the new biopharmaceuticals that are very specific for cancers or 
certain immunologic disease is they have some targeting potential on that.  So I suspect that a lot 
of the push for big data is from industry, it’s not all the pharmaceutical industry, a lot of it is 
medical devices.   
I think the use of information in healthcare again as I said is really local and there’s a 
cycle, I mean there’s actually a pattern there that I find extremely interesting and it’s basically 
this: Information gets entered into the computer and it comes in from multiple sources. It may 
come in from lab results and a lot of it comes in from just interactions between people and gets 
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documented hopefully as structured data but also as text.  Then that information now can be 
acted on by tools in the computer that have to be set up. So the way that it’s of greatest 
importance in the delivery of healthcare is as in its use in two ways. One, its ease in being shared 
with other people including the patient so that more than just the doctor that has the chart can 
have access to that information, but other specialists, hospitals, emergency departments, and 
most importantly the patient can have that information.  So that’s one thing that the flow of 
information in the practice does that’s revolutionary.   
The other thing I would say is that the public health community particularly is quite 
interested in getting involved in the treatment or the management let’s say of chronic illnesses 
and they really haven’t been able to do that up until now. Public health is primarily involved with 
disease outbreak and particularly reportable diseases, infectious diseases, and then disaster 
response. But to start to get involved in chronic conditions, obesity, diabetes, and heart disease 
what public health is really looking for is information where they can identify places that public 
policy can be driven by patterns of diseases that are right now hard to see: smoking habits, 
nutrition, and places in the community where there are high rates of narcotic use.   
Another one is just for public policy decisions. For example, where do we put our 
resources and what are the biggest health threats to the population? So I think for the potential to 
do that is from big data sets is really great. From the perspective of a clinician or a healthcare 
policy person, that’s really driving improvements in quality. 
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Sources of Data and Data Scientists 
It depends on how it’s structured. Providers really don’t interact with big data on that 
level. The closest thing that I could think of to that is a provider would have a hosted EHR so 
they don’t have the servers in their own organization as is the case for small groups and rural 
groups, and so that that information then is hosted externally.  One example is the local Regional 
Extension Center. They’ve been heavily involved in helping providers install their EHR’s and 
have formed a collaboration with a data analytics company and so they then have access to these 
streams of information on providers who they have no relationship with and they can basically 
go to those providers and say do you know how you’re doing in managing your heart disease 
patients and they say no we have no way to get that and they say well look let’s show you and 
here is not only here is your population of patients with heart disease but here’s how you’re 
doing and actually you know here’s the gap. Here’s where you want to be and here’s how you’re 
actually doing. Let us help you fix your processes to improve. In fact, here’s a free iPhone app 
you can have if you join our system and you can actually go in and look for individual patients; 
you can see how they’re doing. You can also look at how they’re doing in aggregate and they get 
their data from the EHR’s and through the laboratories and then they get billing data and they 
can do this.  So that is a way that I’m starting to see a developing and I think that sort of counts 
in the big data, it’s not, certainly not de-identified it’s in a service provider realm that’s 
developing.  
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Organizational Challenges 
I think there’s, it’s really hard to make a case of big data if we’re going to make it’s 
where the money is and it’s been my observation that if we start getting sort of distracted by 
these things that big data can do in terms of disaster response that that really leaves out where 
most of the work that happens that is involved with healthcare quality takes place, and that is in 
the provider’s office.  I think it’s pretty hard to make the argument that it is going to provide a lot 
of benefit for providers and patients on a one-to-one basis.  I’m pretty skeptical about that.   
I think most of the action with information in the EHR has to do with getting it into the 
EHR so that it’s accurate which is a major challenge because there’s a lot of inaccurate 
information in most of the EHR’s.  Also, learning how to report out of it so that practices see 
how they’re doing taking care of their populations on a very local level.  So what percentage of 
my patients, who are my patients first of all, that’s the big one, but after you get that, what 
percentage of them have been immunized properly, have been screened for cancers properly, if 
they have chronic diseases are being taken care of properly, that’s not a big data issue that’s an in 
the practice use of data so I think that is where the real action is as far as use of the EHR’s. 
Unintended Consequences 
The downside I think there are two, and unfortunately I think this is where big data is 
largely being used and what’s unfortunate is it doesn’t get talked about very much.  The 
advocates of even in public health tend to just sort of quietly move to another subject if you bring 
these of negative uses of big data up because they’re so enumerative the potential.  One of them 
is marketing.   
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The other place that I think big data entails a huge risk is simply in abuse from national 
security.  I think it’s very, very clear that the NSA is all over big datasets and there’s no reason to 
think that healthcare is any different. Very clearly there’s a need for government to identify 
individuals who may oppose risk to the rest of the population.  But that’s a very, very different 
proposition than gathering and doing large scale population surveillance and simply sucking up 
everything.  I think we’ve tended to shrug off the revelations that have come out over the past six 
months or so about how large datasets are being used for security agency surveillance which is a 
major departure from what we’ve assumed was the case in the past.  
I think that by setting up large datasets in healthcare in the cloud, I mean we can say that 
they’re secure but those are now just words and so I think we may very well be coming to a point 
where, well there’s something changing and it’s not clear to me what’s going to happen.  I mean 
the Europeans are certainly starting to sort of disconnect themselves from interactions that are 
easily surveyed although they have the exact same issues there and certainly some of their 
security agencies have been part of the whole thing, but I think we’re either moving into a field 
where we just kind of give up on privacy and say well that’s kind of over or we have to say no 
look we actually do take privacy and security seriously. 
Big Data’s Future in Healthcare 
Everything that I have talked about that I see as a benefit for big data can be 
accomplished if the data are completely de-identified.  So public health surveillance, disaster 
preparedness, situational awareness, disease patterns, public policy, every single one of the 
beneficial activities or purposes can be accomplished if there is nothing in there that allows 
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identification of individual patients.  One can argue that if you put in some identifiers it allows 
some additional benefit. For example, if you really wanted more information out of how people, 
what percentage of people with asthma admitted to the emergency rooms are ending up in the 
ICU and then a week later bouncing back then you have to put patient identifiers on them. You 
can get that same information out of delivery system data on the local level if you find a place 
where you need to investigate further.   
So my vision would be that big data sets first of all have strict purposes rather than let’s 
create big data and then figure out what we might do with it.  I think there needs to be a what are 
we addressing, what information do we need, and how are we going to use that information.  I 
think that first of all patients need to be informed of where their information is going so that they 
know and I think they should have an opportunity to opt out if they don’t want it.  Then I think 
that any information that’s gathered and compiled and aggregated and then looked at for public 
policy or for any of the public health purposes we’ve talked about should be strictly de-
identified.  That would be a vision there for what it might look like. Then I think you would 
avoid the two pitfalls which are marketing and a lot of the national security abuse I think would 
be avoided in that case.   
Metaphors and Symbols 
I spend a lot of time thinking about information, but as I said most of it is on a very local 
level.  For example Accountable Care Organizations will really only work if everybody 
understands the metrics against which they’re being compared and everybody is using the same 
metrics, every insurance company is using exactly the same metrics, so one is the saying well 
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we’re measuring the percentage of patients who have hypertension who have a blood pressure 
average on the last three or whatever under 140 over 90 let’s say, and the next insurance 
company says yeah we’re doing that too only it’s actually greater to or equal to, less than or 
equal to 140 over 90. Those are two totally different targets because people round to whole 
numbers.  So and blood pressure is imprecise, or one might say 130 over 80.   
An ideal system would be one in which the providers actually have an internal dashboard 
that’s identical to what the payers are seeing and that the providers are allowed to manage their 
outcomes to where they get to a point where they say we’ve got them where we want them, now 
we send them to the payer and they can come and audit us and make sure that our process is 
correct. So I think we’re going to have to have a lot of transparency.  So how do we set this up so 
that we can actually manage outcomes and costs and agree that we’re both measuring the same 
thing? 
Closing Thoughts 
I’d like to point out that what providers need more than anything is analytics.  They need 
to be able to use the information in their systems to tell how they’re doing and to figure out what 
to do and to set priorities and that’s what’s lacking.  It’s not clear to me that big data, the way it’s 
set up in cloud base will allow that to happen but it may.  One way that big data could be used is 
to identify emergency high utilizers.  
These are patients who are completely overwhelmed by their disease or their medical 
conditions and their social situation, so they end up going back to the emergency room over and 
over again and running costs up at an extravagant rate.  It’s very destructive, and big data could 
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be used to identify places and people where that’s happening. Big data can desperately identify 
social and mental health services needs and that’s the type of thing that probably should be done 
inside a practice.   
So there’s lots of ways that this could be brought in to help in specific situations. But I 
once again want to caution the way we’ve gone about this is let’s build huge datasets and then 
I’m sure some great social benefits will accrue. I think what we’ve done is we’re raising the risk 
of what I consider to be misuses of data in ways that are not necessarily in the public interest. 
Yes, there clearly is a role for big data in public health policy, public health intervention, and 
high utilizers and I’m sure other uses will show up. So having big data capacity is I think very, 
very useful.  Again, I don’t see that it requires identifiable information but you know that may or 
may not hold up. 
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CHAPTER VI. RESULTS 
Overview 
This chapter provides the research study’s findings assembled through a general inductive 
approach to qualitative research which is commonly used in healthcare (D. Thomas, 2003). Data 
were collected through nine semi-structured interviews with key healthcare stakeholders from 
three classes: government, providers, and consumers (advocates).  The results describe (Amedeo 
Giorgi, 2009) and interpret, as accurately as possible, a first-hand account about the phenomenon 
of big data in healthcare across and within the three key healthcare stakeholder classes. 
Triangulation of the three stakeholder groups was an important strategy that facilitated any 
inclination towards researcher bias. The analysis was anchored by the following research 
question: 
Q1: Within and across the narratives of three key healthcare stakeholder classes, what 
are the important categories of meaning or current themes about big data in healthcare? 
Further in-depth analysis produced “units of meaning” used to reconstruct key stakeholder 
narratives into a cohesive yet agile statement about the meaning of big data in healthcare – 
without losing the essence of narratives in their entirety. The words of Van den Berg, translated 
by Van Manen (1997, p. 41) profoundly captures the essence of phenomenology as both a 
philosophy and a research method: 
[Phenomena] have something to say to us — this is common knowledge among 
poets and painters. Therefore, poets and painters are born phenomenologists. Or 
rather, we are all born phenomenologists; the poets and painters among us, 
however, understand very well their task of sharing, by means of word and image, 
their insights with others — an artfulness that is also laboriously practised by the 
professional phenomenologist (M. Van Manen, 1997). 
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 Explication of the Data 
Groenewald (2004) revised Hycner’s description of  “data explication” (Hycner, 1985), 
suggesting “the term [analysis] usually means a ‘breaking into parts’ and therefore often means a 
loss of the whole phenomenon …whereas ‘explication’ implies an … investigation of the 
constituents of a phenomenon while keeping the context of the whole” (p. 17). Explication 
resonated with my edict to maintain the essence of the key healthcare stakeholder narratives. As 
such, explication of the data was yet another strategy to eliminate any predisposition of 
researcher bias on the research design.  
Results 
Four distinct, yet interrelated, important categories of meaning naturally emerged during 
the course of the data explication: (1) Ontological Framework of Big Data in Healthcare; (2) 
Humanistic Dimension of Big Data in Healthcare; (3) Information and Knowledge Science for 
Big Data in Healthcare; and, (4) Governance of Big Data in Healthcare. A description of each 
category of meaning and the number of times an event was coded within each “theme” is found 
in Table 7. Through the process of reading and rereading the text of the transcripts, 
contextualized data initially produced approximately 41 initial nodes. These nodes were reduced 
to 17 distinct “subunits of meaning,” categorized into the four “important categories of meaning” 
Each category of meaning constituted the essence of big data in healthcare as described 
by nine leaders from three key healthcare stakeholder classes. The general inductive approach 
allowed me to derive a description and interpretation of the key healthcare stakeholder narratives 
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while also presenting a description of the categories of meaning within and ultimately across 
each key stakeholder class. 
 
Table 7. Description of four important categories of meaning of big data in healthcare reduced 
from over forty sub-meaning units. 
From a Husserlian phenomenological perspective, the description of narratives, even 
though transcribed and possibly written, still remains a description (Amedeo Giorgi, 2009). 
Keeping with the construct of phenomenology, my objective was to also engage in the 
interpretation of the study participant’s interpretation (“double hermeneutic”) of big data in 
healthcare. I consciously set aside my own presuppositions so as not to bias the data explication 
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and interpretation through bracketing (Groenewald, 2004) out my own experiences about big 
data in healthcare. Bracketing was yet another strategy to control for researcher bias. Using the 
raw transcripts as a primary reference, the clustering of important categories of meaning 
(“themes”) emerged iteratively through the study participant’s own words.  
 Phenomenology focuses on the common elements of a phenomenon, rather than on the 
individual. In keeping with this aspect of the chosen methodology for the study, I did not include 
participant names or pseudonyms in presenting excerpts from the interview transcripts. The 
header box before each category of meaning was extracted from Figure 7 to assist maintaining 
the reader’s orientation of each category of meaning and associated subunits of meaning.  
Findings were not intended to be generalizable across or within key healthcare stakeholder class.   
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Ontological Framework of Big Data in Healthcare 
 
Category Definition 
This category refers to an informal representation of interrelated concepts, knowledge, 
words (and buzzwords) and phrases that describe the characteristics, attributes, and meaning of 
big data which produce information for wisdom and decision making in healthcare. In addition to 
Gartner’s popular characterization (not definition) of big data as Volume, Velocity and Variety 
(3V’s) is here augmented with another “V” - Value (Porter & Teisberg, 2006). Value is created 
by producing, through the disciplines of information and knowledge management, usable 
information for healthcare intelligence and decision making. These attributes and characteristics 
encapsulate big data’s realized – not potential – intent. Many study participants exhibited a 
skeptical position on big data in healthcare by characterizing it as “over-blurted”, “a parody” and 
“the latest craze” and observing the “expression is overused.” Or as a government stakeholder 
said, “it’s a heap of 1’s and 0’s.” When study participants did define big data, intuitive 
references emerged such as “smart data” that has an ability to “answer questions more deeply 
and get down to the causes as opposed to scratching the surface” as described by another 
government stakeholder. This category refers to both human and organizational forces and events 
which drive the emergence of big data in healthcare. Big data drivers are those internal and 
external forces of the healthcare ecosystem which possess the ability influence or drive the use 
and advancement of big data in healthcare. Big data influencers could be a thing (e.g., 
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technology), a policy (e.g., Affordable Care Act) or an attribute (e.g., better question generation). 
According to McKinsey, fiscal concerns, or healthcare costs are the primary driver of big data in 
healthcare.
9
  Provider billing policies, public health surveillance, and marketing to individual 
patients were cited as other drivers of big data in healthcare. 
1.1 Purpose 
The analysis found that big data in healthcare must be collected with a purpose that is 
well defined during the initial planning stage for a project or initiative. Because of the massive 
data sets that are collected and the associated costs of designing systems to capture and analyze 
big data, a stakeholder posited:  
You build data systems, they cost so much money to actually collect the data it’s 
quite expensive.  They’re built for specific designated purposes and it’s fairly 
important that you know what the purpose is before you start.  I just did a 
carefully designed data system that is very purpose specific.  They’re designed for 
a specific utility a specific purpose and they just happen to collect massive 
amounts of data but they’re always for a specific purpose (Provider). 
 
A government study participant pointed out the unintended consequences of purpose-
driven big data by stating, “Purely relying on machine learning without the application of 
subject matter expertise and the application of a clearly defined set of goals can lead to big data 
actually distracting an organization from its core goals and outcomes.” While potential 
nefarious uses of protected health information do exist, study participants overall welcomed 
repurposing big data for an array of uses: 
                                                 
9 http://www.mckinsey.com/insights/health_systems_and_services/the_big-data_revolution_in_us_health_care 
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So public health surveillance, disaster preparedness, situational awareness, 
disease patterns, public policy, every single one of the beneficial activities or 
purposes can be accomplished if there is nothing in there that allows 
identification of individual patients (Consumer). 
 
Another consumer stakeholder agreed with the ideology of planning, with a purpose, for 
big data collection. Planning for big data usage at the onset of a project or initiative suggests that 
simply amassing large data sets as an organizational asset is only part of the strategy to realizing 
big data’s true potential: 
So my vision would be that big data sets first of all have strict purposes rather 
than let’s create big data and then figure out what we might do with it.  I think 
there needs to be a what are we addressing, what information do we need and 
how are we going to use that information (Consumer).   
 
1.2 Precision 
 Terms including precision medicine, personalized medicine, and resource-based medicine 
are interchangeable references to medicine that, at the very least, combines transactional data 
(e.g., claims) with computational biology, and genomics data based on an individual’s genetic 
and social epidemiology profile. The meaning unit – precision – was not interpreted as the 
process of collecting and managing big data but big data’s trustworthiness. The combined 
attributes of big data quality and trust creates confidence in the level of big data’s preciseness. A 
provider government stakeholder states, “I think one of the problems is trust in data quality and 
data fidelity.” He further expressed his view on a lack of confidence in the precision of big data 
connectedness:  
I think people don’t really know yet if this is something, you know, put everything 
in a little black box and it comes out the other end and it gives me a relationship, 
and people say I’m not so sure if that actually is true or not (Provider).  
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 While one provider study participant voiced his concern that, “there’s no proof point yet  
that is kind of real concrete,” another study participant from the consumer stakeholder class pins 
his hopes on the premise that big data precision is necessary to support optimal hypothesis 
generation in patient episodes such as  rare clinical cases:  
So what big data could do is to help bring some precision to when a patient is 
presenting whether or not there’s a strong likelihood of a particular rare disease 
(Consumer). 
  
 A government stakeholder cautions, “Big data is currently fraught with hype and over 
promising.” He also believes big data “is an area of incredible promise for healthcare.” 
Furthermore, there are approximately 500 petabytes of healthcare data in existence today and 
that number is expected to skyrocket to more than 25,000 petabytes within the next seven years 
(Savaiano, 2013).
10
 According to several stakeholder narratives, these clinical and administrative 
data held in fragmented information systems will not produce the timely and accurate insights 
yield better questions for better answers. A government stakeholder adds: 
I think everybody’s hope is that in five years’ time, there will be widespread 
integration of administrative, clinical and patient generated data that will be 
available through big data; it’s assuring that the right person gets the right data 
at the right time and the right format for them (Government). 
                                                 
10
 In the construct of Orders of Magnitude, a petabyte is the equivalent of 1,000 terabytes, or a quadrillion bytes. 
One terabyte is a thousand gigabytes. One gigabyte is made up of a thousand megabytes. There are a million 
petabytes in a zettabyte. 
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1.3 Provenance  
 The consumer stakeholder class elicited responses that focused on the individual and 
population health informational needs: “we’re really interested in how treatments work for 
individuals.” Provenance of big data, which one study participant suggested is the vital 
commodity, notes, “data is very nondescript.”  
 Data provenance refers to the information sources about data and includes data points 
such as contextual and physical metadata and Meaningful Use attestation data. In the government 
stakeholder class, one respondent spoke of the integration of genetics stating, “We were getting 
lots and lots of data coming in from the genome sources from that point and we were injecting it 
and trying to be able to analyze it.” Life science disciplines including biomedicine, neuroscience, 
genetics, and genomics were intentionally excluded in the definition of big data in healthcare. I 
intentionally wanted to let life sciences narratives naturally emerge from the narratives, provided 
study participants viewed the subject as an important theme. Genomics did naturally emerge 
from the narratives as an important source of big data (“New data sources including genomics, 
senomics,and other “-omecs” are out there. Metropolomics, for example, are generating huge 
amounts of data that need to be processed in ways different than we have in the past”). In 
deference to Gartner’s classification of big data, genetics and genomics fit into the High Variety 
classification group. Genetic and genomic data are fundamental to achieving precision in clinical 
hypothesis testing and is foundational to delivering personalized medicine. The richness of 
genetic information was championed across all stakeholder classes: 
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Government: 
I think genomics and the ability to do sequencing is the first statement of it [as a 
driver of big data]. You know, there are a lot of things where we’re getting ideas 
into genetics, we’re getting them information about environment, and we’re 
getting information on health.  What affects us, what affects us mentally, you 
know, our health affects our mental state and our mental state affects our health, 
our emotional states (Government).  
 
Providers: 
I mean the integration of genomic data phenotypic data which is clinical data in 
the electronic medical record. It’s something that every academic medical center 
is racing to do because the answers are not going to be in one or the other.  The 
answers are going to be in the combination of both and so that is absolutely the 
future, a very reasonable approach (Provider). 
 
I think the whole genome sequencing components so again some more of the 
genetics side of the equation over the patient’s life span and helps predefine 
clinical context based on the genetic information. So I think that’s hopefully going 
to help us with neurogenetic diagnosis decision support in the electronic medical 
record again so some of the things you see in 23andMe.com may be more 
sophisticated in terms of patient genomic test reports and that kind of thing 
(Provider). 
 
Consumers: 
Well some of it is the science, you know, now that we’ve sequenced the genome, 
now big data involves the computational biology, you need big data to just be 
able to make sense of all that genetic information (Consumer). 
 
Something we didn’t talk about but is going to be part of big data pretty soon is 
genetic information.  I think it’s just a matter of time before doctors are ordering 
genomic screens, the whole genome, and somebody is going to have to store that 
information somewhere and when it’s stored then somebody is going to want to 
use it for research, so that’s number one and that will take a lot of space, that will 
be really big data (Consumer). 
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 Although information for decision making as an output of big data was important to key 
stakeholder classes, almost all study participants were still plagued by the quality and 
trustworthiness of big data in healthcare, as one study participant put it, “I think there are some 
really risky things about big data.”  Another study participant gathered: 
I think the cause of big data would be better served by characterizing it more 
clearly for a lot of us and their own constituencies if they want to be able to move 
forward.  People can be afraid of it, so between not really understanding what’s 
meant by it by being afraid of any big thing, because big things you know can take 
advantage of not big things, there needs to be, whoever big data is, whatever it is, 
it needs to be clarified and demystified I think, mainly clarified I’d say because 
I’m not sure what the hell they’re talking about (Consumer). 
 
Several study participants emphasized the emergence of other new data sources into the 
big data equation, including “biometric data from sensors which people tend to get excited 
about,” and the emergence of “device interoperability and the data the comes from medical 
devices.” Among all of the transactional and biometric types of data mentioned, one respondent 
added a forgotten source of data - narratives: 
I’m not against that whole thing on natural language processing and using 
narrative, it just has a different goal and the goal is to try and take somebody’s 
really unstructured but maybe highly intelligent thinking and try to sense what 
general thing were they getting at, what can we discern from that … (Consumer).  
 
In two key stakeholder narratives, big data was characterized simply as “a whole heap of 
1’s and 0’s” and “at the end of the day you got a machine language that’s all 1’s and 0’s” 
without structure, governance, and purpose. As a government stakeholder speculated:  
“I know that some people consider big data not to be ‘big’ until it’s in the 
trillions, but we manage 400 billion discrete pieces of information  … and it’s 
growing by about four or five billion data records a year.”  
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Of note is Gartner’s High Variety characterization of big data. Healthcare is a 
transactional business that relies on “administrative data as the foundational component.” But 
stakeholders highlighted a host of data sources commonly used in their day-to-day routine, 
acknowledging that, “it’s incomplete and inaccurate and there are no common standards.” 
“missinginess” is a big problem, and there are an “infinite number of data points I could 
collect.” The following table (Table 8) provides an aggregated summary of the sources of big 
data cited by study participants.  
Articulated Big Data Provenance  
Government Providers Consumers 
Enrollment Data Financial Social Media 
Hospital Data Administrative Public Data 
Physician Data Human Genome Project Demographic Data 
Assessment Data Human Microbiome Project Physical Measures 
Laboratory Data Meaningful Use Standards Personal Medical History 
Medicare Data Management Treatments Narratives (Stories) 
Medicaid Data Sensors/Biometric Other 
Table 8. Big Data provenance of referenced in key stakeholder narratives 
1.4 Gartner 3 V’s 
In the provider stakeholder class, two of the three study participants said big data “means 
a lot of different things to a lot of different people.” Gartner’s “3V’s” characteristics were 
referenced by several study participants across the three classes. One provider study participant 
said, “I like the definition that Gartner coined … where big data is a high volume, high velocity, 
high variety information … used to enhance insight in decision making.”  
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 Provider stakeholders require speed, or in Gartner’s characteristic of big data, High 
Velocity to provide the best clinical care at the lowest cost. But there is more work to be done to 
fully realize the “hype” of big data in healthcare. A provider stakeholder referenced the work of 
IBM and its capability to “consume all the literature so they don’t have to read it.” Another 
stakeholder noted: 
So something that hasn’t been fully mapped out into the analytical processing 
scheme that I want is something that’s more real time feed that I can actually act 
upon much quicker.  So there will be some components that are real time, some 
components that are like data warehouse and dashboard based, and then some 
components that are for big data for large data sets and for better insight.  So I 
can go to my big data to find the hypothesis.  I can go to a data warehouse to test 
that hypothesis and I can use my real time data to basically put that hypothesis 
into action with decision support (Provider). 
 
Summarizing the insight of the many study participant viewpoints on the Gartner’s “3V’s” 
characteristics of big data in healthcare that are currently in use and those which we can 
anticipate, one study participant asserted: 
The sources of data that we use are pretty varied even though I’d say that 
administrative data is the foundational component.  It actually meets the Volume 
and the Variety criteria we use records for multiple parts of the Medicare system, 
the Medicaid system, the enrollment data, hospital data, physician data, 
assessment data, laboratory data, Medicare data, and Medicaid data.  I know 
we’d obviously be interested in adding other paired data to the mix. Then there’s 
survey data, there is some pretty rudimentary Meaningful Use attestation data but 
we don’t have any actual Meaningful Use data yet (Government). 
 
1.5 Value 
Consistent with increasing healthcare costs, one provider healthcare stakeholder believes, 
“Value based purchasing and moving away from the lack of accountability of fee—for service- 
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service” is key driver. Consumers of healthcare seek personalized medicine that is unique to their 
individual medical care and treatment plans. One consumer stakeholder gathered the “rapid rise 
of performance measurement” is a driver of big data in healthcare. Clinical performance 
measures (CQM) are developed by measurement developers to focus on patient-centered 
measures and the patient experience, creating value for patients. Another stakeholder believes 
big data is being driven by healthcare industry marketing strategies. The stakeholder proclaimed, 
“Industry really sees big data as an opportunity to selectively market to the American people 
based on their healthcare individual needs.” Then he further elaborates it is possibly all 
unnecessary: 
I think there’s a sort of euphoria being built around it that is not necessarily, I 
think it’s, and you get this sense there’s this sort of train leaving the station and 
everybody is supposed to get on it and yet as I said I think where information has 
the greatest potential to improve health and raise cost is in the way it’s used in 
individual provider’s practices and in delivery systems (Consumer). 
 
National health spending has grown at historically low rates following the deep recession 
that ended in 2009. Whether this slowdown stems from broader economic factors, structural 
changes in the healthcare system, or some combination of the two,
11
 big data in healthcare is 
seen as a commodity that if harnessed by technology and humans, can help make the delivery of 
healthcare even more cost-effective. But there was general disagreement on whether the costs of 
building healthcare systems and collecting and analyzing data is rising or falling. A government 
stakeholder says, “It’s much cheaper to collect big data and it’s cheaper to store it,” and a 
                                                 
11 Source: Kaiser Family Foundation (www.KFF.org)  
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provider stakeholder adds, “Hardware is getting faster and is making itself available at low cost 
points.” But another healthcare leader suggests that the exorbitant costs of collecting big data 
have to justify their spending to manage big data: 
First of all it costs a certain amount of money to extract the data and analyze it.  
So organizations spend billions building up these systems but they have a hard 
time justifying spending a million to analyze all that data, so it just is crazy but 
that is seen as a challenge (Consumer). 
  
 Another consumer stakeholder is in agreement. He speculates that there is an association 
between deriving enough value from searching for optimal answers and good questions: 
The third thing is just the extreme costs, you know, we got to look for ways to 
make this more efficient cost-wise and I think part of it is deciding that there’s 
enough value in getting the answers to the questions that can be asked that you 
give up on the notion that your money is one of the ways, your data is one of the 
ways you make money.  I think some of the big HMO’s and others have seen their 
data as a commodity that they can capitalize on and that really gets in the way of 
data sharing and being in the learning healthcare system (Consumer).   
 
Summary 
 There is an awareness problem about big data in healthcare. A consumer study participant 
admitted, “Nobody’s ever defined it for me but I’ve heard it used a lot.” Another frankly 
commented, “I never thought about it until you asked me. I just assumed that I sort of knew what 
it was.” A government stakeholder narrative insightfully cautions us that because of the 
awareness issues associated with big data in healthcare, big data could potentially loose its 
momentum: 
If I look at it today and big data has kind of lost some of the meaning that it had at 
the early part and maybe even gained, and eventually will probably gain maybe a 
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specific definition to make it useful again. Some government stakeholder views of 
and formed opinions on big data in healthcare revealed feelings of cynicism and 
relevance. Its existence and possibly importance is undeniable. However, it 
requires a collaborative, momentous effort to define it and broadly diffuse its 
meaning – fast (Government).  
 
Another government stakeholder suggests that big data “is currently fraught with hype 
and over promising,” and he also thinks big data “is an area of incredible promise for 
healthcare.” Key healthcare stakeholders perceive big data as a buzzword or slogan that is not 
universally understood. Also other drivers of big data in healthcare were uncovered – a consumer 
stakeholder gathered that while the “rapid rise of performance measurement” is a driver of big 
data in healthcare, another stakeholder believes big data is being driven by healthcare industry 
marketing strategies (“industry really sees big data as an opportunity to selectively market to the 
American people based on their healthcare individual needs”). A government study participant 
confirmed McKinsey’s assertion that big data can influence the spiraling costs of healthcare. He 
commented, “We need to make the care we deliver less expensive and more efficient overall.” In 
addition, “culture and leadership” are important influencers of the explosion of big data in 
healthcare. Another study participant supported the notion that government rules drive big data 
in healthcare, “Because it places data and the ability to harness and leverage data at multiple 
points throughout the healthcare ecosystem at the center as opposed to at the trenches.” 
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Humanistic Dimension to Big Data in Healthcare 
 
 
Category Definition 
This category is a philosophical and ethical stance that, augmented with technology, 
emphasizes the value and agency of human beings’ cognitive and critical thinking contributions 
towards optimizing the potential of big data in healthcare. Big data in healthcare is foundational 
to achieving precise decision making and refined hypothesis generation. The unparalleled ability 
of the human mind is crucial to realizing the potential of big data in healthcare. The anatomy of 
the human body which is a complex maze of interacting systems and organs that make big data 
in healthcare unlike any other big data generated in industries such as retail, transportation, and 
banking. The reduction of narratives in this category inductively generated four meaning units 
including humanities, narratives, bioethics, and pattern recognition.  
2.1 Humanities 
 Achieving big data in healthcare, according to government stakeholders is an ability to 
link the capabilities of computers to the capabilities of humans. Where computers will facilitate 
the movement towards Singularity, analytics still requires humans to make decisions based on 
those findings. A study government participant pointed out, “it’s the human view of the data and 
it’s transferring, it’s gaining knowledge out of that data, transferring it to the human so that the 
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human can actually do something useful with it.”  Another study participant gathered there is a 
complementary role for humans and computers:  
The computer is not a human brain and while we have computers that attempt to 
match many of what people do, much of what doctors do we don’t have computers 
that can do all that doctors can do and that final step of processing, especially in 
complicated cases really needs to take place in the human mind, but it is 
processing of data for sure (Provider).  
 
Computers, and specifically highly portable tablets and smartphones, have become 
commonplace in inpatient hospital and outpatient clinic examination rooms. Technology is 
essential to facilitating access to complex drug databases and interoperating with patient’s health 
histories and narratives of other clinicians almost instantaneously. Technology is also 
fundamental to establishing “health homes” for a physician practice’s panel of patients. Yet, with 
the advent of health information technology, key healthcare stakeholders do not want to lose the 
spirit of the doctor-patient relationship. A study participant in the provider stakeholder class 
asserted that there is a “human therapeutic relationship between patient and doctor.” From the 
analytical domain, providers see computers as being instrumental and necessary to provide 
personalized care demanded by patients.  Study participants from this stakeholder class 
undoubtedly maintain that while the capabilities of computers and humans are vastly different, 
they are interrelated:  
Again, I don’t think it’s going to necessarily replace what we currently do.  I think 
you’re still going to need people who are going to have to, you know, the big 
debate is will it be to the point where I don’t even need extraction (Provider). 
 
Advocates for consumers were concerned about the erosion of the “human therapeutic 
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relationship” between patient and doctor and cautions against the reliance on technology in the 
exam room and at the bedside. A study participant hopes, “It doesn’t lose its human side.” 
Another study participant commented on the over-reliance of technology and the sterilization of 
the patient-provider relationship:   
There’s way too much of a reliance on technology and information the part of 
healthcare professionals.  Even just these clunky electronic health records, I 
mean the doc doesn’t even look at you anymore. They’ve got their head in the 
computer, let alone take the stethoscope out and listen, or just take a look at you 
or listen to your story.  Somehow don’t create this automation of a healthcare 
professional, nurses, you name it, who forgets that there’s a human-being sitting 
right there and just produces these weird robotic type of interactions where they 
don’t think about the situation (Provider).   
 
Another consumer study participant expounded further on the differences between 
computers and humans. Human brain cognition is rooted in “intuition” and “how humans are 
really good at figuring out the relative importance of different conflicting information and 
computers don’t do that well.”  
2.2 Narratives in Healthcare 
Narratives in medicine are usually captured at the point of care and are often embedded 
in the patient’s electronic medical record. While this unstructured source of big data is an 
important personal account of the patient’s experience, big data in healthcare is not usually 
associated with “storytelling.” While narrative medicine is the one-to-one interpersonal clinical 
conversation between provider and patient about illness, healthcare narratives captures the many-
to-many conversations among healthcare stakeholders not just on illness, but about the 
experiential accounts of healthcare processes, insurance, access, and a host of other purposes 
related to the entire encounter with the healthcare system. A government study participant 
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shared, “I can’t ever foresee a time when you won’t want to have the ability to collect narrative 
for at least some of the electronic record.”  One consumer stakeholder also suggests narratives 
are an integral part of the human experience and should not be lost as a data source that is not in 
the form of 1’s and 0’s:  
This is what I suggested to my Watson friend there at IBM was you could add into 
this, they take a lot of the clinical data, scientific data, but I think you should add 
in the patient experience.  That trajectory is meaningful.  What docs do they go to 
first? Which ones sent them on their way? What was the sequence of docs they 
saw? What sequence of drugs they might have been given, what was the sequence 
of tests, are there certain things that you could make out of that that are 
consistent or at a high predictive value for a given disease that you could 
interrupt that odyssey early.  That to me would be an important application of big 
data in rare disease (Consumer). 
 
2.3 Medical Ethics (Bioethics) 
Published scholarly literature on bioethical analysis customarily focuses on human 
healthcare including issues of abortion, euthanasia, cloning, and health disparities. Big data and 
information in healthcare is an emerging topic in the field of medical humanities and bioethics. 
Big data bioethics was derived from the narratives of two consumer stakeholder’s experience. 
The discipline of medical ethics allows moral discernment to ground the understanding of illness 
and health. A study participant posits:     
… once you get into the ethics and you start to understand the place of illness and 
the human condition really want to understand that, it’s the humanities that 
renders it much more clearly than any science does (Consumer). 
 
Another consumer stakeholder introduces the element of uncertainty about what is done 
in healthcare by policy and clinical professionals. By learning to talk to patients about big data 
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and how it will be used to facilitate creation of individual treatment plans to cure illnesses, such 
conversations present a moral dilemma for the entire healthcare system:   
I think a subpart of this is we have got to learn to talk to the patients about how 
these data, how and why these data are being used and why it’s a good thing and 
certainly leave room for people to opt not to participate, but mainly beat that 
drum that, you know, we’re practicing with uncertainty.  We don’t know what 
we’re doing and we can learn from the data and you could contribute 
(Consumer). 
 
2.4 Pattern Recognition 
In healthcare, pattern recognition, or assignment of labels to variables is a key statistical 
operation in population health and public health. There similar study participant views on 
whether the computer is more adept at pattern recognition than humans. One study participant 
proclaimed, “There’s a whole bunch of different things the human brain tends to work on 
intuition and pattern recognition on a speed that is far faster than computers actually,” while 
another study participant spoke of the advantages of the human brain and its pattern recognition 
capabilities:  
So if I want blood pressure to be set up as a graph so I can see whether it’s 
getting better or worse with the individual numbers on a spreadsheet.  They’re 
very, very good at it, but we have to remember all the time that computers aren’t 
anywhere near as smart as the person that’s using them, so what the human brain 
is really good at is recognizing in patterns where we didn’t know there was a 
pattern, computers can’t do that at all (Consumer).   
 
Key healthcare stakeholders identified the human dimension as complimenting the 
capabilities of technology (“I don’t have a really strong faith that computers are going to 
somehow be smarter than people”), working as an integrated unit to achieve big data’s latency. 
And the emergence of big data is well documented in industries including aerospace, 
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transportation, and banking. However, in healthcare, big data is a very different and complex 
endeavor which makes comparisons with other industries difficult. Comparisons of big data in 
healthcare to other industries that have mature big data capabilities are spurious and as one study 
participant remarked cannot be compared across industries: 
I was giving an international speech in Brussels. While I was talking about 
measuring quality and safety somebody got up and asked me, ‘well why don’t you 
do it just like a bank has an ATM,’ and I didn’t laugh but I felt like it.  I just said 
because everything isn’t an integer, it’s not as simple as a balance sheet or 
income statement, or a checking account. It’s a whole different ball game and the 
relationship between processes and outcomes in healthcare is not totally defined. 
You can give the same drug to two patients in the same way, the same age, the 
same diagnosis and they’ll react differently, and it’s just we’re not making 
patients (Government). 
 
Another consumer stakeholder delved into the complexity of human organisms and the 
connections across intricate bodily systems which constitutes the entire person. His narrative 
supports the ideology that comparisons with industries that produce “widgets” and defines their 
unit of analysis (e.g., retail) is unauthentic and that in the delivery of healthcare, the person has 
to be viewed holistically, making big data in healthcare unique:   
We’re looking at human-beings holistically.   The reductionist approach I think as 
useful as it has been needs to be augmented, I won’t say it needs to be replaced, 
but it needs to be augmented, a much more holistic approach.  You know, I can 
look at cells all day long but until they're organized into tissues, into organs and 
into systems and then into whole species and individuals it really sort of doesn’t 
matter. So it’s understanding human health, understanding how choices we make 
in policy, shifting policy decisions so that we put investment where it matters the 
most as far as human condition and I think letting people realize their full 
potential as far as health and happiness as well.  My vision is if it can lead to 
opening and the democratization of health (Government). 
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Summary 
Harmonization between technology and humans was an essential perspective shared by 
many study participants of humanism in big data. While big data in healthcare is still an 
emerging phenomena, stakeholders in the three key stakeholder classes uniformly agree that the 
potential of big data will not be achieved without the complementary relationship between 
humans and technology. It was widely suggested that big data in healthcare is vastly different 
than big data in other industries because the complexity of human anatomy and physiology are 
not comparable to any “widget” that can be defined and produced by other industries. A 
consumer stakeholder summarizes this point succinctly:    
One explanation is that one treatment is better than the other, that’s what you’d 
like to think, but first you have to resolve the possibility that it might be because 
the patients are different and that there’s confounding selection bias that patients 
who get one treatment are just different in ways that effect outcomes from the 
patients who get the other treatment (Consumer).   
 
As humans and technology combine to realize the potential of big data, big data 
information science and knowledge management is a framework that allows the vast “natural 
resource” of big data to produce precise insights and knowledge. The next category explores 
study participants experiential knowledge about the association and application of information 
science, knowledge management and the role of the data scientist in healthcare and big data. 
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Information Science & Knowledge Management and Big Data in Healthcare 
 
Category Definition 
This category consists of the interconnected fields of information science and knowledge 
management, facilitated by a team of scientists, primarily concerned with the analysis, storage, 
dissemination, and ontologies of big data and its knowledge engineering and visual 
representation. This category also includes study participant perspectives and insights on the 
skills and knowledge of the data scientist. The healthcare system, in part, is defined by its many 
disparate transactional (e.g., financial) and claims information technology systems which are 
created with the intent to derive healthcare intelligence.  
3.1 Information Science 
The intentionality of this important category of meaning arose from a hypothesis that 
there is an implied relationship between medicine and the discipline of information science. In 
saying true to phenomenological research, during the in-depth interviews, I did not frame a 
definition of information science – allowing the conversation to flow naturally based on the 
study participants experiential knowledge. Only one study participant inquired about what was 
meant by information science. All study participants were asked to specifically state “yes” or 
“no” and further elaborate either way. This study participant introduced the notion of cloud 
computing and the assumption of its privacy and security:  
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What [big data] means to me is that you assemble information from multiple 
sources but then get assembled in a large dataset and who knows where that 
actually resides in various servers around the country or even around the world I 
suppose which is sort of euphemistically referred to as the cloud and assuming 
that privacy and security constraints are being considerations for being adhered 
to which is I think a big question mark (Consumer). 
 
From the government stakeholder’s experience, it was generally agreed that medicine is 
an information science, or at least it “could be.” One government study participant responded, 
“I’m not sure I’m qualified as a non-clinician, but yes.” In the information-rich field of medicine, 
when data was once a result of healthcare delivery, data and its resulting knowledge is now a 
prerequisite for delivering high quality, cost effective care. One study participant offered an 
argument regarding medicine as an information science is at the epicenter of care delivery:  
It used to be you could almost argue it needs to be the center with providers and 
beneficiaries orbiting around it or at the very minimum it needs to be on the same 
level as what was previously considered the other core components in healthcare 
delivery, clinical knowledge (Government). 
 
One respondents’ narrative challenged me to reflect even deeper on the question and how 
it was posed. Which discipline emerged first?  Their responses elicited further exploration into 
the history of medicine and information by commenting, “I would say that information science 
pre-dated medicine and allowed medicine to prosper.” While this statement is arguable, it piques 
a curiosity into further research and interpretation on the subject. A “double hermeneutic” was 
also accentuated, as I attempted to interpret the study participants interpretation of what was 
meant by an information science. The question objectively asked about medicine, but in 
reviewing my reflexive field notes, I wrote, “… a definition of information needs to be included, 
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and medicine could be misinterpreted as healthcare delivery.” A study participant highlighted 
this point pretty succinctly: 
Yes, absolutely, medicine has always been an information science but whether or 
not that information has been at the individual patient level, at the group of 
patients a provider takes care of or at the population level has been the thing that 
has changed. So when we see the big data revolution we’re seeing that 
transformation of the maturity of information science in medicine go from that 
individual patient, the anecdote to the types of patients, the whole constellation of 
patients I’ve seen my career, my experience, to understanding the relationship of 
clinical and biochemical data across population (Provider). 
 
The only stakeholder to definitively claim that medicine is not an information science 
resides in the government stakeholder class. Even still, the study participant suggests big data is 
“also about smartly moving information around clinicians,” which is suggestive of the 
knowledge engineering and information sharing dimensions of information science. It is 
disputable whether a definition of information science would have biased this study participant’s 
negative answer about big data as an information science. Looking back on my field notes, I 
documented the study participant was “very sure of his response and gave no indication of 
uncertainty.” As sure as this study participant was certain medicine is not an information science, 
another study participant concluded:  
Oh I’ve been saying that for 20 years. Medicine is an inherently an information 
science, the better data you have the better you can diagnose.  The more 
effectively you can select treatment, the better you can actually see those 
treatments. It’s unquestionably an information science (Provider). 
 
Unlike narratives from the government stakeholder class, a study participant from the 
provider stakeholder class acknowledges a reliance on just transactional data generated in the 
163 
 
 
delivery of healthcare which was collected for that singular purpose. This study participant 
asserted:  
I suppose you could add another of the Gartner’s V’s which is something that’s 
been a problem has been Veracity meaning that all the transactional systems 
work properly when people enter things perfectly the way it’s supposed to that 
doesn’t always happen and even then just the way the data architecture is sorted 
in the transactional systems that has really designed for transactional processing 
(Provider). 
 
As a dimension of information science and a core attribute of healthcare delivery, 
including information technology and HIT interoperability, information sharing was discussed 
extensively by each study participant. There was a desire (possibly influenced by legislative 
mandates), among key stakeholder class to share data and information; however, a paradigm 
shift has occurred, according to one government respondent: “[Data] is much cheaper to collect 
and it’s cheaper to store … at the same time there’s a cultural shift going on where people are 
much more willing to share it.”  There was also disagreement about how much information is 
shared and the consequences for (or not) doing so. One government stakeholder wittily 
suggested: 
We do share, but in my opinion we don’t share enough. If I share something and 
lose out … then that kind of means I’m going to be less likely to share” or 
furthermore, “organizations don’t want to share and we’re not necessarily 
incentivized to share (Government).  
 
Whether these barriers such as incentives and competition are real or perceived, 
organizational culture and competition plays a central role in sharing information assets in 
healthcare.   
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 Study participants from the provider stakeholder class shared a strong desire to share 
data, information and knowledge across the entire healthcare ecosystem. Empowering providers 
and consumers was mentioned as an objective, but one provider remarked “especially in 
healthcare it’s hard to share some of this data outside” because of real and perceived barriers 
which includes “transparency”, and “people worried about sharing data or fighting for silos or 
turf.” One provider stakeholder concluded that things are getting better because of the leadership 
role federal government has assumed and the historic precedent set by “liberating” big data and 
releasing it for research and innovation in sites like www.Healthdata.gov:  
The good news is that federal government and state governments, are beginning 
to take the data that they’re paying us for with Medicaid and Medicare and many 
other things and put it out there for us to use, for researchers to use and so when 
it comes to some clinical data, performance data you can actually begin to 
download big datasets publicly online (Provider). 
 
Providers are also collaborating to create cooperative big data sharing cooperatives. The 
perception is integrated delivery systems potentially have enormous amounts of big data and 
customarily keep it within the clinically or financially integrated health system for their own 
competitive advantage. But their big data combined with big data from other large delivery 
systems (e.g., “My big data – Your big data”) creates an unprecedented amount of aggregated 
big data for precise decision making. Another study participant inferred:  
We can start to collaborate together and as we work out the content of those data 
systems together so that we share the data back and forth it will accelerate the 
whole process.  So the things that I could run a trial on that it would take me six 
months, I mean that’s compared to ten years right now, the structure I might be 
able to get them done in six months, well under that structure we could do it in 
three weeks or at least that’s the idea (Provider). 
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3.2 Hypothesis Generation 
While there was no attempt to generalize study participant’s narratives, an ability to find 
answers to complex questions was a driver that resonated with each of the three stakeholder 
classes. As one provider study participant observed, “If I can answer those questions, it can then 
lead me to more relevant questions of causes and the etiology of the disease.” Other study 
participants provided the following insights on hypothesis generation: 
Having said that, the drivers that are pushing IT, getting us more into big data 
that will invite us to try and answer the questions that will allow computers to be 
more helpful are certainly driving costs (Government). 
 
Also,  
 I think there are a whole lot of drivers to this. The data complexity, the data 
volume is increasing and the richness of what is there is increasing to throw out 
to ask questions we never could ask before.  We’re also collecting a lot of junk but 
clearly that’s the big deal right, you go gold mining and it’s not all gold 
(Government). 
 
Essentially, the three government study participants uniformly expressed the fact that big 
data allows for hypothesis generation and alternatively better question development in 
healthcare. In the provider stakeholder group, similar to the government stakeholder group, one 
stakeholder believes the ability to develop good questions is a byproduct of big data which has 
an ability to produce – good answers: 
 There’s effectively no limit to them, so good answers come from good questions, 
nearly always to answer that good question you have to have data that matched 
that question, right, and so that’s that idea back again (Provider). 
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3.3 Information Technology 
Information technology and clinical decision support are to conduits healthcare 
intelligence for providers (“How do we make sense of all the data that we’re getting from the 
science?”). There is also relevant application in policymaking and healthcare consumerism. A 
consumer stakeholder suggests that clinical decision support is required to organize and generate 
contextually relevant information: 
The second thing that’s revolutionary is that that information then becomes the 
input for decision support engines and there’s a whole bunch, there’s a whole 
array of ways that clinical decision support can be set up, it can be in templates 
that prompt us to remember to do things we would otherwise forget.  You know, 
chart order entry facilitators, again to help us to just make it easier and more 
efficient to order something because most of our orders are complicated and 
involve more than one thing or at least a lot of them are, you know, data 
presentation like graphs or spreadsheets and charts that’s where we can see 
information over time, and then of course, prompts and alerts and things like that 
(Consumer).   
 
 Several study participants found that clinical decision support is an important function of 
information technology which facilitates information organization and structure. A consumer 
study participant posits that this is the primary role of computers which are best suited for the 
task: 
The other thing computers are really good at is when we have to actually slow 
down and think something through and figure something out then computers can 
organize information in ways that make it easy for us to solve difficult problems.  
So that’s really the use of computers (Consumer).   
 
According to a couple of the government stakeholders, electronic health records must 
continually evolve to provide the clinical decision support and information structure that is 
necessary to organize clinical big data and its resultant information. National policy including 
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Meaningful Use Stage 2, which is a process designed to aid clinical decision support provides a 
standardized framework, but may not be achievable as a government study participant opines:  
An example is the electronic health record where we’re very poor at structuring 
clinical information so we come along and we turn everything into electronic 
form and we somehow expect that electronic records to solve all our problems 
and it doesn’t do that unless you think through how you’re going to structure the 
data before it goes in and what everybody else is doing.  You’re going to have big 
data and right now there are over 2,000 records that have been certified by 
CCHIT as meeting the Meaningful Use Stage One criteria and they’re all written 
in different languages, different interfaces, different databases and they can’t talk 
to each other.  So it’s kind of a mess (Government). 
 
Study participants point out an important task to clinical decision making that has not 
happened in healthcare: structuring the entire knowledge base of medicine (“We haven’t 
structured the information in healthcare to the extent necessary to allow big data to have the 
kind of impact it will potentially have on the future”). While the advent of new analytical 
methods and the Variety and Volume of big data in healthcare presents a tremendous opportunity 
to structure healthcare’s vast body of knowledge in a meaningful way, a government study 
participant adds:   
We need to go through the whole knowledge base of medicine that way and map it 
and it’s, you know, nobody is even talking about doing that right now so we’re a 
very long way from getting medicine to the point where we can do the kinds of 
things that they can do in other industries where the structure of data is simpler 
(Government). 
 
  With the advent of advanced health information technology, including electronic health 
records, and personal health records, big data is an asset for provider organizations, such as 
Accountable Care Organizations, government agencies, and consumers, alike.  Big data, which 
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“definitely correlates with technology,” has allowed the dimension of genomic data to enter into 
the equation of healthcare delivery, as a stakeholder pointed out:   
Well, I think that the availability of big data is certainly something that’s driving 
it, whether it’s clinical technology to measure biochemical signals from people or 
sequence genes or sequence proteins or sample the air or whatever. The 
availability of data is one thing that’s driving it (Government).  
 
Consistent with increasing healthcare costs, a provider stakeholder believes, “Value 
based purchasing and moving away from the lack of accountability of fee—for service- service” 
is another driver, while another spoke of the new electronic health record standards that are a 
result of new healthcare legislation: 
 I think another one is the Office of the National Coordinator has been pushing 
these Meaningful Use Standards and that’s resulted in an abundance of data, and 
there’s more demand on doing analytics with the data and they’ll be actually in 
Stage Three more expectations around producing outcomes and you can’t really 
produce outcomes without data (Provider). 
    
Two of the three study participants in the consumer class felt the unintended consequences 
of sharing big data were problematic. While sharing data and repurposing it for use by other 
stakeholders in the information value chain, consumers were concerned that if data ends up in the 
wrong hands, privacy will be potentially compromised. One study participant summed it by 
stating “I might be concerned that the data that we shared might be used for some purpose other 
than the stated research questions.” While potential nefarious uses of protected health 
information do exist, the ability to link structured and unstructured data is the strength of 
technology:  
I think obviously the rapidly emerging technologies in this area do allow people 
to crunch ever larger numbers of data in helping us bridge the gap between 
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structured data analysis and unstructured data analysis, which I think is very 
important (Government). 
 
And the rise of “apps” developed to satisfy the demand for information access on mobile 
technology allows key healthcare stakeholders the ability visualize and assess information, often 
in real time, to make comparisons of peer activity, as one consumer stakeholder construed: 
… here’s a free iPhone app you can have so you can look in if you join our system 
and you can actually go in and look for individual patients, you can see how 
they’re doing and what the gaps are for individual doctors, you can look at how 
they’re doing in aggregate and they get their data from the EHR’s (Consumer).    
  
 Another consumer stakeholder study participant expressed an ability to make sense of the 
data and information they receive: “Some of it is just trying to make sense of all the information 
that we have now so it’s an organizing approach.  Its how do we make sense of all the data that 
we’re getting from the science?” Another study participant suggested technology allows people 
the luxury to focus and think through complex problems rather than pour though intricate 
statistical operations and organizational exercises that once took weeks to accomplish can know 
be done in a matter of seconds:  
The other thing computers are really good at is when we have to actually slow 
down and think something through and figure something out then computers can 
organize information in ways that make it easy for us to solve difficult problems.  
So that’s really the use of computers (Consumer). 
 
3.4 Learning Systems 
Participants in this study talked about creating healthcare learning systems which allow 
organizations involved the opportunity to “ask and answer the questions, to share the findings 
broadly, and to drive quality up and cost down.”  Learning systems in healthcare are similar to 
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traditional clinical trials with the difference being learning systems allow provider organizations 
the ability to conduct clinical trial –like “research” on patient data warehoused in their 
information system networks, effectively generating thousands of published papers in a single 
year. The provider stakeholder revealed:    
There’s this concept that effectively every patient goes on trial because of the way 
the data systems are structured. Now the jargon we used for that is a learning 
health care system where you build the learning, the knowledge management and 
it’s an information science tool that comes out of this you quickly learn is it’s 
perhaps the key capability in a system like this, it’s knowledge management.  How 
do you identify best practice knowledge, how do you systematically and routinely 
deploy it into routine use (Provider).  
 
Another provider stakeholder mentioned his organization has created an immense data 
repository that warehouses patient claims data and demographic data, that while not 
standardized, allows multiple healthcare provider organizations to collaborate on a distributed 
learning network and learn from the data: 
 
We are involved in a collaborative project that established a virtual data 
warehouse of basically it simplified data sharing by having a very reasonable 
similar data model that’s federated across all different organizations and it has 
demographic data, physical measures, personal medical history, management 
treatments, diagnosis, health claims and so forth and basically this data model 
retains control and stores data and stores kind of standardization across all sites 
(Provider). 
 
 Generally, the consumer class produces massive amounts of source data from claims 
data, narratives and now sensors. Generally, as the participants for a host of public and private 
funded clinical trials, this class relies on others in the notional healthcare information value chain 
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to reduce big data into credible information for its intended use. One study participant 
concluded:    
To me it simply means lots of data, lots more than you’re used to and you know, 
the reason big data is important is because without it you wind up with studies 
that are almost always too small.  Smaller than ideal, because it’s just simply is 
too costly to go out and collect all this data on the very large numbers of people 
that you need.  So we’re hopeful that the existence of these big sources of data 
allows us to do studies in a million people instead of 10,000 (Consumer). 
 
Members of the consumer stakeholder class are usually targeted to participate in clinical 
trials, or in this case learning systems in which “everybody participates in some kind of 
learning,” including patients. A provider study participant shared his vision of a learning system 
and shared the insight that learning can be distributed across all stakeholder classes. The study 
participant suggested healthcare organizations are in a central position to generate and spread 
clinical knowledge: 
Once you have it you’ve created a learning environment and by a learning 
environment I mean a circumstance in which you can generate valid clinical 
knowledge by carefully structuring changes within that data environment, so I 
change a particular element of care and then causally figure out what that did to 
patient outcomes.  So you see the idea? We call it a learning health care system 
(Provider). 
 
3.5 Data Scientist  
I have always had a healthy curiosity about the role and skill that the “new” data scientist 
must possess with the advent of big data in healthcare. The provider stakeholder class offered a 
range of perspectives and insights into this profession. As clinical researchers, their training 
appeared to produce the richest insights into the knowledge and skills of a data scientist to 
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manipulate big data. Consistent with findings from the literature review, the specialized skillset 
of the data scientist emerged as an important subunit of meaning across key stakeholder classes. I 
consciously set aside my own presuppositions about the skill and role of data scientists so not to 
influence the explication and interpretation of the data. Providers generate and consume large 
amounts of and require their employed or contracted data scientists to have “an ability to think 
logically,” as one study participant surmised. Training in medicine, business, and the sciences 
were the trademark for this stakeholder group. As such, while each study participant has the 
analytical skills to lead data-rich environments, one study participant shared: 
I have people who manage big data for me. I have a team of skilled data scientists 
who are part IT knowledge, part systems integrator, part subject matter experts, 
part analyst programmer; a data scientist isn’t necessarily one person.  You have 
a data scientist practice in which people specialize but talk to each other but you 
might have somebody doing the IT integration stuff and another separate subject 
matter expert and another programmer (Provider). 
 
Of note, there were a couple of colorful and profound insights elicited from the provider 
stakeholder class regarding the data scientist. One provider study participant proclaimed, “A 
professional scientist or not … a scientist without data is a philosopher” potentially as 
cautionary words of wisdom to scientists with such “sexy” titles.
12
  
A couple of the study participants were aware of the potential limited labor supply of data 
scientists with the requisite skills to manage and analyze big data. Their narratives pointed out 
recruitment will be a barrier, as a study provider study participant acknowledged, “There’s still a 
very limited skill set out in the industry in terms of the people who know how to do this, so it’s 
                                                 
12
 In the book, Keeping Up with the Quants, Thomas Davenport and D.J. Patil proclaimed: “Data Scientist: Sexist 
Job of the 21
st
 Century.” 
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going to be hard to recruit a team of data scientists” and as another observed: 
Finding somebody who’s got 10 years of experience in big data is going to be 
pretty impossible to find.  So getting experienced people, there’s going to be a lot 
of on the job training and that’s going to be a challenge for people (Provider). 
 
While providers typically use a third party administrator to perform the role of data 
scientist, particularly in small to medium sized provider organizations, the data scientists’ 
competencies are more than “creating reports and dashboards.”   It’ also about being a trusted 
partner, managing large data sets with a degree of confidentiality, implementing analytics, , and 
“creating the analytics and using the data and the knowledge and insights to translate them into 
decisions about how to improve” the care of patients. One provider stakeholder gathered:  
 … now it’s the funniest thing on this, most of my statisticians have some 
computer science background and regard themselves, they see themselves as 
fairly competent data architects. So as far as I can tell all of the data architects 
see themselves as analysts but when you’re more than past familiarity with both 
fields you’re different, and they’re radically significantly different (Provider). 
 
It appears to be a fair assessment to say that, as another provider posits, “a data scientist 
is more than one person” and in order for knowledge to be optimally gleaned and analyzed – to 
fully thrive – another study participant suggested we need “citizen scientists” who might find 
insights overlooked by the relatively small cadre of bona fide data scientist. 
Summary 
This category examined the study participant’s perspectives and insights into the place 
and role of information science and the skills of the data scientist. Information science and 
knowledge management are interdisciplinary fields that are essential to realizing the enormous 
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potential of big data in healthcare. However, information science is typically implied as core a 
discipline in healthcare and rarely acknowledged as the foundation of healthcare delivery. The 
role of the data scientist is also critical to harnessing the potential of big data in healthcare. 
However, several study participants posit that the role of the data scientist is multi-faceted and 
usually does not consist of a single person. Even still, it’s recognized that the combination of 
knowledge and skill of the data science team are in short supply. The next session examines the 
results of a common objective across the key stakeholder classes: governance of big data in 
healthcare.  
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Governance of Big Data in Healthcare 
 
Category Definition 
This category examines study participant narratives about the attributes that are essential 
to establishing and sustaining a consensus-based framework for broad oversight and governance 
of policies and definitions of big data in healthcare. A set of common standards for big data 
could help improve data exchange among all healthcare stakeholders and would enable patients 
and providers to isolate parts of health and medical records, respectively, for refined analysis and 
information sharing. Classification systems called groupers, which include Episodic Care 
Groupers, (ECG) and Ambulatory Care Groupers (ACG) describe the "illness-burden" of 
populations (Weiner, Starfield, & Lieberman, 1992). While groupers are used within the 
healthcare industry for specific purposes (e.g., risk adjustment), they are not adopted as a 
universally accepted standard of big data.  
4.1 Common Standards 
 Within the government stakeholder class it is known that a lack of governance and 
common standards, or a “central use policy” termed by one government stakeholder for big data 
in healthcare stifles big data growth and a realization of the true potential of big data. Such a 
deficiency appears to keep big data firmly entrenched in a spiral of big data “hype.” A familiar 
theme materialized in the government stakeholder class: establish a consensus-based common 
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big data definition. Study participants concluded it will take time to refine and validate a working 
(or agile) definition, as precision in decision making and hypothesis testing are important 
attributes of big data’s output.   One study participant remarked:  
I want to get people to use the same definition for enough time so that we can 
aggregate data, match it up against reality and then refine the definition so that 
the sensitivity and specificity of it, the accuracy, when the true positives and not a 
lot of false positives, not a lot of false negatives, so that all gets worked out by 
making the definition very precise and having people record it that way 
(Government). 
 
Study participants suggested activation of a common standard for major clinical problems 
represented in patients would include “both processes and outcomes of care.” Of particular 
importance, the United States was on the threshold of a conversion from the International 
Classification of Diseases – Version 9 (ICD-9) to ICD-10 which facilitates data better analysis of 
disease patterns and treatment outcomes among a host of other healthcare benefits. While 
implementation of ICD-10 has been delayed, the updated code set with requires detailed clinical 
documentation could be the impetus to cultural change to include both processes and outcomes 
of care that the study participant suggests. However, there are segments within the healthcare 
industry that oppose conversion to ICD-10 including costs of implementation, a lack of an 
infrastructure to conduct end-to-end testing, and simply an aversion to change. 
With the multitude of applications and software vendor products, such standards would be 
fundamental to comparisons across a uniform set of big data. As it stands, even with the advent 
of electronic health records, no such standards are ready for testing and validation.  Study 
participants in the provider stakeholder class recognize the lack of a common standard for big 
data in healthcare. In research, which is a data-intensive endeavor, there are institutional review 
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Boards (IRB) which govern data and data collection standards that “say what people can and 
can’t do with the data and who can and can’t see things to protect our patients.” In the delivery 
of healthcare, a study participant felt that without big data standards and governance, data 
aggregation would not be possible and questions whether big data in healthcare is big enough 
due to the absence of a common set of standards:  
We need our big data to get bigger.  We need to actually aggregate this stuff.  So 
to do that what does the future need – it needs standards.  It needs standards for 
clinical data, standards for research data, standards for educational data, that’s 
beginning to emerge but it’s definitely not there yet. We need reasonable and 
rational policies around how to protect these data but also how we can flexibly 
use and release the data (Provider). 
  
The absence of big data governance and common standards is a perceived barrier to big 
data’s untapped potential. This raises an important question: without big data standards in 
healthcare, is big data truly big? 
4.2 Legislation 
Healthcare legislation over the last twenty years has been a focal point of political 
debates at the national and state levels.  As such, legislation was another influencer identified by 
several of the study participants. A government key stakeholder supported the notion that 
government rules drive big data in healthcare, “Because it places data and the ability to harness 
and leverage data at multiple points throughout the healthcare ecosystem at the center as 
opposed to at the trenches.” This stakeholder further added: 
I think another one is the Office of the National Coordinator has been pushing 
these meaningful use standards and that’s resulted in an abundance of data, and 
there’s more demand on doing analytics with the data and they’ll be actually in 
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Stage Three more expectations around producing outcomes and you can’t really 
produce outcomes without data (Provider). 
 
A core issue for each of the three stakeholder classes is repurposing data for different 
uses which could lead to breaches of privacy. In the absence of big data governance in 
healthcare, study participants identified several unintended consequences that potentially could 
come to fruition based on the current informal structure and a lack of governance associated with 
big data in healthcare. A stated unintentional consequence was a lack of oversight and adherence 
to data privacy policies, which one study participant noted, “There’s a lot of work to be done on 
patient privacy and oversight.” Eventually without governance, the healthcare industries will 
“just kind of give up on privacy.”   A consumer study participant remarked:  
I think it’s unrealistic to expect providers and patients to really adhere to strict 
privacy and security standards which for the past 10 years we’ve taken very, very 
seriously and then have it a very, very highest  governmental level completely all 
of those standards just find out that a government agency is writing rough shot 
over them and just sort of shrug our shoulders and say you know, who knew, but I 
mean maybe that’s you know, maybe that’s possible but I think it really is a crisis 
that has to be addressed (Consumer). 
 
Study participants in the consumer class advocated for rigorous patient privacy policies. 
Two consumer study participants suggested that while there are standard patient privacy rules in 
effect, the industry should rethink these rules because, “we just kind of give up on privacy and 
say well that’s kind of over or we have to say no look we actually do take privacy and security 
seriously.” Study participants pondered the questioned current federal rules regarding 
Institutional Review Boards and human study subject oversight as a barrier to effectively employ 
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big data. A consumer study participant agrees there is much more work to be done, even 
potentially easing the framework of current patient privacy rules: 
Yes, everything has to be done to keep this data secured and protect people’s 
privacy, on the other hand, when these studies are not posing any physical harms 
to patients because we’re just looking at data, you know, you do not need to 
require that a patient sign a 10 page or 20 page consent form.  Even in certain 
randomized trials, yes, you need a consent form but it doesn’t need to be 20 pages 
long if it’s a very low risk question.  So I think figuring out these issues about now 
that we’ve got big data, how do we work with IRB’s and human subjects oversight 
to rationalize how we use it and how we talk to patients about use (Consumer). 
 
4.3 Aligned Incentives 
A consumer stakeholder believes that within the current unstructured approach to big data 
in the healthcare industry, “incentives aren’t necessarily aligned to make it easy to change.”  
Another study participant articulated, “Raising the risk of what I consider to be misuses of data 
in ways that are not necessarily in the public interest” in the absence of big data incentive 
alignment. These risks create different standards for different stakeholder classes; this results in 
unaligned incentives. The confluence of a lack of both data standards and transparency (“I think 
we’re going to have to have a lot of transparency”) creates a culture of mistrust among 
healthcare stakeholders. A study participant commented:  
If it’s holding providers to a different standard then you can’t tell what’s going 
on, so an ideal system … you get to transparently manage your population 
according to outcomes that everybody agrees upon both inside the delivery system 
and among the ones are paying for it (Consumer).   
 
Uniform data standards like ICD-10 exist to classify illness.  However, ICD-10 is one data 
set among potentially hundreds or thousands used in the delivery of healthcare. The absence of a 
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common classification system, ontologies, policies and aligned incentives for big data emerged 
as a real barrier to realizing the potential of big data.     
Summary 
Common standards and privacy are commonly referenced subunits of meaning identified 
by the three key stakeholder classes. However, study participants highlighted the unintended 
consequences of increased competition to develop and publish healthcare intelligence and 
unaligned incentives are barriers to effectively achieving big data’s potential in healthcare. There 
is evidence of common standards on data through government policies, including Meaningful 
Use. But big data taxonomies and ontologies are nonexistent. This is especially troublesome 
given the emergence of genomics data as an integral source of data that enables precision 
medicine and informed decision making. Governance of big data in healthcare is an objective of 
the three key stakeholder classes and must include “the patients who need to be kept in the 
governance.” 
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CHAPTER VII. DISCUSSION AND INSIGHTS 
Overview 
This section discusses the findings of the research and compares study participant 
insights to observations found in the scholarly and grey literature. The study’s research question, 
Within and across the narratives of three key healthcare stakeholder classes, what are the 
important categories of meaning or current themes about big data in healthcare, was designed to 
elicit a priori insights into the attributes, definitions, and uses of big data in healthcare. As a 
reference, I restated the observations found from the modified systematic review of the literature 
to make comparisons between findings from the literature and study participant narratives.  The 
research uncovered important categories of meaning or themes within and across three key 
healthcare stakeholder classes. The aim was not to generalize the study’s findings. Rather, the 
explication of study participant narratives was intended to delineate categories of meaning to 
find common themes within and across study participant narratives and construct a cohesive 
‘story’ or framework of big data in healthcare. Unique themes were also included as an important 
source of data. Also, a “main takeaway” is offered at the beginning of each category as a 
fundamental fact or point of reference for all stakeholder classes to adopt. 
Category of Meaning #1:   Ontological Framework of Big Data in Healthcare 
Main Takeaway: Without a consensus-based “framework” of big data in healthcare, 
‘buzzwords’ and slogans will continue to play an important role in describing big data’s meaning 
in healthcare.  
182 
 
 
Many characteristics, definitions and references to big data across various industries were 
mentioned by study participants. A review of the scholarly literature found a host of definitions 
on “big data” including “it’s [big data] a characterization of the never-ending accumulation of 
all kinds of data” (EMC2, 2012),  and big data “is the ability to mine and integrate data, 
extracting new knowledge from it” (Roney, 2012). Or “big data is the belief that any sufficiently 
large pile of sh** contains a pony” (Arbesman, 2013). Begley (2011)  defined big data in 
healthcare as “the healthcare context to longitudinal medical claims data for millions of patients 
linked to their EHR (p .50)” Begley’s definition conservatively quantifies big data in the 
“millions” where petabytes, even terabytes are now the gold standard of healthcare big data 
quantification. This definition illuminates a common problem of attempting to quantify big data 
in healthcare: data are counted by patient encounters, not petabytes. 
The scholarly and grey literature on “big data” and “healthcare” also confirmed there is 
no consensus on what big data means in healthcare (Dumbill, 2013; Villars et al., 2011). 
Findings from the stakeholder narratives were consistent with the literature. Study participants 
generally did not know what big data in healthcare meant (“nobody’s ever defined it for me”; 
“it’s like a parody”; and, “it needs to be clarified and demystified”). While Gartner’s credible 
“3V’s” of High Volume, High Velocity, and High Variety were referenced across the three key 
stakeholder classes, the oft-cited ‘characteristics’ of big data is not a definition. Gartner’s 
characteristics of big data have entered into the lexicon of big data in healthcare as buzzwords 
(T. Borangiu & V. Purcarea, 2008; Davenport et al., 2012; Rooney, 2012) that continue to play 
an important role in the absence of a vetted consensus-based definition. 
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Depending on the scholarly communication or source of grey literature, one could find at 
least two additional “V’s” – Value (Porter & Teisberg, 2006) and Variability (Gartner, 2013) that 
have emerged as some of the important buzzwords that characterize modern big data. 
Across all stakeholder classes, the multitude of big data definitions do not sufficiently address 
the enormous complexity of healthcare’s aim of delivering precision medicine, commonly 
referred to as personalized medicine. In a recent paper by Ward and Barker (2013), they collated 
four common definitions of big data which “gained some degree of traction” (p. 1) agnostic to 
industry and market sectors. The definitions were extrapolated from big technology and 
consulting firms, including Gartner, Intel, Oracle, and Microsoft. After generalizing 
characteristics of each company’s interpretation of big data, they constructed their own 
definition: Big Data is a term describing the storage and analysis of large and or complex data 
sets using a series of techniques including but not limited to NoSQL, MapReduce and machine 
learning (Ward & Baker, 2013). This is a progressive definition of big data that intentionally 
omits Gartner’s 3”V’s”. Instead, Ward and Baker take into account the tools and technology 
required to evolve big data into information and knowledge. Yet, based on key stakeholder 
perspectives, their definition seemingly falls short of recognizing the complexities of the “black 
box” of big data in healthcare - people. 
Ward and Baker’s insight into big data is consistent with the perspectives of key 
healthcare stakeholders: big data is only a single dimension of a larger framework whose end 
goal is precise information derived with a purpose. Shaw (2014) points out “historically, … 
scientists would plan for an experiment to collect and analyze data … because of the price of 
storing a bit of data has dropped 60 percent … people now collect everything and then search for 
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significant patterns in the data” (p. 34). Several study participants disagreed with such a theory. 
A provider study participant pronounced “it’s important that you know what the purpose is 
before you start.” The vision of big data from the perspective of a consumer study participant 
was to “have strict purposes rather than let’s create big data and then figure out what we might 
do with it.” Shaw even agrees his perspective has its inherent risks, which includes data dredging 
– data which is statistically significant by chance resulting in poor “scientific output from 
throwing everything against the wall and seeing what sticks” (p. 34). 
Study participants offer the wisdom that though a consensus-based big data definition is 
necessary, its maturity and widespread adaption will not happen overnight. A government 
stakeholder postulates the industry needs to “use the same definition for enough time so that we 
can aggregate data” for initiatives like healthcare learning networks. 
Category of Meaning #2:  Humanistic Dimension of Big Data in Healthcare 
Main Takeaway: There is a dual ‘humanistic dimension’ to big data in healthcare that 
takes into (1) account people’s cognitive contributions; and, (2) the uniqueness of human data as 
a unit of analysis. 
Big data in healthcare, in part, is about empowering people with information and 
knowledge to make evidence-based decisions about policy, clinical treatment plans, and 
healthcare consumer choices. Study participants agree, “Empowering the people whose data it is 
should be an important value for all of us as we go forward.” Medical humanities and medical 
ethics as a potential practical application in the policymaking process (Greenhalgh & Russell, 
2009) is an intensely explored subject. Yet, key healthcare stakeholders generally agree 
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narratives and the ability to listen to stories remain an essential skill that adds to the body of 
knowledge in evidence-based healthcare – augmented with the power of big data analytics. Study 
participants fear the art of listening to stories and the “human therapeutic relationship” will be 
lost with much of the industry focus on conquering the big “data deluge.” A government 
stakeholder further elaborates that “purely relying on machine learning without the application 
of subject matter expertise” does not foster precise knowledge for decision making. 
While computers are a necessary requisite and tool of big data in healthcare, the human 
dimension of big data cannot be lost in the “hype” of defining big data in healthcare. Study 
participants agree that computers organize information extremely well, but the human mind is 
calibrated for unparalleled intuition, speed and pattern-based recognition. Absent from any big 
data definition, characteristic or attribute found in the scholarly and grey literature was the 
importance of the humanistic dimension of big data in healthcare. Data and information in 
healthcare is still imprecise. Whether used for development of new healthcare legislation or 
patients sharing stories about health and healthcare, narrative provides meaning, context, and 
perspective (Greenhalgh & Hurwitz, 1999). Gardner (2013) found “individual instances 
[narratives] are part of an ever-growing study of pedagogy of a health humanities approach that 
focus on narrative, sometimes called ‘narrative medicine’… and involves narrative in a number 
of ways, including qualitative analysis” (p. 4).  The essence of this research advocates for 
introducing narratives beyond exam rooms, but across the healthcare information value chain, 
especially as a data collection methodology that is part of big data as a source of clinical and 
policy making data. 
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In addition, the human body is uniquely complex. Study participants surmised that big data in 
healthcare is unlike big data generated in other service industries (“genomics, senomics, and 
other “-omics” that are out there. Metropolomics for example are generating huge amounts of 
data that need to be processed in ways different than we have in the past” - Provider). 
Transactional data used in day-to-day healthcare delivery, human genome data, and human 
microbiomic data, if integrated with social epidemiological data, will eventually create an 
unthinkable amount of big data from just a single person. 
Category of Meaning #3:  Information and Knowledge Science and Big Data in Healthcare 
Main Takeaway: The ability to link and visualize genomic, environmental, and other 
heterogeneous sources of complex data positions the disciplines of information science and 
knowledge management at the center of the delivery of healthcare and medicine. 
The literature review produced the following observations: (1) consumers of healthcare do 
not have enough trustworthy, credible information to understand the scope and depth of big data 
and its impact on their health and healthcare, and (2) the gulf between “life sciences” and 
“healthcare” is closing – fast. Big data is entrenched in life sciences research, including genetics, 
biomedical research, computational biology, and nanomaterial science. However, these sciences 
are quickly making its way into point-of-care decisions (e.g., shared physician and consumer 
decisions about treatment plans). 
In its strategic plan for the Department of Medical Information Science at the University 
of Illinois  administrator’s confirmed, “in the 21
st
 Century, Medicine will be viewed as an 
Information Science” (Schatz, 2006).  Shaw (2014) proclaimed “information science promises to 
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change the world” (p. 1).  This statement is consistent with most study participant’s ideology 
about medicine as an information science, or as one provider stakeholder stated, “medicine and 
maybe you mean healthcare is an information science.” In fact, a government study participant 
speculated, “Information science pre-dated medicine and allowed medicine to prosper.” While 
his proclamation is debatable, there is no question among most key healthcare stakeholders, 
medicine, or healthcare, is an information rich endeavor (Villars et al., 2011) that is “also about 
smartly moving information around clinicians.” A government stakeholder gathered, “Until you 
were able to classify that in terms for differential diagnosis and how I should treat it, medicine 
was basically voodoo and witchcraft ... the better data you have the better you can diagnose.”   
Indirectly, another provider summarized information science as being foundational to 
medicine: “the more effectively you can select treatment, the better you can actually see those 
treatments.” At the very core of medicine is science and evidence (J. Bellamy & Bledsoe, 2006; 
Sackett et al., 1996; Thyer & Myers, 2011), proliferated by the disciplines of information science 
and knowledge management. But according to several study participants across the key 
healthcare stakeholder classes, medicine is much more than an information science.  
In 2006, the National Science Foundation identified a core set of capabilities that are 
fundamental to the role of the data scientist including: collaboration, coordination, and the ability 
to conduct research and education using digital data collections; serve as a mentor; and, design 
and implement education and outreach programs. These capabilities are consist with  Davenport 
et al. (2012) who wrote, “data scientists understand analytics, but they also are well versed in IT, 
often having advanced degrees in computer science, computational physics or biology- or 
network-oriented social sciences. Their upgraded data management skill set — including 
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programming, mathematical and statistical skills, as well as business acumen and the ability to 
communicate effectively with decision-makers — goes well beyond what was necessary for data 
analysts in the past” (p. 23). 
Study participants want data scientists to also be able to “think logically” with “profound 
specialty knowledge” and perform “as a competent data architect.” Many of the skills identified 
by the National Science Foundation were noteworthy among study participants across the 
classes. Healthcare consists of many domains, (e.g., quality, payment, policy) and in order to 
effectively create information from big data in healthcare, specialty domain skills and knowledge 
are an essential capability key healthcare stakeholders. Study participants identified a list of 
skills and knowledge necessary for the data scientist to become an integral member of the care 
delivery team. Participants of this study advise simply calling yourself a data scientist does not 
necessarily make you a data scientist, as one government stakeholder points out, “A scientist 
without data is a philosopher.”  
Harvard Business Review touted the data scientist as the sexist job in the 21
st
  Century 
(Davenport & Patil, 2012), with demand for data scientists sharply on the rise. The U.S. alone 
will need 140,000 to 190,000 people with deep analytical skills by 2018 just to keep up with the 
pace of innovation (Brown et al., 2011) and the explosion of big data. The problem as two 
provider study participants observed, “There’s still a very limited skill set out in the industry in 
terms of the people who know how to do this … finding somebody who’s got 10 years of 
experience in big data is going to be pretty impossible to find.”   
The healthcare industry is inherently one of the most information-rich market sectors. 
Study participants surmise the entire healthcare ecosystem would be well served by uniformly 
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employing the disciplines of both information science and core. This vision can only be realized 
with governance and a common set of standards. The next section explores governance of big 
data in healthcare.  
Category of Meaning #4: Governance of Big Data in Healthcare 
Main Takeaway: Data stewardship, modern and refined privacy rules, and a set of common 
standards are required for all healthcare stakeholders to realize the benefits of big data in 
healthcare. 
The NCVHS is an eighteen member statutory public advisory committee to HHS that has 
created selection criteria for interoperable clinical data standards and standards for e-prescribing 
body (Grossmann, 2010) and other national standards for federal rule-making. No standards have 
been passed or are currently under consideration for big data in healthcare (Pavolotsky, 2012) – a 
vision of several key healthcare stakeholders. Study participants from both provider and 
consumer stakeholder classes envision “widespread integration of administrative, clinical and 
patient generated data that will be available through big data.” But the literature suggests a 
fundamental barrier to widespread big data integration: health system fragmentation (L. R. Burns 
et al., 2002) of heterogeneous health and healthcare data (Grossmann, 2010).  
Consistent with the literature, participants in this study identified competition (Cukier, 
2010; Frangenberg, 2013; Grossmann, 2010) as a problem in the healthcare industry (“There’s a 
“desire to maintain a competitive edge” – Provider and “that means having a competitive 
advantage over somebody else and in today’s world that is information.” - Government). Study 
participants across all key stakeholder classes generally agree the lack of a governing body and 
190 
 
 
organizing framework for big data in healthcare prevents the industry from realizing the true 
benefits of big data in healthcare. Several study participants called for a “common set of 
standards and user policies.” In the absence of such a framework, unintended consequences such 
as barriers to wide-spread sharing will continue to plague the healthcare industry. Study 
participants offer the wisdom that though a consensus-based big data definition is necessary, its 
maturity and wide-spread adaption will not happen overnight. A government stakeholder 
postulates the industry needs to “use the same definition for enough time so that we can 
aggregate data.”    
Study participants believed privacy was an issue as several pointed out current federal 
rules are not appropriate for big data in healthcare. In order for privacy to be effective, HIPAA 
rules must be revisited, as patients are sharing increasing amounts of data about themselves and 
their health. McGraw (2012) asserts “federal privacy regulations do not set clear and consistent 
rules for access to health information to improve health care quality” (p. 75). The linkage of life 
sciences data (e.g., genomics) alone to traditional transactional healthcare data dramatically 
changes the privacy landscape, effectively requiring an overhaul of healthcare privacy laws. 
Genomic information is fundamentally identifiable and the privacy implications are profound 
(Shaw, 2014).  
Contributions and Implications for Future Research  
This research is significant because it: (1) produced new thematic insights about the 
meaning of big data in healthcare through narrative inquiry; (2) offered an agile definition of big 
data that can be deployed across all industries; and, (3) made a unique contribution to scholarly 
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qualitative literature about the phenomena of big data in healthcare for future research on topics 
including the diffusion and spread of health information across networks, mixed methods studies 
about big data, standards development, and health policy.  
In Burns (2013) feature article, Healthcare’s Big Data Tsunami, the author postulated, 
“the big data tsunami in healthcare is washing ashore today and few healthcare organizations are 
effectively dealing with it” (p. 59).  The next logical question is: why are healthcare 
organizations not be prepared to effectively deal with what is widely presumed to be an 
organizational asset (and in some circles, healthcare’s “natural resource”)? Through qualitative 
and phenomenological research using narrative, this study provided new knowledge about the 
important categories of meaning of big data in healthcare through the insights and perspectives 
of nine key healthcare stakeholders. The results found big data in healthcare remains poorly 
defined – relying almost exclusively on axioms to explain its purpose, provenance, and meaning. 
Dr. Myles Rennaker, director of a governmental agency admits, “Nobody ever defined for me.” 
While Gartner’s widely-publicized (updated from 3) “4V’s” of High Volume, High Velocity, 
High Varity and High Veracity is entrenched into the lexicon of healthcare organizations, Dr. 
John Boyken, associate dean at a major medical school adds, “It’s a popular term that means a 
lot of different things to a lot of different people.”  Buzzwords are deeply-rooted as important 
descriptors of big data. They provide sorely needed context to a potentially transformative 
organizational asset. Nonetheless, Dr. Rennaker concludes healthcare standard’s organizations 
must “clarify and demystify” big data in healthcare.  
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Findings from this qualitative study also uncovered a critical dimension of big data that 
perilously has been overlooked, or dismissed, in the many well-intended offers to “characterize” 
big data in healthcare: the humanistic dimension of big data in healthcare. The humanistic 
dimension of big data emphasizes the cognitive prowess and contributions of the human mind, 
the extraordinary complexity of the human body as a source of big data, and the lost narratives 
and relationships forged between people. And as a government stakeholder shared after reading 
the executive summary on the study, “I think you have articulated the attributes that make 
healthcare different. This paper represents a contribution to resetting expectations more in line 
with reality, which can facilitate more effective use of computers and large databases to 
contribute to research, diagnosis, treatment, and quality measurement.” 
The widespread integration of vast amounts of genomics data, environmental data, and 
new sources and diversity of data generated by wearable devices and sensors with traditional 
transactional healthcare datasets requires improved statistical, computational methods, and 
visualization tools (Shaw, 2014). The healthcare industry is at the threshold of such widespread 
big data integration, fueled by the Triple Aim of improving the experience of care, improving the 
health of populations, and reducing per capita costs of health. Such a vision is why the 
interdisciplinary fields of information science and knowledge management play a crucial role in 
the delivery of 21
st
 Century medicine.  
Health and healthcare data provenance include metadata and Meaningful Use attribution 
data, not to mention public health surveillance data and global health data.  With the never 
ending possibilities of adding to healthcare data provenance, there was near unanimous 
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consensus that big data in healthcare requires a common ontology for healthcare organizations to 
effectively utilize this “natural resource.”  With truly massive amounts of heterogeneous big data 
being collected now in disparate databases, there is a concrete need for standards advisory 
organizations like the National Committee on Vital and Health Statistics (NCVHS) and the 
National Institute of Standards (NIST) in partnership with private sector companies and federal 
organizations to recommend a consensus-based definition and ontology of big data in healthcare. 
Big data generation and integration in healthcare is best served by defining its provenance, 
privacy and precision, and purpose (4”P’s”). Study participants concluded governance of big 
data in healthcare will allow healthcare organizations to not only “effectively deal with the data 
tsunami,” but generate and share sought after knowledge and wisdom for healthcare intelligence 
across the healthcare information value chain.   
  Big data in healthcare is not customarily discussed in qualitative terms. While not 
intended to be generalizable, this phenomenological research uncovered foundational insights 
and perspectives capable of augmentation with basic research in disciplines to include social 
network analysis and health policy development. For example, a phenomenology study using 
narrative can inform policy makers and researcher which barriers impede the flow of information 
between key healthcare stakeholders and how healthcare stakeholders influence the fidelity of 
information that is shared within networks?  The findings from this rigorous qualitative study 
that uncovered the “know about” big data can be used as the foundation to conduct further mixed 
methods research hypotheses that explores the “know that” about big data. Such a study using 
regression or path analysis can then generalize the themes and subunits of meaning found in this 
194 
 
 
study. Furthermore, these findings can also provide standards advisory organizations with 
experiential insights and knowledge about defining a big data definition germane to health and 
healthcare.  
Finally, derived from the nine key healthcare stakeholder narratives, I offer the following 
agile “definition” of big data, which could serve as a spring board for a consensus-based 
framework for big data in any industry:  
“Big data” is both an organizational philosophy and strategy, enabled by 
information science discipline, to purposefully collect, link and analyze a variety 
of heterogeneous data resources and data ontologies, requiring the confluence of 
people and computers to generate precise information displayed through 
advanced visualization tools. 
Lessons Learned 
There were many valuable lessons learned from conducting this phenomenological study. 
First, among the many qualitative methods available to me to conduct this important 
research, a phenomenological study using narrative was appropriately chosen to answer the 
research question. This research is an important foundational qualitative study to fully 
understanding the meaning about big data in healthcare. The experiential knowledge of key 
healthcare leaders provided timely, thick descriptions the big data phenomena in healthcare. 
Perhaps a mixed methods study design would add further rigor to the findings in this study. 
Using modern quantitative data analysis methods adds tremendous insight and value (Shaw, 
2014). Weber (1990) points out that the “best content-analytic studies use both qualitative and 
quantitative operations” (p. 2). Future research using a mixed methods approach would certainly 
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yield new insights and rigor to the research topic, particularly as big data and information sharing 
practices are explored. 
Second, interviewing patients, caregivers, and other healthcare consumers would have 
been ideal – achieving an unparalleled richness and truth about healthcare consumer’s views. 
The consumer advocates provided outstanding narratives; however, the voice of the patient is 
rarely integrated into policymaking. I have developed a passion for capturing the narratives of 
healthcare consumers and look forward to pursuing such work in future academic and 
professional endeavors.    
Finally, the phrase “large data sets” was often found in the literature but was not included 
in this study so to maintain consistency with the study term, “big data.” In retrospect, including 
“large data sets” might have added additional sources of scholarly literature to the study. Several 
study participants mentioned, “Managing large data sets of implementing analytics.” 
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CHAPTER VIII. CONCLUSION 
Within and across each of the three key healthcare stakeholder classes, big data in 
healthcare remains a misunderstood phenomenon. Unfortunately, the absence of a consensus-
based, industry-wide definition of big data enables buzzwords to maintain a prominent and 
important descriptor of the phenomena. While key healthcare stakeholders accentuated a keen 
awareness of big data, most lacked a concise understanding of its meaning and relied on either 
Gartner’s 4 V’s characteristics of High Volume, High Variety, High Velocity, and High Veracity 
as a definition or conceding to not understanding what it really means. One consumer 
stakeholder frankly admitted:   
I think the cause of big data would be better served by characterizing it more 
clearly for a lot of us if they want to be able to move forward.  People can be 
afraid of it. So between not really understanding what’s meant by it, whatever it 
is, it needs to be clarified and demystified I think, mainly clarified I’d say because 
I’m not sure what the hell they’re talking about (Consumer). 
 
Big data is employed extensively in other industries in which a multitude of lessons 
learned can be applied. However, there persists a shortsighted supposition that big data in 
healthcare is the same as or even nearly identical to big data in industries that define their 
products. Stakeholders agree that the human dimension of big data is what makes big data in 
healthcare unique from every other industry sector – from human’s cognitive ability to recognize 
patterns to our complex physiology and genetic makeup. A common unit of analysis in 
healthcare is a human who’s phenotypic and microbiomic makeup is unique from one individual 
to the next.  
197 
 
 
Information science is an interdisciplinary field that is a fundamental core to delivering 
evidence-based medicine and healthcare intelligence. The information science framework 
includes the 3 ”C’s” of big data collection, classification, and curation as well as linking and 
creatively visualizing big data sets (Shaw, 2014) over its lifecycle. The information science field 
enables the transformation of “big data” into “smart data,” which satisfies stakeholders thirst for 
precision and trust, to be used for a variety of healthcare intelligence uses. The reformed 
healthcare industry which demands exceptional value for care delivered is in the midst of an 
emerging health information economy which requires a new big data governance framework 
where health information technology interoperability, metadata provenance, usage policies, and 
common standards will allow big data to be analyzed and shared across a connected, “many-to-
many” healthcare information value chain. 
In summary, this research provided four main categories of meaning and four takeaways 
for key healthcare stakeholders to consider: 
1. Without a consensus-based “framework” of big data in healthcare, ‘buzzwords’ and slogans 
will continue to play an important role in describing big data’s meaning in healthcare. 
2. There is a dual ‘humanistic dimension’ to big data in healthcare that takes into account (1) 
people’s cognitive contributions and (2) the uniqueness of human data as a unit of analysis. 
3. The ability to link and visualize genomic, environmental, and other heterogeneous sources of 
complex data positions the disciplines of information science and knowledge management at 
the center of the delivery of healthcare and medicine. 
4. Data stewardship, modern and refined privacy rules, and a set of common standards are 
required for all healthcare stakeholders to realize the benefits of big data in healthcare. 
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Finally, medicine is not only rooted in information science. It is a confluence of many 
other sciences and arts, including the medical humanities, which include capturing patient 
narratives and their unique ‘stories’ in an ethical manner. Such big data need not sit stagnant in 
electronic health records, but be used as a credible source of ‘big data’ that generates knowledge 
about personalized healthcare. This is the disruptive innovation in a reformed, patient-centered 
healthcare system that healthcare policymakers must seriously employ as a credible data source 
in the development of healthcare policy. As one provider stakeholder fittingly summed up big 
data in healthcare: 
Big data doesn’t mean unstructured data. You always create data for a purpose, 
right.  That’s the human creation.  It always has purpose, you have to understand 
the purpose if it’s going to be effective.  
 
And then everything else is just a tool.  
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APPENDIX A. STUDY DESIGN 
Phenomenological Study using Narratives 
Phenomenology is a philosophy that had its beginnings in the early years of the 20
th
 
Century and became explicitly aware of itself in 1913 (Husserl, 1970). Phenomenology became 
popular in the social and health sciences, especially in sociology (Borgatta & Borgatta, 1992), 
psychology (A. Giorgi, 1985), and education (M  Van Manen, 1980). While phenomenology has 
a rather ambiguous history, as late as the 1970’s, its popularity in the social and health sciences 
has potential applicability to current healthcare issues, including the persistent phenomena of 
healthcare disparities, social epidemiology of social networks and population health. 
Phenomenological research tends to converge with qualitative research strategies (Amedeo 
Giorgi, 2009) in which narratives are used as data (Clandinin, 2013).  
Phenomenological and narrative-based methodologies have a modest history in public 
policy. These methodologies embrace an assortment of epistemologies ranging from 
interpretative methods to empirically-oriented narrative policy frameworks. While narratives are 
indeed used in the exploration and practice of policy, my practical experience in healthcare 
policy development lead me to believe general lay person narratives offered in the policymaking 
context are frequently treated as purely persuasive mechanisms, not as part of the body of 
evidence (Steiner, 2005) relevant to phenomena, policy-making or public administration (Borins, 
2012). A Cornell University e-Rulemaking Initiative (Epstein, Heidt, & Farina, 2013) perhaps 
frames the void of multidisciplinary collaboration between the general lay person and 
government policy-makers best:  
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Given the disparity in power between government decision-makers and the public, 
ways of arguing for a particular policy position and perceptions of valid evidence 
constitute important boundary objects that make many civic engagement efforts 
ineffectual. Members of the lay public largely do not have the skills and the 
culture necessary to engage in formal argumentation based on empirical data. 
Yet, they possess the unique situated knowledge of living with existing policy or 
proposed policy changes. Helping the two communities to establish a shared 
repertoire may help in creating better policy solutions (Epstein et al, 2013, p.20). 
  
Epstein et al (2013) also provides a coherent perspective for capturing the narratives of 
both policymakers and the general public with the creation of a narrative framework that 
embraces the “value of narratives as input in the policymaking process” (p. 1). In today’s modern 
healthcare delivery system, there remains a dearth of phenomenological studies encompassing 
narrative (Clandinin, 2013; Amedeo Giorgi, 2009; M  Van Manen, 1980). Scholarly evidence 
supports my decision to approach the inquiry of big data in healthcare through semi-structured 
interviews with ten leaders from three key healthcare stakeholder classes: government, providers, 
and consumers. A narrative describes the lived experience of a single individual; a 
phenomenological study describes the meaning for several individuals of their lived experiences 
of a concept or a phenomenon. Phenomenologists focus on describing what all participants have 
in common as they experience a phenomenon. The basic purpose of phenomenology is to reduce 
individual experiences with a phenomenon to a description of the universal essence (M  Van 
Manen, 1980). The following (Table 9) provides a comparative summary of potential study 
design options considered to conduct this study. 
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CHARACTERISTICS NARRATIVE 
RESEARCH 
(DENZIN & LINCOLN, 
2002) 
PHENOMENOLOGY 
(MOUSTAKAS, 1994) 
CASE STUDY 
(STAKE, 1995) 
Focus Exploring the life 
of an individual 
Understanding the 
essence of the 
experience 
Developing an in-
depth description 
and analysis of a 
case or multiple 
cases 
Type of 
Problem Best 
Suited for 
Design 
Needing to tell 
stories of 
Individual 
experiences 
Needing to describe the 
essence of a lived 
phenomenon 
Providing an in-
depth 
understanding 
of a case or cases 
Discipline 
Background 
Drawing from the 
humanities 
including 
anthropology, 
literature, history, 
psychology, and 
sociology 
Drawing from 
philosophy, 
psychology, and 
Education 
Drawing from 
psychology, law, 
political science, 
Medicine 
Unit of 
Analysis 
Studying one or 
more individuals 
Studying several 
individuals that have 
shared the 
Experience 
Studying an event, 
a 
program, an 
activity, 
more than one 
individual 
Data Collection 
Forms 
Using primarily 
interviews and 
Documents 
Using primarily 
interviews with 
individuals, although 
documents, 
observations, and 
art may also be 
considered 
Using multiple 
sources, such as 
interviews, 
observations, 
documents, 
artifacts 
Data Analysis 
Strategies 
Analyzing data for 
stories, 
“restorying” 
stories, developing 
themes, often using 
a chronology 
Analyzing data for 
significant 
statements, meaning 
units, textural and 
structural 
description, description 
of the “essence” 
Analyzing data 
through 
description of the 
case and themes of 
the case as well as 
cross-case themes 
Table 9. Comparative summary of narrative inquiry, narrative research, phenomenology and   
case study 
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Either of the study designs evaluated in Table 9 was adequate to conduct this research 
study. Healthcare has historically used a shallow toolbox of research practices to elicit 
knowledge and insights. Experimental (e.g., randomized trials) and quasi-experimental designs 
have been overused in clinical practice, in part, because the science (and art) of medicine is 
grounded in developing a credible evidence-base that informs clinicians and patients. Evidence-
based medicine is defined as the conscientious, explicit and judicious use of current best 
evidence in making decisions about the care of individual patients (Sackett, 1997).  Evidence-
based medicine is also founded on the principle that scientific inquiry is superior to expert 
opinion and testimonials. It is not often narrative is used to inform decisions in healthcare – 
making this phenomenological study a timely scholarly contribution. The following are examples 
of a phenomenological study encompassing narrative with a similarly-sized study population.  
In Gabrielson’s (2009) dissertation, a qualitative study using narrative analysis of 
interviews with ten older lesbians (aged 55 and over) who made a financial commitment to live 
in a continuous care retirement center (CCRC) specializing in lesbian, gay, bisexual and 
transgender (LGBT) care was conducted. The specific aims of the study were to: 
 Describe what has impacted older lesbians' decisions to live in an LGBT-specific CCRC; 
 Describe factors that both positively and negatively impact older lesbians’ perceptions of 
elder care (Gabrielson, 2009). 
The study combined two qualitative strategies (across-case, thematic analysis and 
narrative analysis) and used a convenience sample.  
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Another comparable study in phenomenology using narrative was conducted by Baily 
and Tilly (2002) in which their study was a constructivist approach to narrative in which ten 
stories about death, physical and emotional vulnerability from three key informant groups: 
patients, caregivers and nurses were analyzed. Bailey and Tilly (2002) suggest that the events 
were not recounted to convey objective reality but to convey meaning, concluding that these 
stories were reconstructed in a way to convey their perspective of an event, rather than 
decontextualized truths (Bailey & Tilley, 2002).  
An important depth-related study that provided a framework for the analysis of big data 
was conducted by Halevi and Moed (2012) where they explored the term big data as it evolved 
in the peer-reviewed literature. They sought to understand big data as a topic of study and the 
scientific problems, methodologies and solutions that researchers focused on in relation to it. 
Through a modified systematic review of literature in Scopus, an abstract and citation database 
of peer-reviewed literature (http://www.info.sciverse.com/scopus), Halevi and Moed (2012) 
uncovered three important themes from their research: 
 The first appearance of term big data in scholarly literature appears in a 1970 article on 
atmospheric and oceanic soundings;
13
 
 Early papers (1970 until 2000) were led by computer engineering, building materials, 
electric generators, electrical engineering, telecommunication equipment, cellular 
telephone systems and electronics disciplines; and, 
                                                 
13 This is an important finding, as many sources of ‘grey literature’ credit the first references to the term ‘big data’ 
circa 2000. 
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 From 2000 onwards, the field is led by computer science followed by engineering and 
mathematics disciplines (Halevi & Moed, 2012). 
These findings are significant. It suggests a strong correlation between the rise of big data in 
direct parallel to advances in technology, science and mathematics. Intuitively, with the advent 
of HIT in healthcare, there has been a direct upsurge in the notion of big data, too, along with the 
renaissance of the data scientist.  
Worldview Paradigm 
At the foundation of any research project are epistemologies, or philosophical 
worldviews (Creswell, 2009) which include postpositive, social construction, 
advocacy/participatory and pragmatism. These types of worldviews influence the type of 
research design (qualitative, quantitative, or mixed methods) the researcher selects as the most 
effective method to study the intended topic (Table 10).    
FOUR WORLDVIEWS 
Postpositivism Constructivism 
 Determination 
 Reductionism 
 Empirical Observation and 
Measurement 
 Theory Verification 
 Understanding 
 Multiple Participant Meaning 
 Social and Historical Construction 
 Theory Generation 
Advocacy/Participatory Pragmatism 
 Political  
 Empowerment 
 Collaborative 
 Change-Oriented 
 Consequences of Action 
 Problem-Centered 
 Pluralistic 
 Real-World Practice Oriented 
Table 10. Four Philosophical Worldviews 
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As data is gathered and synthesized, assumptions are formed to test claims or hypotheses.  
Depending on the type of research conducted, a researcher can begin (and end) with either 
philosophical worldview that presents the best fit to the intended course of study. Theoretically, a 
researcher, as well, could seamlessly traverse each of the four ontologies described by Creswell 
(2009):  
 Postpositivism worldview,  which is considered the traditional form of learning and is 
grounded in measurement of observations and outcomes;  
 Constructivism worldview, where researchers seek to understand the world in which 
they work and live by collecting data personally, interpreting the results and forming 
conclusions;  
 Advocacy/Participatory worldview, which holds that politics are intertwined in the 
research and that there is a political or advocacy action agenda for change; and, 
 Pragmatism worldview, which holds that there is no singular system or philosophy 
that researchers are committed to and employ mixed methods of study and multiple 
methods that happen to work at that time (Creswell, 2009, p. 6). 
Early in my professional and academic career, my philosophical position manifested from 
having worked in diverse healthcare settings, including federal and state government, academia 
and private sector managed care organizations which require a practical and academic 
perspective for which to understand the work. After contemplating and absorbing each of these 
worldview beliefs for at least two academic school years, it is clear that my epistemological 
position about the phenomena of big data in healthcare can be constructed as follows: a) data, 
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information and knowledge are contained within the perspectives of people that are experienced 
in healthcare and big data, either as a policymaker, provider or consumer; and b) my academic 
and professional experience is unique and allowed me to collaboratively engage with the study 
participants in collecting and constructing meaning about big data in healthcare.  
Denzin and Lincoln (2002) postulate a relevant vignette which undoubtedly influences 
my study design approach: 
Constructivism - Knowledge consists of those constructions about which there is 
relative consensus (or at least some movement toward consensus) among those 
competent (and, in the case of more arcane material, trusted) to interpret the 
substance of the construction. Multiple "knowledges" can coexist when equally 
competent (or trusted) interpreters disagree, and/or depending on social, 
political, cultural, economic, ethnic, and gender factors that differentiate the 
interpreters. These constructions are subject to continuous revision, with changes 
most likely to occur when relatively different constructions are brought into 
juxtaposition in a dialectical context (p. 113). 
 
By virtue of conducting a phenomenological study, which has a very deep history in 
philosophy (Groenewald, 2004), my philosophical grounding in constructivism was reinforced.  
This study is about discovery of important categories of meaning about big data in 
healthcare through the experiential knowledge of nine key healthcare stakeholders. By listening 
to, writing, describing and interpreting text of an individual’s “lived experience,” I also 
successfully elicited original, first-hand data about rich social, cultural, and institutional 
narratives (Clandinin, 2013) that are potentially lost in a quantitative approach. Make no mistake, 
Amedeo Giorgi (2009) was clear that “a completely full experiment requires both aspects” (p. 
39) of quantitative and qualitative approaches.  I did not consider a mixed method analytical 
technique, drawing on my training as an epidemiologist, Leinweber (2011) points out that the 
“best content-analytic studies use both qualitative and quantitative operations” (p. 2). However, 
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researching the qualitative aspects of the healthcare big data phenomena yielded a timely and 
much richer description about the phenomena. Phenomenology using narratives is appropriate 
and timely for the phenomena under study.  
Interview Procedures 
Each study participant was given the list of the interview questions as part of the 
Interview Guide (Appendix C) at least one week prior to the scheduled initial interview. While 
there was no formal preparation required, sending the questions ahead of time allowed each 
study participant to think through a sequence of events and topics that were possibly forgotten to 
memory. An executive summary no longer than three pages was sent to each study participant in 
a PDF format.  
While the study topic was positively received by potential study participants and industry 
leaders, a moderate-level risk loomed: potential candidates who verbally and informally agreed 
to participate in this study could recuse themselves for a number of factors, including, schedules, 
new commitments, time-lapsed between initial contact and interview, and the end of the current 
federal fiscal year (September 30, 2013). To mitigate this risk, I kept potential study participants 
informed of the progress of the study’s development through email. This was important because 
at the onset of my data collection period, the federal government historically shut down its 
operations between October 1 and October 16, 2013. 
Of the study participants selected, six were geographically located in the Mid-Atlantic 
region (Figure 5) of the United States because of the density of federal healthcare agencies and 
integrated delivery systems. The region is also a hub for national patient advocacy organizations. 
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The remaining three study participants were selected from the Midwest and Pacific Coast 
regions. 
After ten study participants were selected from the purposive sample, each signed and 
returned the original copy of the Participant Study Consent Form (Appendix B). A one-hour 
interview was subsequently scheduled. No potential study participant declined verbally or by 
email. 
 
Figure 5. Geographic regional sampling frame from which purposive sample will be drawn 
(source: Internet: Google Images www.google.images.com) 
Semi – Structured Interviews 
A semi-structured interview has a freewheeling (Bernard, 2006) quality – the flow of the 
interview, rather than the order in the interview guide (Bailey & Tilley, 2002) which provides 
explicit directions about how the interview will be conducted, guides the healthcare “stakeholder 
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– researcher” collaboration. A copy of the Interview Guide that provided clear instructions to 
guide this study is in Appendix C.  
Each initial interview lasted approximately 43 to 60 minutes, with one interview lasting 
one hour and 16 minutes. Five interviews were held in the study participant’s place of work, 
three were held over the phone, and two were held through Skype. Each study participant 
conducted their interview from their place of work with the exception of two who took the 
interviews from their homes. 
The semi-structured interviews served as the primary data collection method; my written 
field notes were a secondary source of data along with additional supplemental data. Four of the 
participants provided additional sources of data, including Microsoft PowerPoint slides from 
previous presentations on big data, a book co-authored by a study participant, and a URL to a 
personal website.  
  Study participants responded to 11 open-ended questions and one yes-no question that 
elicited further elaboration. I solely conducted each interview and recorded the “conversation” 
on an Apple iPhone 5S. The data were immediately loaded into a secure password-protected data 
management account and uploaded for transcription and analysis. I augmented the recordings 
with personal field notes kept in a dedicated journal. Follow up interviews occurred face-to-face 
in the study participant’s place of work, via Skype and on the phone. The intent was to maintain 
the most comfortable setting for study participants to share their in-depth narratives about big 
data in healthcare. No other research interviewers were used in this study. The interview guide 
was about the most structured part of the interviews. 
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Bracketing 
For a major federal project, I conducted twenty-five semi-structured interviews with 
middle to senior-level managers in a large healthcare agency to chronicle and synthesize their 
requirements for and insights into an enterprise-wide portfolio management initiative. I 
developed a study guide to help facilitate the interviews; however, this elite group of federal staff 
relied on my ability to navigate an informal conversation, keep them engaged and respect their 
limited time.  
During interviews, I maintained a collaborative rather than an objective or neutral 
relationship with each study participant. One of the lessons learned from the aforementioned 
experience was to engage in an informal conversation with lots of flexibility, but maintain a 
degree of structure bound by the interview guide. From this in-depth, six-month long project, I 
also learned that semi-structured interviewing works very well in projects where researchers 
engage with high-level bureaucrats and elite members of a community—people who are 
accustomed to efficient use of their time (Bernard, 2006). 
I have reflected a lot on my role during this research study. My research has uncovered 
the fact that there are a couple of prominent ideologies on the level of involvement of the 
researcher. Dahlberg’s (2006) notion of ‘bridling’ provided a reference that guided my 
interactions with each study participant. Bracketing, or putting aside my experiences beliefs and 
opinions, is a commonly used approach in phenomenology studies. It was very difficult to simply 
set aside my presuppositions, opinions and ideas about a topic I am very close to. However, to 
get to the “truth” of the story, I successfully set aside my personal knowledge and ideologies on 
big data in healthcare and remained conscious of each study participant’s lived experience, 
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employing my excellent listening skills. There were three aspects of bridling that guided my 
presupposition as described by Bremer (2009):  
 Like “bracketing,” bridling is “the restraining of one’s pre-understanding in the form of 
personal beliefs, theories, and other assumptions that otherwise would mislead the 
understanding of meaning and thus limit the research options” (pp. 129 – 130).  
 It is also about the “understanding as a whole” not just the “pre-understanding”-this is done 
so as to not “understand too quickly, too carelessly” (p. 130). It is an “open and alert attitude 
of activity waiting for the phenomenon to show up and display itself within the relationship” 
(p. 130); and,  
 It is forward looking rather than backward looking, allowing “the phenomenon to present 
itself” (p. 130)(Bremer, Dahlberg, & Sandman, 2009). 
Data Management 
There were many types of data that required management: documents, interview 
transcripts, field notes, websites and books. During the first semester of the doctoral program, I 
began ‘memoing’(Miles & Huberman, 1994), or journaling. Journaling is a process of 
maintaining a written record of my experiences, activities, thoughts, and ideas on regular basis. It 
is a practice that I maintained throughout my studies and research. I used Evernote as the 
primary electronic document management system to manage and secure websites and other 
documents except the raw transcripts. As a supplement to the electronic media, I maintained a 
dedicated written journal to document reflections and thoughts about this research process.  
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All interview audio files were stored and managed in a dedicated, secure, password-
protected Apple iTunes account which I only had access. Six (6) months after the date of the 
final study analysis, all iTunes audio files associated with this research study will be destroyed 
and not be available for use in further research, articles or publications.  
Transcription 
 Only after permission was granted in writing and verbally approved by each study 
participant, each interview was recorded using an Apple iPhone 5s. I took hand-written field 
notes to supplement each recording. Field notes were kept in a confidential journal;  
 After recording each interview, the audio file was converted into a written transcript through 
a technique called “parroting:”  
o Download the audio file to an Apple iTunes secure cloud platform using a Mac Air laptop;  
o Through Dragon NaturallySpeaking 12 Premium Student/Teacher edition software, a 
recording of the interview was heard through the Dragon headset;  
o No later than one day after each interviews I listened to the recorded text;  
o For quality control, the audio file was re-checked against transcription. 
 I used Microsoft Word as the word processor to manage text data recorded from each audio 
interview. A password protected file for each interview was created to ensure privacy and 
eventually merged for analysis.  
 Files were saved based on the coding scheme in Table 13. To maintain confidentiality, no 
study participant names were associated with any file. I assigned a web-generated 
pseudonym to each participant. Rather than use an impersonal identification code, I chose to 
maintain authenticity of narratives realism by assigning traditional names.    
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Timeframe 
All data collected from the initial semi-structured interviews and subsequent follow up 
interviews were conducted between September 23, 2013 and December 10, 2013.  
Data Analysis Procedures 
For this research study, I employed a commonly used content analysis framework: a 
general inductive approach to qualitative analysis (Elo & Kyngäs, 2008; D. Thomas, 2003; 
Zhang & Wildemuth, 2009)
14
. A general inductive approach to qualitative content analysis is a 
valuable alternative to more traditional methods when attempting to identify important themes or 
categories within a body of text (Zhang & Wildemuth, 2009).The technique is drawn from a 
variety of related techniques used in exploratory qualitative research, qualitative content analysis 
and constructivist grounded theory (Pope, Ziebland, & Mays, 2000) which if a theory were to be 
used is the closest theory that relates to this research study.
15
 Thomas (2003) purports that the 
primary purpose of the inductive approach is “to allow research findings to emerge from the 
frequent, dominant or significant themes inherent in raw interview data, without the restraints 
imposed by structured methodologies” (p. 2). I chose this framework because the general 
inductive approach is frequently reported in health and social science research (D. R. Thomas, 
2006; D. Thomas, 2003) and information & library sciences (Zhang & Wildemuth, 2009) and 
has a close counterpart, quantitative content analysis.  
                                                 
14
 David R. Thomas is professor at the School of Population Health, University of Auckland 
 
15
 This is a phenomenological study. Dewey’s Theory of Experience (1938) is most often cited as a philosophical 
underpinning of narrative inquiry. 
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Qualitative data analysis involves searching for emerging themes, first within an 
interview and then across a series of interviews. The search for emerging themes is common 
practice in qualitative research and involves the interplay between data and the emerging themes 
(Tan & Hunter, 2003). There is no one method to analyze narrative data, and arguably, there are 
a host of appropriate analytical methods for a qualitative study in information studies (Table 11).  
Trustworthiness 
Though as novice researcher and rising scholar-practitioner, my personal goal was to 
conduct an ethical high quality research study on big data in healthcare. Qualitative researchers, 
who frame their studies in an interpretive paradigm, think in terms of trustworthiness as opposed 
to the conventional, positivistic criteria of internal and external validity, reliability, and 
objectivity (Denzin & Lincoln, 2002; Guba & Lincoln, 1985). To ensure trustworthiness, I relied 
on two methods: triangulation of stakeholder participation of three key healthcare stakeholder 
classes and stakeholder checks, which were important to ensure I maintained the essence of each 
stakeholder’s narrative. Stakeholder checks were also an invaluable method to capture additional 
new information from study participants post initial interview. Many of the study participants 
provided additional data and clarified inaudible or erroneous interpretations of their words.  
My objective was to not merely connect “thick descriptions” of narrative, but to create a 
trusted, meaningful account about big data in healthcare through the insights of those who know 
the subject best.  
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Study Limitations 
This study posed three limitations that could have potentially impacted this study. The 
first limitation was the construct of a phenomenological encompassing narrative study design. 
Small qualitative studies yield very limited information about a phenomenon from a limited 
sampling frame.  The study participants selected from the purposive sampling strategy produced 
credible and reliable original data. Second, I had no expectations of achieving saturation of 
themes that were generalizable to the entire healthcare ecosystem. This study focused on three 
key healthcare stakeholder classes out of many that constitute the healthcare ecosystem. “Key” 
healthcare stakeholders could be defined differently by other researchers. I chose not to poll 
other healthcare experts to validate if the three classes identified in this study as “key.” Third, 
patient privacy is protected by federal laws that would jeopardize this study. Patient privacy is 
not a risk related to this study as it has been mitigated by purposively selecting responsible 
consumer advocates who are well positioned to assist patients in decision making about their 
health issues (Petronio, Sargent, Andea, Reganis, & Cichocki, 2004). 
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GENERAL 
INDUCTIVE 
APPROACH 
(THOMAS 2003) 
 
GROUNDED 
THEORY 
(CHARMAZ, 2006)  
INTERPRETATIVE  
PHENOMENOLOG
ICAL 
ANALYSIS (IPA) 
(SMITH ET AL., 2009)  
 
DISCOURSE  
ANALYSIS  
(POTTER, 1996)  
Study Aim 
& 
Research  
Question 
To examine 
topics and 
themes, as 
well as the 
inferences drawn 
from them, in the 
data and to 
generate theory 
To generate 
theory from 
empirical data 
(e.g. stigma in 
mental health)  
 To understand 
individual in-depth 
experience;  rooted 
in psychology 
To capture 
nuances of text or 
public discourse 
(e.g., 
understanding 
political theory) 
Sampling & 
Methods 
Samples usually 
consist of selected 
texts which can 
inform the 
research 
questions being 
investigated. 
 
Purposive 
sampling  
 
 
Range of 
perspectives 
and stay true to 
research 
question; 
unstructured 
questionnaire 
  
Theoretical 
sampling  
Homogenous sample 
and stay true to 
participants’ stories; 
unstructured 
questionnaire  
 
 
Purposive sampling  
  
Documents, 
speeches, 
newspapers, mass 
media  
 
 
 
Purposive/  
Theoretical 
sampling 
Analysis Identification of 
descriptive and 
interpretative 
themes that 
actively engages 
the researcher and 
participants 
Data-driven  
Constant 
comparison and 
iterative 
approach  
  
Identification of 
descriptive and 
interpretative themes 
that actively engages 
the researcher and 
participants   
Detailed, 
thorough analysis 
of discourses – 
speeches, written 
text, 
conversations   
Researcher’s 
Position 
Immerse in the 
data and allow 
themes to emerge 
from the data 
Potential ‘bias’ 
is managed  
Paramount; 
importance of 
reflexivity   
High level of 
interpretation or 
abstraction 
expected  
Table 11. Comparison of common qualitative data analysis methods 
Some of the assumptions of a general inductive approach are described below: 
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 Data analysis was determined by both the research objectives (deductive) and multiple 
readings and interpretations of the raw data (inductive).  
 The primary mode of analysis was the development of categories from the raw data into a 
model or framework that captures key themes and processes judged to be important.  
 The research findings result from multiple interpretations made from the raw data by the 
researcher who codes the data. Inevitably, I independently made decisions about what was 
more important and less important in the data. 
 Trustworthiness of findings was assessed (a) triangulation within across key healthcare 
stakeholders and (b) feedback from participants in the research (D. R. Thomas, 2006; D. 
Thomas, 2003; Zhang & Wildemuth, 2009). 
I did consider four alternative approaches commonly used in the social sciences: general 
inductive approach, grounded theory, Interpretative Phenomenological Analysis (IPA) and 
discourse analysis. Because of the time it took to develop an adequate working knowledge of 
qualitative content analysis, I chose a credible data analysis procedure that allowed me 
systematically apply important categories of meaning necessary to ‘restory’ study participant 
narratives. 
Presentation of Findings and Conclusions 
The framework of a general inductive approach provided a vetted approach to presenting 
research study findings. I must note that while this data analysis approach was a good starting 
point, the final presentation of the findings is undetermined. In the case of a general inductive 
approach to content analysis, the coding process played a central part in how data the data was 
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reported; I am thankful for NVIVO 10. The general inductive approach did not produce counts 
and statistical significance; instead, it effectively uncovered patterns, themes, and categories 
important to a social reality. I let the themes emerge from the coding scheme before I defined 
how the data was to be presented. While I visualized many, many approaches to presenting the 
data, with the guidance of my committee, the study’s finding as they are presented felt like the 
most appropriate way to present these important ‘stories’ on the phenomena of big data in 
healthcare. So that study is replicable, I monitored and reported analytical procedures and 
processes as completely and truthfully as possible (Patton, 2005). Where possible, I included 
tables, graphs, and charts (Miles & Huberman, 1994), and did not deviate from the true objective 
of completing a qualitative phenomenological study.  
I attempted to maintain a balance between both interpretation and description of themes, 
and important categories of meaning.  Description gives readers background and context (Denzin 
& Lincoln, 2002). An interesting and readable report provides sufficient description to allow the 
reader to understand the basis for an interpretation, and sufficient interpretation to allow the 
reader to understand the description (Patton, 2005).  
My curriculum vita (CV) is included at the end of this dissertation. 
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APPENDIX B. STUDY PARTICIPANT CONSENT FORM 
 
SCHOOL OF INFORMATION STUDIES  
343 Hinds Hall Syracuse, NY 13210 
An Epidemiology of Big Data 
  
My name is John Young and I am a professional doctorate student at Syracuse 
University, School of Information Studies. I am inviting you to participate in a research study. 
Involvement in the study is simple, voluntary and with very little risk, so you may choose to 
participate or not. This document will explain the study to you and please feel free to ask 
questions about the research if you have any. I will be happy to explain anything in detail if you 
wish. 
I am interested in learning more about the important categories of meaning about big data 
in healthcare – through the experiences of ten leaders representing three key healthcare 
stakeholder classes: government, providers and consumers. You will be asked to provide your 
insights by participating in a face-to-face interview at your place of work. Interviews will take 
approximately up to two hours of your time, beginning with an initial one hour interview. A 
subsequent follow-up interview either face-to-face or by phone will be used to validate and 
enhance your narrative. Your participation will be a contribution towards providing new 
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knowledge about important categories of meaning about big data in healthcare through an 
intertwined ‘story’ of ten key healthcare stakeholders. 
Your privacy is important and your responses will remain confidential. I will assign a 
unique number to your responses, and only I and my faculty advisor will have the key to indicate 
which number belongs to which participant. In any articles I write or any presentations that I 
make, I will use a made-up name for you and I will not reveal details or I will change details 
about where you work.  
I would like to audio record this face-to-face interview using an Apple iPhone 5 so that I 
can use it for reference while proceeding with this study. I will be the only one who will hear the 
audio recordings, which will be transcribed by me. I will not record this interview without your 
permission.  If you do grant permission for this conversation to be recorded, you have the right to 
end the interview at any time. 
This project will be completed by February 15, 2014. All interview recordings will be 
stored in a secure, password protected Apple iTunes account that I will only have access to until 
six (6) months after that date. The audio files will then be destroyed. Your study data will be kept 
as confidential as possible, with the exception of certain information we must report for legal or 
ethical reasons. 
Contact Information: 
If you have any questions, concerns, complaints about the research, contact my faculty advisor 
and professor, Dr. Jian Qin at (315) 443 - 5642. If you have any questions about your rights as a 
research participant, you have questions, concerns, or complaints that you wish to address to 
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someone other than the investigator, if you cannot reach the investigator, contact the Syracuse 
University Institutional Review Board at 315-443-3013.  
All of my questions have been answered, I am 18 years of age or older, and I wish to 
participate in this research study. I have received a copy of this consent form (please keep a copy 
of this consent form for your records). 
___ I agree to be audio recorded. 
___ I do not agree to be audio recorded. 
_________________________________________    _________________________ 
Signature of participant                                                                          Date  
_______________________________________     
Printed name of participant                                         
_________________________________________    _________________________ 
Signature of researcher                                                                   Date  
_________________________________________     
Printed name of researcher           
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APPENDIX C. INTERVIEW GUIDE 
 
SCHOOL OF INFORMATION STUDIES  
343 Hinds Hall Syracuse, NY 13210 
An Epidemiology of Big Data 
Interview Guide 
Script: 
 Thank you for inviting me to your office and agreeing to participate in this research 
study.  My name is John Young and I am a graduate student in the doctorate of professional 
studies – information management program at Syracuse University, School of Information 
Studies in Syracuse, NY.  This initial interview will take about 60 minutes and will include 11 
questions regarding your experiences and insights about big data in healthcare. I would like 
your permission to audio record this interview, so I may accurately document the information 
you convey. I will also keep hand-written notes to supplement the audio recording. I will 
schedule another follow-up face-to-face or telephone interview to check if you have additional 
insights to share and to ensure my draft transcription accurately reflects your narrative.  If at 
any time during the interview you wish to discontinue the use of the recorder or the interview 
itself, please feel free to let me know.  Your privacy is important; all of your responses will 
remain confidential.  
 
Your confidential responses will be used to contribute to new knowledge about themes, 
challenges and meaning about big data in healthcare using a narrative-based data collection 
method. A coherent ‘story’ from three key healthcare stakeholder classes: government, 
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providers, and consumers will be the outcome of the study. The purpose of this study is to 
discovery important categories of meaning about big data in healthcare. 
  
At this time I would like to remind you of your written consent to participate in this study.  
I am the responsible researcher for this research project: An Epidemiology of Big Data. You and 
I have both signed and dated each copy, certifying that we agree to begin this interview.  You 
will receive one copy and I will keep the other under lock and key, separate from your reported 
responses.  Thank you. 
 
 Your participation in this interview is completely voluntary.  If at any time you need to 
stop to take a break, please let me know.  You may also withdraw your participation at any time 
without consequence.  Do you have any questions or concerns before we begin?  Then with your 
permission we will begin the interview. 
 
A phenomenological study encompassing narrative captures a holistic account of 
people’s experiences related to a phenomenon.  The objective of this phase of the research is to 
capture study participant’s insights and perspectives about big data in healthcare in their own 
words. The following questions are guide for the interview to ensure I have collected the 
intended information. The trustworthiness and credibility of this study relies on study 
participant’s to talk openly and objectively about various aspects of big data in their daily 
routine and within their healthcare organization.  There are no right (or wrong) answers and no 
preparation beyond your subject matter knowledge and experience is required. 
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   DESCRIPTION RATIONALE SOURCE 
IQ1 What does big data mean to you? 
Your organization? What about big 
data in healthcare specifically? How 
did you arrive to this conclusion? 
I am looking for categories of 
meaning derived from 
experiential knowledge which 
could inform a cohesive 
definition of big data. 
(Dumbill, 2013; 
Villars et al., 
2011) 
IQ2 Describe some of the important 
professional and academic 
experiences that prepared you for 
your current position. Please 
emphasize any academic training or 
practical preparation. 
I am seeking to understand 
how study participant evolved 
professionally which could 
provide insight into 
professional development of 
big data in healthcare. 
(Borgman, 2012) 
IQ3 What makes ‘big data’ different from 
‘data?’ Are there certain attributes? 
This is the only ‘yes’ or ‘no’ 
question, but please elaborate: Is 
medicine an information science? 
Big data is a “buzzword” that 
is poorly defined.  
(Borangiu & 
Purcărea, 2008; 
Davenport et al., 
2012; Rooney, 
2012; Sackett et 
al., 1996; Smith, 
1996) 
IQ4 Describe the drivers and influencers 
that impact ’big data’ in healthcare?    
Big data has been slow to 
catch on in healthcare. IQ3 
provides professional and 
organizational insights into 
drivers and influencers of big 
data 
(Bollier & 
Firestone, 2010; 
L. R. Burns et al., 
2002; Sullivan, 
2011) 
IQ5 Describe the ‘big data’ sources (e.g., 
data sets) you use. How do you get 
access to these data sources? Does 
someone else manage access to and 
analysis/interpretation of ‘big data?’ 
Big data requires computing 
platforms and analytics that 
are not customarily available 
on a desktop. Provides content 
and context into the 
capabilities, support, tools 
needed to manage and use big 
data. 
(Anderson, 2004; 
Davenport & 
Patil, 2012; 
Eysenbach, 2008; 
Pryor & Donnelly, 
2009; Rhoads & 
Ferrara) 
IQ6 Describe the organizational 
challenges of making data driven. 
Can ‘big data’ help address these 
challenges? 
These challenges might 
provide insight into why big 
data has been slow to evolve 
in healthcare. 
(Porter & 
Teisberg, 2006; 
Weisbrod, 1991) 
IQ7 Describe what ‘big data’ you share? 
How do you share it? With whom do 
My thought here is by 
understanding 
multidisciplinary perspectives 
(Theodor 
Borangiu & 
Victor Purcarea, 
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you share your ‘big data?’ about big data, this study 
could be a small step towards 
informing further studies in 
health data sharing policy. 
2008; Gorman, 
1995; Porter & 
Teisberg, 2006) 
IQ8 Describe any uses, unintended 
consequences, or reuses of big data. 
Should big data be repurposed for 
secondary use by each of the three 
stakeholder classes? Please 
Elaborate. 
Here, I am hoping to capture 
data on any unintended 
consequences of big data and 
whether data prepared for 
government can be used for 
consumers. 
(Borgman, 2012; 
Kerr, Norris, & 
Stockdale, 2007) 
IQ9 Describe your vision of a future state 
of big data in healthcare. What are 
your hopes for big data? 
Provides content and 
framework for current gaps 
between “as is” and “to be” 
big data. 
(Borangiu & 
Purcărea, 2008; 
Feldman et al., 
2012) 
IQ10 Metaphors and symbols are 
prevalent in healthcare. Can you 
describe any big data metaphors or 
symbols that resonate with you or 
your organization? Why? 
Metaphors like “data deluge”, 
the new oil,” and “data 
tsunami” all attempt to 
describe big data and highlight 
the challenges of doing so.  
(Burns, 2011) 
IQ11 Please elaborate on any points about 
big data not covered in these 
questions that make sense for you 
and add other points that are unique 
to you and your organization. 
Always end with an open-
ended question in the event I 
missed something. 
(Borins, 2012; 
Boyce & Neale, 
2006; Ryan & 
Bernard, 2003) 
Table 12. Semi-Structured Interview Questions and Rationale 
Script continued- 
This concludes the initial interview. I will follow up with next steps about the follow up 
interview. Thank you very much for taking time from you busy schedule to participate in this 
research study.  
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APPENDIX E. INTERVIEW DATA EXPLICATION SCHEME 
STEP ACTIVITY DESCRIPTION 
Step 1 Prepare the Data After transcription from audio to text, I formatted the raw 
data files into a common format (e.g., font size, margins, 
questions or interviewer comments highlighted). I printed 
and made backups of each raw data file and kept hard copies 
each interview in a single binder. 
Step 2 Close Reading (and 
Rereading) of the text. 
The raw text files were read in detail to become familiar with 
the content and gain an understanding of the categories of 
meaning or “themes” and details in the text. 
Step 3 Develop Categories 
and a Coding Scheme 
Categories and a coding scheme were derived primarily from 
the semi-structured interview data. Other data sources 
including scholarly and grey literature, study participant 
supporting materials, (e.g., books, resumes) were also 
analyzed. This study did not require a theoretical framework; 
categories were inductively generated from the interview 
data.  
Step 4 Overlapping Coding 
and Un-coded Text 
Among the commonly assumed rules that underlie qualitative 
coding, two are different from the rules typically used in 
quantitative coding: (a) segmentation of text was coded into 
more than one category and (b) a considerable amount of the 
text was not assigned to any category. 
Step 5 Code All the Text and 
Continuing Revision 
and Refinement of 
Category System 
Within each category, I searched for subunits of meaning and 
included contradictory points of view and new insights. I 
select appropriate quotes that conveyed the core theme or 
essence of a category. The categories were often combined 
and linked when the meanings are similar. 
Step 6 Draw Conclusions 
from the Coded Data 
This step involved making sense of the themes or categories 
identified, and their properties. I began making inferences 
and presented the reconstructions of categories of meaning 
derived from the data, including exploring different 
dimensions of categories, identifying relationships between 
categories,  uncovering patterns within and across healthcare 
stakeholder classes, and testing categories against the full 
range of data. 
Table 13. Coding Scheme: A General Inductive Approach 
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